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Abstract 
 
 
 
 
Direct observations of a wide variety of natural habitats have established that 99 % of microorganisms 
grow in form of biofilms, complex structured communities of microorganisms associated with surfaces 
and embedded in a self-produced extracellular polymeric substances. Biofilms are able to colonize 
every surface that offers minimal conditions for the life included all human artefact surfaces. 
Consequently, industrial installations, work benches, water distribution systems and also medical 
devices can be covered by biofilm with devastating consequences in terms of social and economic 
impact. The most detrimental property of bioﬁlms is that conventional biocidal practices often prove 
inadequate. Indeed, adopting the sessile mode of life, microorganisms improve their resistance to 
antimicrobial agents up to several orders of magnitude. In addition, increasingly restrictive regulations 
limiting the use of substances hazardous to human health and the environment, have resulted in 
several biocides being banned. In this contest the development of new improved effective solutions 
able to replace the presently dominating drug/device products is becoming imperative.  
An innovative approach could be the use of biocide-free anti-biofilm compounds with novel targets, 
unique modes of action and properties that are different from those of the currently used 
antimicrobials. Recently, the use of sub-lethal doses of bio-inspired molecules able to interfere with 
specific key steps that are needed to establish bioﬁlms have been proposed as an alternative strategy 
to prevent biofilm formation. Since this approach deprives microorganisms of their virulence 
properties without affecting their existence, the selection pressure for antibiotics and biocides 
resistance mutations decreases. In this contest, nature represents an immense source of new bioactive 
substances with unrivalled structural diversity and complexity. Recently, the natural compounds 
zosteric acid (ZA) and salicylic acid (SA) have been proposed as alternative biocide-free agents able to 
significantly reduce, at sub-lethal concentrations, both bacterial and fungal adhesion and to play a role 
in shaping biofilm architecture, in reducing biofilm biomass and thickness and in extending the 
antimicrobial agents performance.  
In this project, ZA and SA were selected as suitable anti-biofilm compounds to provide new effective 
preventive or integrative solutions against bacterial and fungal biofilm formation available for a wide 
range of applications. Specifically, the aim of the project was to develop new anti-biofilm materials by 
covalently anchoring ZA and SA to commercial available polymeric materials, allowing the anti-biofilm 
compounds to preserve the biological function upon the conjugation process and over a working 
timescale.  
The conjugation reaction was performed in such a way to orient the molecules with their active 
scaffold externally exposed on the surface so that to ease the interaction with the target 
microorganism. In this study, a detailed chemical and functional information necessary to ZA and SA 
to exert their anti-biofilm activity was obtained without affecting the active structure of the 
investigated molecules. 
In Chapter 3 a 43-member library of small molecules based on ZA scaffold diversity was designed and 
screened against Escherichia coli to identify important structural chemical determinants for ZA anti-
biofilm activity in order to select potential functional groups that could be exploited for the covalent 
linkage to an abiotic surface. The compounds were characterized by: i) the introduction of substituents 
at different positions on phenyl ring; ii) the removal of the insaturation; iii) the substitution of the 
carboxylic acid with an alcohol, an aldehyde and ester functionalities. Both E/Z isomers were also 
prepared in order to explore the role of the double bond. All the molecules were submitted to 
biological assays in order to evaluate their ability to be a carbon and energy source and to affect both 
planktonic growth and microbial adhesion at several concentrations. Structure/anti-biofilm activity 
relationship considerations revealed that the carboxylic acid moiety conjugated to the double bond in 
Abstract 
2 
 
trans configuration was an essential requirement in ZA chemical structure to guarantee a good anti-
biofilm performance. In contrast, the deletion of the sulphate ester group seemed not to compromise 
the ZA anti-biofilm activity. Moreover, the biological results revealed that the para position on the 
phenyl ring could be considered a good point for the coupling to a polymer. Indeed, p-aminocinnamic 
(p-ACA) acid bearing the same ZA active scaffold and an amino group in the para position of the phenyl 
ring was selected as suitable compound to form a covalent linkage with appropriate functional groups 
of the polymeric material. 
Besides cinnamic acid analogs, another class of derivatives related to the scaffold of salicylic acid has 
been investigated. Also in this case, the addition of an amino group in the para position of the phenyl 
ring of SA structure did not affect the molecule anti-biofilm performance. Indeed, p-aminosalicylic acid 
(p-ASA) bearing the chemical structure of salicylic acid and an amino group in the para position of the 
phenyl ring was selected to be covalently coupled to a polymeric materials.   
In Chapter 4 the molecular mechanisms and pathways by which ZA and SA affect the biofilm formation 
in E. coli were investigated. In this study, a pull-down system combined with a mass spectrometry-
based approach was successfully employed to screen the whole E. coli proteome in order to identify 
the molecular targets implicated in ZA and SA anti-biofilm responses. By successfully exploiting the 
information obtained from the previous work, p-ACA and p-ASA were chosen as suitable molecules to 
successfully immobilize ZA and SA active scaffold on a chromatography solid phase support via an 
amide bond. Mass spectrometry analysis of SDS-PAGE-resolved pull-down proteins revealed that both 
ZA and SA in E. coli directly interact with the same protein WrbA. On the basis of previous studies 
reported in the literature, we supposed a mechanism by which ZA and SA interact with WrbA 
negatively modulating its activity and leading to an enhanced production of both the cell signal indole 
and reactive oxygen species that cooperate in a complex network of events leading to the inhibition of 
biofilm formation. The blast search inside Bacteria and Fungi databases revealed that WrbA sequences 
exist in a diversity of microorganisms with a high percentage of identity, suggesting a possible 
important role of this protein in the microbial life, probably associated to the response against 
environmental stresses. Because of the presence inside other microorganisms of a protein with a 
similar sequence and activity, it can be supposed that ZA and SA interact with these proteins with a 
potential anti-biofilm effect also in these microorganisms. Only related to SA, FkpA and Tdh were also 
identified as possible molecular targets, suggesting the presence of a complex and overlapping 
regulatory network controlling quorum sensing, motility and biofilm formation. 
Based on the information provided by experiment reported in the previous chapters, in Chapter 5, ZA 
and SA were successfully covalently immobilized on low density polyethylene surface, providing new 
no-leaching bio-hybrid materials available for a wide range of applications. A specific protocol to 
expose ZA and SA active scaffold on the external surface of a polymeric material via an amide bond 
was set up, allowing the anti-biofilm compound active moieties to directly interact with bacterial cells 
and successfully exerting their function even immobilized. Firstly, oxygen plasma treatment was 
employed to activate the low density polyethylene surface. Subsequently, the graft-polymerization 
with 2-hydroxyethyl methacrylate and the immobilization of the selected bioactive molecules on the 
polymeric surface successfully provided the new materials. Attenuated total reflectance Fourier 
transform infrared spectroscopy and confocal laser scanner microscope (CSLM) analyses proved that 
the polyethylene surface was successfully functionalized with ZA and SA molecules. The anti-biofilm 
performance of the innovative materials was investigated against E. coli biofilm using the CDC reactor 
able to simulate flow conditions normally encountered in vivo. The number of adhered cells on both 
traditional and functionalized polyethylene surface was established by plate count assays. Biofilm 
grown on both treated and control material was also submitted to live/dead staining procedure and 
analyzed by epifluorescence microscope. Both plate count assays and microscope observations 
showed a 60 % percentage reduction of biofilm growth on both ZA and SA functionalized materials, 
with a mechanism that did not affect bacterial viability. CLSM analysis also revealed a dramatic impact 
of immobilized zosteric acid and salicylic acid on biofilm morphology, showing a biofilm with a 
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significantly reduced thickness and polysaccharide matrix amount. Moreover, biofilm grown on 
functionalized surfaces showed enhanced susceptibility to ampicillin and ethanol, that further reduced 
biofilm biomass up to 95 %. 
In conclusion, in this study a polyethylene surface was successfully functionalized with the antibiotic-
free natural compounds ZA and SA, providing new, improved solutions able to reduce the incidence of 
biofilm formation. In this approach, no molecules are leached from the surface, sidestepping the 
problem of the compound kinetic release, providing long term protection against bacterial 
colonization, and reducing the risk of developing resistant microbial strains, as the concentration of 
the anti-biofilm agent is constantly below the lethal level. In addition, the knowledge of ZA and SA 
structure/anti-biofilm activity relationship and molecular targets involved in their anti-biofilm activity 
open the way to new additional studies to generate more potent derivatives based on the same target 
and activity structure. 
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Introduction 
 
 
 
 
The nature of biofilms 
 
Direct observations of a wide variety of natural habitats have established that 99 % of microorganisms 
grow in form of biofilms, complex structured communities of microorganisms associated with surfaces 
and embedded in a self-produced extracellular polymeric substances (EPS). Biofilms are able to 
colonize every surface that offers minimal condition for the life, both abiotic and biotic, including 
extreme environments such as the walls of pores in glaciers, hot vents or the bottom of the ocean 
(Costerton et al., 1987). Biofilm formation also appears early in the fossil record and is common 
throughout a diverse range of organisms in both the Archaea and Bacteria domains (Hall-Stoodley et 
al., 2004).  
The ability to form biofilms is an ancient and integral characteristic of prokaryotes and probably 
biofilms are the first form of life recorded on earth, dating back 3.5 billion years, and the most 
successful one. In the context of evolution and adaptation it is likely that biofilms provided homeostasis 
in the face of the fluctuating and harsh conditions of the primitive earth. However, the protective 
conditions offered by life on surfaces and the necessity to colonize new environments might have led 
to the concurrent development of both sessile and planktonic forms (Hall-Stoodley et al., 2004). It is 
believed that planktonic cells are important for rapid proliferation and spread into new territories, 
whereas sessile populations are focused on perseverance thanks to their ability to survive in hostile 
environments (Pace et al., 2006). Anyway the inclination for bacteria to become surface bound is so 
ubiquitous in diverse ecosystems that it suggests a strong survival and/or selective advantage for 
surface dwellers over their free-floating counterparts (Dunne, 2002). When residing within a biofilm, 
microorganisms experience a certain degree of shelter and homeostasis that helps them to persist in 
the environment. One of the key component of this microniche is the surrounding EPS, a mixture of 
components such as polysaccharides, proteins, nucleic acids and lipids that form the scaffold for the 
three-dimensional architecture of the biofilm. EPS immobilize biofilm cells and keep them in close 
proximity, thus allowing for intense interactions, including cell–cell communication, and the formation 
of synergistic microconsortia, often leading to a strict mutual metabolic dependence of 
microorganisms within the biofilm (Davey et al., 2000). In particular, cell to cell communication system, 
known as quorum sensing, allows bacterial cells to communicate resulting in a cohesiveness of function 
that benefits an entire population and allows the community to operate as a living system (Smith et 
al., 2010). Moreover, since cells are maintained in close proximity to each other, horizontal gene 
transfer is facilitated promoting the genetic information exchange and maintaining a large and well-
accessible gene pool. Significantly higher rates of conjugation in bacterial biofilms compared to 
planktonic populations have been reported (Flemming, 2008). In addition, owing to the retention of 
extracellular enzymes, EPS generate a versatile external digestive system, sequestering dissolved and 
particulate nutrients from the environment and allowing them to be utilized as nutrient and energy 
sources. It is also reported that matrix increases levels of protection against environmental stresses, 
such as depleted nutrient, moisture and oxygen levels, inhospitable surrounding pH and salinity, 
excessive shear forces and UV exposure, and even metal toxicity. Additionally, life in a biofilm protects 
against attacks by a host immune system’s protective proteins and signaling molecules, phagocytes, 
antibiotics and disinfectants (Flemming et al., 2010). 
Biofilm formation is a complex dynamic process by which cells undergo a range of phenotypic switches 
over time. During some stages of biofilm development, as much as 50 % of the proteome can be 
differentially produced compared with the same cells growing in planktonic culture (Southey-Pillig et 
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al., 2005). Earlier studies in environmental and industrial microbiology have examined biofilm 
formation in various ecosystems, and concluded that bacteria form biofilms in essentially the same 
manner regardless which environment they inhabit (Costerton, 1997). In the ﬁrst step of bioﬁlm 
formation, planktonic microorganisms move into close proximity with the surface, which may have 
several physico-chemical characteristics that are important to determine the rate and the extent of 
the attachment process. The process of microbial adherence to surfaces is also largely dictated by a 
number of variables such as the species of bacteria, cell surface composition, nutrient availability, 
hydrodynamics, and global regulatory networks (Dunne, 2002). Some studies also suggest that motility 
is very important for planktonic cells initial contacts with a surface since flagella-mediated motility can 
bring the cell within close proximity of the surface to overcome repulsive forces between bacterium 
and the surface (Pratt et al., 1998). This initial attachment is reversible and is generally mediated by 
non-specific interactions such as electrostatic, hydrophobic, or van der Waals forces. When the loosely 
bound microorganisms consolidate the adhesion process by producing exopolymers and adhesins that 
complex with surface materials, adhesion to the surface becomes irreversible and microorganisms can 
not dislodged by gentle rinsing (Dunne, 2002). Once bacteria have irreversibly attached to a surface, 
bacterial cells undergo phenotypic changes, and the process of bioﬁlm maturation begins. 
Microorganisms grow and multiply, start to form microcolonies, produce extracellular polymers and 
communicate via quorum sensing signals. The results is an intricate structure composed by discrete 
matrix-enclosed communities of microbial cells that may include one or of many species (Davey et al., 
2000). Depending on the species involved, the biofilm may be composed of 10-25 % cells and 75-90 % 
matrix, and the matrix material often appears to be most dense in the area closest to the core of the 
biofilm (Costerton, 1999; Flemming et al., 2010). Mature biofilms display discrete temporal and spatial 
structure because of differences in local conditions such as nutrient availability, pH, oxidizing potential, 
and so on. For example, cells near the surface of the biofilm are exposed to higher concentrations of 
oxygen, while near the center oxygen is rapidly depleted to near anaerobic levels. The steep oxygen 
gradients are paralleled by gradients for either nutrients or metabolites from the biofilm, which creates 
a heterogenic environment. In adapting to these local environmental conditions microorganisms 
within a biofilm display many genotypes and phenotypes with broad metabolic and replicative 
heterogeneity, providing the community as a whole with enormous capability to resist stresses 
(Steward, 2008). Finally, individual microcolonies from the mature biofilm may detach from the 
surface, reenter the planktonic state, translocate to a new location and may reattach to new areas, 
initiating a new cycle of biofilm formation. Therefore, biofilm formation may be cyclical in nature. 
Nutrient starvation, overexpression of alginate lyase, loss of EPS, and quorum sensing may be involved 
in the control of biofilm detachment. Mechanisms of bioﬁlm dispersal can be dictated by survival for 
escaping unfavorable habitats aiding in the development of new niches or may be initiated by the 
bacteria themselves without any obvious perturbation (Stoodley et al., 2002; Pace et al., 2006). 
 
 
 
The deleterious impact of biofilms on human world 
 
The study of biofilms has skyrocketed in the past 20 years due to increased awareness of their 
pervasive effect on human life with devastating social and economic implication. On a global scale, 
biofilm-related costs incur billions of dollars to the agricultural, engineering, and medical sectors of the 
economy (Plyuta et al., 2013).  
Especially in the clinical sector, biofilms create relevant problems. The correlation between biofilms 
and infectious disease is a connection that is becoming well documented in the medical community, 
and the National Institutes of Health in the USA estimates that 80 % of all bacterial infections occurring 
in the human body are biofilm related. An estimated 17 million new biofilm infections arise each year 
in the USA, which result in up to 550,000 fatalities annually (Davies, 2003). Biofilm infections are rarely 
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resolved by the host's immune system. Biofilm bacteria release antigens and stimulate the production 
of antibodies, yet bacteria residing in biofilms are resistant to these defence mechanisms (Davey et al., 
2000). The role of biofilms in the contamination of medical implants has also been well established in 
the clinical area. Every day implantable medical devices such as prosthetic heart valves, cardiac 
pacemakers, total joint replacements, renal dialysis, ventricular shunts and various types of catheters 
are applied in almost all fields of medicine for managing critically ill patients (von Eiff et al., 2005; Hall-
Stoodley et al., 2004). Unluckily, these implants become potential surface for biofilm formation causing 
devastating medical complications such as life-threatening systemic infections and malfunctions that 
in most of cases may require device removal (von Eiff et al., 2005). These drastic interventions bear 
obvious implications in term of patient morbidity, mortality, prolonged hospitalization and increased 
healthcare costs (Darouiche, 2007). It has been estimated that catheter-associated urinary tract 
infections are the most common source of hospital-acquired infections accounting for approximately 
40 % of all nosocomial infections worldwide, with approximately 900,000 cases in the United States 
alone annually and cost that ranges from 296 million to 2.3 billion dollars each year (Jhonson et al., 
2006; Lo et al., 2014). 
The detrimental effects of biofilm, can be also felt across numerous industries causing a particular 
costly problem in nearly every industrial water-based process, including water treatment and 
distribution, food processing, utilities and marine-based industries. The result is the loss of billions of 
dollars each year related to the decrease in industrial productivity as well as to the industrial system 
physical deterioration such as pipe plugging and corrosion (Stowe et al., 2011). In particular, bioﬁlms 
formed in food-processing environments are of special importance as they have the potential to act as 
a persistent source of microbial contamination that may lead to threaten the microbiological quality 
and safety of food products resulting in food-borne disease (Cappitelli et al., 2014). It has been 
estimated that in the USA, foodborne illness causes 9000 human deaths and affects 6-80 million people 
every year (Rayner et al., 2004). In addition, the presence of detrimental bacteria on food processing 
surfaces shortens the time between cleaning, reduces heat transfer efﬁcacy or even equipment 
obstruction, produces metal corrosion in pipelines and tanks resulting at least in metal loss and food 
contamination with consequently economic losses (Van Houdt et al., 2010; Cappitelli et al., 2014). 
Biofilms are the predominant mode of microbial growth in drinking water networks and high purity 
water production and distribution systems (Farkas et al., 2013). Flemming and colleagues (2002) 
estimated that approximately 95 % of bacterial cells are attached to pipe walls as biofilm communities 
while less than 5 % are found in the water phase. Detrimental effects may occur, including microbially 
induced corrosion, disinfectant depletion, aesthetic problems i.e. colour, odour and taste degradation 
and microbiological deterioration of drinking water (Farkas et al., 2013; Polo et al., 2014). Bioﬁlms are 
also ubiquitous in the marine world. The surfaces of ship hulls or underwater pipelines are rapidly 
conquered by bioﬁlms of bacteria and fungi which mediate subsequent attachment and growth of 
mussels, polychaete worms, or barnacles. These bioﬁlms contribute to early corrosion and higher fuel 
consumption during displacement due to increased hydrodynamic drag (Garcia-Fernandez et al., 
2009).  
Biofilm are found on almost every household surfaces, including toilets, sinks, countertops, and cutting 
boards in the kitchen and bath as well as air-conditioning and heating system surfaces. Also high-
surface areas and repeated exposure to moisture and nutrients make kitchen surfaces ideal habitats 
for the concentration, growth and potential spread of bacterial biofilm. Raloff (1996) reported that the 
majority of 75 dishrags and 325 sponges harbored Escherichia coli, Salmonella spp., Pseudomonas spp. 
and Staphylococcus spp. In another study involving 213 houses, 47.4 % tested positive for Listeria 
monocytogenes, with dishcloths and various other utensils and structural surfaces being the most 
highly contaminated items (Beumer et al., 1996). Poor disinfection practices and ineffective cleaning 
products may increase the incidence of illnesses associated with pathogenic organisms in the 
household environment as well as the deterioration of air quality (Rayner et al., 2004). 
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Unexpectedly biofilm also affect stone surface of stone buildings and monuments, both historic and 
modern (Crispim et al., 2003). As a consequence of complex interactions within microbial community 
and its substrate biodeterioration processes occur. Microrganisms may act by extracting nutrients 
from the substrate, by active penetration below the surface or by production of acid metabolites, 
siderophores, chelating materials and osmolytes that degrade minerals. The consequences are 
aesthetic and structural damages of stone and the decay of the buildings and monument in the long 
term period (Young et al., 2008).  
It is estimated that more than 10,000 species of bacteria and fungi develop complex biofilm on plant 
surfaces causing diseases that damage plants and plants products. The kind and amount of losses 
caused by plant disease vary with plant or plant product, pathogen, locality, environmental, etc. and 
may range from slight to 100 % loss.  The financial losses and social consequences are inevitable 
especially for countries who depend on their own plant produce for their existence (Agrios, 2012). For 
example Xanthomonas oryzae pv oryzae causes one of the most important disease of rice in many 
parts of the worlds and is very destructive in Japan, India and other parts of Asia. As more than 50 % 
of world population relies on rice for basic nutrition, it is clear that damage of rice production poses 
significant economic and social risk (Khoshkdaman et al., 2012).  
However, it is very important to point out that biofilms are an integral part of the natural environment 
and can also serve very beneficial purposes, such as in the treatment of drinking water, wastewater 
and detoxification of hazardous waste (Ashraf et al., 2001; Farkas et al., 2013). 
 
 
 
Anti-biofilm traditional strategies: biocides and antibiotics 
 
For decades, abatement of biofilm growth has commonly been achieved by applying biocides and 
antibiotics to surfaces or by incorporating them into synthetic polymer-based products. In particular, 
the coating of device surfaces with one or two antimicrobial substances or the entrapping of these 
agents within the device material are the approaches most often used to obtain devices with different 
antimicrobial spectra and duration. Materials containing antibiotics and disinfectants are in part 
commercially available and already used in clinical applications (Francolini et al., 2010).  
However, despite considerable efforts, the past 30 years have yielded little beneﬁt from this practice 
or available products and reviews are not unanimous about their beneﬁt (Jhonson et al., 2006; 
Nowatzky et al., 2012). In the recent years, the inherent resistance and/or tolerance of sessile 
microorganisms to antimicrobial has been found to be a general phenomenon. Sessile bacteria can be 
up to 1,000-fold more resistant to antibiotics and biocides treatment in comparison to planktonic 
bacteria of the same strain, depending on the species-drug combination. For example, a β-lactamase-
negative strain of Klebsiella pneumoniae had a minimum inhibitory concentration of 2 µg/mL ampicillin 
in aqueous suspension. The same strain, when grown as a biofilm, was scarcely affected (66 % survival) 
by 4 h treatment with 5000 µg/mL ampicillin, a dose that eradicated free-floating bacteria (Anderl et 
al., 2000). Paradoxically, once dispersed from the biofilm, those bacterial cells typically revert to an 
antibiotic susceptible form which suggests that resistance of bacteria in biofilms is not acquired via 
mutations or mobile genetic elements (Davey et al., 2000; Pace et al., 2006). On the contrary the 
restricted susceptibility of biofilms to antimicrobials depends on the characteristics of the biofilm 
organisms as well as the antimicrobial agent and the environment (Harrison et al., 2007).  
The presence of a diffusion barrier provided by the EPS has a potential to reduce the penetration of 
antibiotics or biocides either by physically slowing their diffusion or chemically reacting with them. 
Local accumulation of metabolic products may also lead to condition which can directly antagonise the 
action of an antimicrobial agent. For example EPS acts as an ion exchanger, and sequesters hydrophilic 
and positively charged molecules as in the case of the antibiotic category of aminoglycosides (Pace et 
al., 2006). In Pseudomonas aeruginosa biofilms, both tobramycin and gentamicin (aminoglycosides) 
Chapter 1 
 
9 
 
penetrate more slowly due to interaction with extracellular polymers such as alginate (Nichols et al., 
1988). β-lactamase is believed to accumulate in the bioﬁlm matrix as a result of secretion or cell lysis, 
deactivating β-lactam antibiotics in the surface layers more rapidly than they diffuse into the bioﬁlm 
(Anderl et al., 2003). Similarly secreted catalase protects aggregated bacteria by preventing full 
penetration of hydrogen peroxide into the bioﬁlm (Stewart et al., 2000). In addition tolerance could 
be related to restricted penetration into individual bacteria. A recent study identiﬁed a mutant of P. 
aeruginosa that expressed classical bioﬁlm architecture, but remained fully susceptible to the three 
antibiotic classes tested. Because the mutant lacked periplasmic glucans, which were shown to bind 
tobramycin, tolerance in wild-type bioﬁlms was attributed to the sequestration of antimicrobial agents 
in the periplasm (Mah et al., 2003; Van Bambeke et al., 2003).  
The slow growth rates of biofilm communities have also been posited as a factor in increased biofilm 
resistance to eradication (Pace et al., 2006). Within a biofilm, there exists a heterogeneous population 
of cells which differ in growth rates dependent upon the area in which are located. Bacterial cells 
embedded deep within the biofilm matrix grow more slowly due to lack of nutrients and oxygen. Cells 
with reduced metabolic activity are also inherently more recalcitrant to antimicrobial therapies as 
almost all antibiotics target biosynthetic processes occurring in actively growing bacteria such as the 
biosynthesis of proteins, RNA, DNA, peptidoglycan and folic acid. Therefore most antibiotics that are 
capable of killing growing and dividing bacterial cells tend to be very inefficient at killing non-
multiplying bacteria (Hurdle et al., 2011). This, coupled with the differential penetration distances into 
a biofilm that antimicrobials display, explains how some drugs fail to completely eradicate biofilm 
bacteria (Worthington et al., 2012). In particular a top-to-bottom gradient of decreasing antibiotic 
susceptibility is reported. This gradient originates in the surface layers of bioﬁlms where there is almost 
complete consumption of oxygen and glucose, leading to anaerobic nutrition-depleted niches with 
restricted metabolic activity in their depths (Fux et al., 2005). Transmission electron microscopy 
revealed that sessile bacteria were affected by ampicillin near the periphery of the biofilm but were 
not affected in the interior, where bacterial cells probably grew slowly or entered in a stationary-phase 
state due to the limitation for nutrients and oxygen (Pace et al., 2006). 
Genetic studies also indicated that sessile cells are more tolerant to antimicrobial agents since express 
certain resistance genes that protect biofilms from the killing effect of the antimicrobial agent. Bacteria 
may acquire antibiotic/biocide resistance through either horizontal gene transfer (such as genes 
encoded on plasmid, transposon, or integron) or through mutation in different chromosomal loci. 
Hausner and collaborators (1999) demonstrated that conjugation processes in biofilms were 1,000-
fold higher than those determined by conventional plating techniques, indicating that gene transfer 
occurs far more frequently in biofilms than planktonic cell. In addition it is reported that 
microorganisms in a biofilm state mutate at higher rates to evolve resistance and alleviate the 
particular stress on the community (Blazquez, 2003). Approximately 20 % of Psuedomonas isolates 
from the lungs of cystic fibrosis patients display this phenomenon, making the task of treatment even 
more challenging (Oliver et al., 2000). Antibiotic resistance is becoming one of the most pressing 
clinical problems in modern medicine. The intensive use of antibiotics has dramatically increased the 
frequency of resistance among human pathogens reducing the possibility of treating infections 
effectively and increases the risk of complications and of a fatal outcome. New antibiotics and new 
therapeutic strategies are requested by healthcare sector to address this challenge. However, one of 
the major problems facing the antibiotic-drug discovery sector is the difficulty in identifying new drug-
like compounds with suitable antibacterial activity (Wright et al., 2007; Cegelski et al., 2008).  
Biofilms may also escape the effects of antibiotics without undergoing genetic mutation for the 
presence of a persistence subpopulation of microorganisms in highly protected phenotypic state 
similar to spore called persisters (Stewart et al., 2001). These persister cells arise due to a state of 
dormancy in which cells are metabolically inactive. As a consequence, persisters are less sensitive to 
antibiotics because the cells are not undergoing cellular activities that antibiotics can corrupt, which 
results in tolerance (i.e., no growth and slow death). Persister cells in bioﬁlms appear to be responsible 
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for the recalcitrance of chronic infections since they are responsible for biofilm regrowth when the 
level of treatment drops (Wood et al., 2013). 
Another problem concerning the use of antimicrobial agents is that the majority of them do not appear 
to have been tested against biofilm organisms, largely due to inherent technical difficulties and the 
lack of a suitable consensus method. Although one standardized biofilm method has been accepted by 
the American Society for Testing and Materials (ASTM E2196-12), there are no such methods that have 
been approved or endorsed by the regulatory agencies (EMPA technology report, 2013).  
Considerations regarding the use of biocides should also take into account that chemical treatments 
to prevent biological damage often involve considerable amounts of potentially dangerous substances. 
Sooner or later biocides and antibiotics are released into the environment and, as they are not 
generally specifically targeted against deteriorating microorganisms, they are potentially dangerous 
for human health and the environment (Young et al., 2008; Shultz et al., 2011). Especially many of 
them are persistent in the environment since they do not break down into safer constituent parts but 
rather remain intact over prolonged periods of time (Sousa et al., 2014). For example, tetracycline 
antibiotics are one of the primarily antibiotics groups used for veterinary purposes, for human therapy 
and for agricultural purposes. Due to their extensive usage, most of the actual evidence suggests that 
they are omnipresent compounds found in different ecological compartments. In particular, their 
highly hydrophilic character and low volatility have resulted in signiﬁcant persistence in the aquatic 
environment exhibiting serious environmental problems including ecological risks and human health 
damages. Antibiotics residues promote the development of antibiotic resistant microorganisms, which 
can induce adverse effect to human health by increasing the risk of certain infections. In addition, the 
occurrence of tetracycline antibiotics in the environment inhibits the growth of some terrestrial and 
aquatic species (Daghrir et al., 2013). Similarly over the past 40 years the biocidal organotin 
compounds tributyltin (TBT) have been intensively used for the protection of ship hulls and for this 
reason have been largely released into waters. This led to deleterious effects onto non-target aquatic 
organisms, such as abnormal growth, reproductive failure, sterility and premature death of various 
marine species at concentrations even below 1 ng/L (Xu et al., 2005a). Moreover, each year a large 
proportion of crop is lost due to plant pathogens and in order to maintain the productivity, more and 
more chemicals are being added in the natural environment (Oerke, 2006). These chemical pesticides 
enter the food chain resulting in serious harmful effects on human health. According to a survey made 
by the World Health Organization more than 50,000 people in developing countries are annually 
poisoned and 5000 die as result of the effect of toxic agents used in agriculture (Patel et al., 2013). 
Recently the risk to human and animal health and their environmental impact have increasingly 
discouraged biocide use. This is readily seen in the number of recent policies, directives, technical 
reports, strategies, recommendations and regulatory decisions designed to reduce antimicrobial 
agents consumption, ensuring the prudent use of these fragile strategies, and protect speciﬁc agents 
that are critically important for human and animal health and wellbeing (Directive 98/8/EC; 
Recommendation 2002/77/EC; SCENIHR report 2009; EFSA Summary Report 2012). In particular the 
European Community Directive 98/8/EC of the European Parliament concerns the authorization for 
the marketing of biocidal products within the member states and, at the European Community level, 
establishes a list of approved active substances that may be used in biocidal formulations and banned 
such compounds that posed severe environmental and human risks, i.e. TBT-based compounds are 
completely banned. Approximately 18 compounds are currently used as antifouling booster biocides 
worldwide as alternatives to metal-based and TBT compounds. However, even the approved biocides, 
such as chlorothalonil, Irgarol 1051, and Sea-nine 211, pose the danger of causing a nonselective 
toxicity. For instance, the mode of action of Irgarol 1051 is based on the inhibition of photosynthetic 
electron transport in chloroplasts that can occur at concentrations < 1 mg/L, many times more the 
lowest EC50  values reported for algae and crustaceans (Xu et al., 2005b). 
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Innovative eco-friendly strategies for controlling biofilm formation 
 
The numerous problems coming from the use of conventional approaches have directed the scientific 
community to develop alternative more effective strategies that are perceived as safe by the public 
and pose negligible risk to human health and the environment. An innovative approach could be the 
use of biocide-free anti-biofilm compounds with novel targets, unique modes of action and properties 
that are different from those of the currently used antimicrobials. Recently the use of sub-lethal dose 
of bio-inspired molecules able to interfere with specific key steps that are needed to establish bioﬁlms 
has been proposed as alternative strategy to control biofilm formation (Villa et al., 2009; Villa et al., 
2010; Villa et al., 2012; Villa et al., 2013). Since this approach deprives microorganisms of their 
virulence properties without affecting their existence, the selection pressure for antibiotics and 
biocides resistant mutations decrease, posing promising perspective to restore the efficacy of 
traditional antimicrobial agents (Rasko et al., 2010). According to the biofilm formation process, 
different key steps are considered promising targets for developing innovative anti-biofilm products. 
The interaction with the surface sensing process keeps pioneering cells in a planktonic form limiting 
the adhesion of microorganisms to the surfaces. Cell-to-cell communication has also emerged a good 
point of attack since it is responsible of important mechanisms for controlling the development of 
highly structured and cooperative biofilm consortia. Such communication among Gram-negative 
bacteria involves N-acyl homoserine lactones, small secreted molecules that can be self-recognized in 
dose-dependent manner, and a complex set of transcription factors of quorum sensing-controlled 
genes (Karatan et al., 2009). The interference with these cell-to-cell communication processes 
inevitably results in biofilm matrix damages with destabilization of the biofilm physical integrity. 
Finally, detachment promotion of established biofilm have been presented as a further suitable 
mechanism to control biofilm formation (Cappitelli et al., 2011; Villa et al., 2013). 
In this context nature represents an immense source of new potential bioactive substances with 
unrivalled structural diversity and complexity (Wong et al., 2008). Plants and animals have adaptively 
developed fascinating and sophisticated strategies over millions of years to prevent harmful bacterial 
colonization on their living tissues in response to an ever-present pathogen pressure. In particular both 
aquatic and terrestrial plants offer very interesting classes of biologically active, low-molecular-mass 
(<5 kDa) compounds, like alkaloids, terpenoids, ﬂavonoids and coumarins, peptides, glycosides, 
nucleosides and polyphenols (Villa et al., 2013). Several studies on marine plants suggested that in 
most of the cases these compounds manipulate the expression of specific phenotypes that represent 
different stages of biofilm process rather than killing microorganism (Harder, 2008). The mime of these 
natural strategies is a promising starting point for novel improved effective anti-biofilm solution able 
to replace the presently dominating drug products (García-Fernández et al., 2013).  
Several studies were carried out to explore the anti-biofilm performance of a multitude of compounds 
coming from nature. For example the extract from the root of Rubus ulmifolius was proved to inhibit 
Staphilococcus aureus biofilm formation interfering with cells surface adhesion without limiting 
bacterial growth (Quave et al., 2012). Differently furanones produced by the marine macroalga Delisea 
pulchra were demonstrated to perturb bioﬁlm processes interfering with bacterial cell-to-cell 
communication without aﬀecting the growth rate (Wu et al., 2004). Similarly a number of ﬂavonoids 
found in citrus species were proved to be antagonists of N-acyl homoserine lactones and autoinducer-
2-mediated cell–cell signaling affecting bioﬁlm formation by Vibrio harveyi and E. coli (Vikram et al., 
2010). The methanolic extract obtained from Cuminum cyminum was also shown to act as quorum-
sensing inhibitor, interfering with the N-acyl homoserine lactone activity and inhibiting the swimming 
and swarming motility, the production of the extracellular polymeric substances and the bioﬁlm 
formation in several bacterial pathogens (Issac Abraham et al., 2012). Finally the efﬁcacy of sub-lethal 
concentrations of Muscari comosum bulb extract in modulating the extracellular signal responsible for 
bioﬁlm dispersion was reported (Villa et al., 2012). Villa and collaborators (2013) highlighted that in 
most of the cases the response depicted by the surface in the presence of these natural compounds is 
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not dose molecule dependent but explain a non-linear pattern with a parabola-like shape proﬁle. This 
profile resembles a hormetic property, an adaptive situation in which the response to an 
environmental stressor varies with the level of exposure (Calabrese et al., 2002). 
 
 
 
New experimental approaches to identify promising natural anti-biofilm 
molecules 
 
Recently, the scarcity of information about the molecular scaffolds that inhibit/disperse bacterial 
biofilms, has addressed the scientific community toward new experimental approaches consisting in 
high throughput screenings in which a thousand of molecules can be rapidly analyzed and identified 
as active compounds (Whortington et al., 2012; Khan et al., 2014). One of the first reports detailing 
the screening of a large library of compounds with the objective of identifying novel small molecules 
that possessed anti-biofilm activity was written by Schachter and co-authors (2003) who developed a 
high-throughput strategy for extracting, purifying and characterizing a library of more than 150,000 
natural compounds coming from plants. In 2005, Ren and collaborators (2005) screened 13,000 
compounds from 176 plant families and identified ursolic acid (3β-hydroxy-urs-12-en-28-oic acid) from 
the tree Diospyros dendo as a new bioﬁlm inhibitor. Ursolic acid was demonstrated to be completely 
non-toxic towards E. coli, P. aeruginosa, V. harveyi, and successfully inhibited the formation of these 
bacterial bioﬁlms. Transcriptome analyses on E. coli treated with ursolic acid suggested that this plant-
derived compound may function as a signal that induces cells to remain too motile hindering cell 
adhesion or destabilizing already formed bioﬁlm (Ren et al., 2005). Junker and co-author (2007) 
reported a high throughput screening to identify novel small molecules able to inhibit and disperse P. 
aeruginosa biofilm developing a new luminescence-based assay. A total of 66,095 molecules derived 
from libraries containing known bioactive compounds, natural products, and commercially available 
entities were screened for their anti-biofilm performance at concentration not affecting bacterial 
growth. Of the compounds analyzed, 61 (0.09 %) were shown to possess notable activities in bacterial 
anti-attachment assays. This screening led to the discovery of a novel benzimidazole able to inhibit 
biofilm formation by the pathogenic bacteria P. aeruginosa, K. pneumoniae, Erwinia amylovora, and 
Shigella, methicillin-resistant S. aureus and S. aureus Newman without affecting bacterial growth 
(Sambanthamoorthy et al., 2011). Panmanee and colleagues (2013) proposed a high-throughput 
screening of 42,865 compounds to identify compounds that inhibit formation of Staphylococcus 
epidermidis biofilms and found 16 able to act as anti-biofilm compounds at sub-lethal dose. Examples 
of other libraries also included the screening of 80 known eukaryotic protein kinase inhibitors with 
ATP-like scaffolds against E. coli biofilm formation by Wenderska and co-authors (2011), the analysis 
of 8000 for their ability to inhibit motility in Vibrio cholera by Rasmussen and colleagues (2011), the 
test of 312 marine-derived extracts for both biofilm inhibition and dispersal by Navarro and co-workers 
(2014). 
All these studies allowed to isolate several natural or analogues of natural anti-biofilm compounds 
with a diverse array of chemical structures and biological activities. A number of natural products that 
possess the ability to inhibit or disperse bacterial biofilms have been used as the starting points for 
medicinal chemistry programs in which synthetic manipulation of the natural product scaffold has 
allowed for the design of more efficacious compounds (Worthington et al., 2012). A structure-based 
virtual screen for the identification of putative quorum-sensing inhibitors was carried out using a 
focused database comprising compounds that process structural similarities to known quorum-sensing 
inhibitors furanone 30, patulin, the P. aeruginosa LasR natural ligand and known a quorum sensing 
receptor. This screening led to the discovery of three compounds, which were all recognized drugs, 
namely salicilyc acid, nifuroxazide and chlorzoxazone, which were subsequently prove to inhibit 
quorum-sensing regulated gene expression at sub-lethal concentration (Yang et al., 2009). 
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Computer-aided drug design techniques have also been employed in the search for new biofilm 
modulators. One such study involved the investigation of 51 active compounds derived from 
traditional Chinese medicines which antibacterial properties had been previously documented. By 
virtually determining if any of the target compounds exhibited similar docking characteristics in a 3-D 
environment to a known inhibitor of the Agrobacterium tumefaciens quorum sensing transcriptional 
regulator protein TraR, the authors hypothesized that hits in the virtual screening would translate into 
compounds that would also display anti-biofilm activity against P. aeruginosa. Five compounds that 
performed well in the virtual screens were effectively able to inhibit biofilm development and 
completely disperse P. aeruginosa biofilms with no noticeable effect on bacterial growth (Zeng et al., 
2008). 
 
 
 
Zosteric acid a new promising anti-biofilm compound coming from seagrass 
 
Zosteric acid or p-(sulphooxy)cinnamic acid, a secondary metabolite from the seagrass Zostera marina, 
was proved to be a powerful anti-biofilm compound against both bacteria and fungi with a species-
specific activity. Xu and collaborators (2005a) observed a significant reduction (92.5 %) in marine 
bacterial bioﬁlm coverage with 500 mg/L of zosteric acid while Stanley and colleagues (2002) reported 
that with 1000 mg/L of zosteric acid the fungal adhesion of Colletotricum lindemuthianum and 
Magnaporthe grisea on both abiotic and plant leaves surfaces was reduced by 40 %. Similarly Villa and 
coauthors (2010) demonstrated that 500 mg/L of zosteric acid decreased E. coli and Bacillus cereus 
cells adhesion more than 90 % whereas they reported that the zosteric acid eﬀective concentration 
for Aspergillus niger and Penicillium citrinum was 1000 mg/L with a biofilm maximum reduction of 57%. 
Villa and collaborators (2011) also showed that 10 mg/L zosteric acid reduced Candida albicans 
adhesion by at least 70 % leading cells to the inability of forming filamentous structures. More recently 
Polo and colleagues (2014) proved that 200 mg/L of zosteric acid caused a reduction of 80 % P. 
aeruginosa biofilm coverage. Cryosectioning of different biofilms combined with microscopy 
observations also revealed a significant impact of zosteric acid on thickness and morphology of both 
bacterial and fungal biofilm (Villa et al., 2010; Villa et al., 2011, Polo et al., 2014). In addition, zosteric 
acid was reported to enhance the sensitivity to different antimicrobial agents such as chlorhexidine, 
chlorine, hydrogen peroxide, and cis-2-decenoic acid (Villa et al., 2011). 
In order to study the zosteric acid mechanism of action whole cell proteome of E. coli without and with 
sublethal concentrations of zosteric acid has been studied. Proteomic analysis revealed that proteins 
with altered expression level in response to the anti-biofilm compound were involved in stress, 
motility, quorum-sensing and metabolism/biosynthesis mechanisms. Zosteric acid was also proved to 
increase the autoinducer-2 concentration, the reactive oxygen species, the tryptophanase and the 
indole synthesis. In addition, Villa and coauthors (2010) reported that zosteric acid is not a 
chemorepellent but it stimulates individual E. coli cell movement by increasing flagellin production, 
causing the bacteria to wander across the surface instead of adhering firmly and developing biofilm. 
Indeed it was supposed that zosteric acid acts as an environmental cue leading to global stress on 
bacterial cells, which favors the expression of various proteins necessary to escape from adverse 
conditions (Villa et al., 2012). Zosteric acid chemical structure is characterized by a sulfate ester group 
at one end and a conjugate carboxylic group on the other side. Stanley and colleagues (2002) 
hypothesized that the basis of the anti-biofilm effect lies in the high affinity for water shown by its 
sulfate group that increase the hydrophilicity of cell surface. However, a recent study demonstrated 
that the antifouling agent did not affect cell surface wettability and highlighted the role of the 
carboxylic group as the active moiety of the molecule since the methyl ester derivate of zosteric acid 
showed no anti-biofilm activity (Villa et al., 2011). 
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The potentiality of this molecule as a suitable anti-biofilm compound to replace the biocide-based anti-
biofilm traditional strategies also resides in its very low toxicity towards the organisms and the 
environment. Xu and coauthors (2005b) evaluated a low toxicity of zosteric acid to P. putida and 
aquatic bacteria using the Microtox assay and static toxicity assessment. Moreover zosteric acid 
showed no measurable LD50 for larval ﬁsh with an acute toxicity proﬁle similar to table sugar and had 
a half-life of a few days in seawater (Flemming, 2005). Using in vitro experiments with suitable primary 
cell based models, Villa and collaborators (2011) demonstrated that 10 mg/L of zosteric acid did not 
compromise the cellular activity, adhesion, proliferation or morphology of either the murine fibroblast 
line L929 or the human osteosarcoma line MG-63. Ecotoxicological tests also did not highlight direct 
toxicity effects toward the crustacean Daphnia magna (Polo et al., 2014). With the goal of determining 
the general features of its behavior in the environment, Polo and coauthors (2014) also obtained 
different chemical and physical properties of zosteric acid suggesting a low bioaccumulation potential 
and the water compartment as its main environmental recipient.  
In the past, zosteric acid was isolated from Zostera marina through extraction with methanol 
(Zimmerman 1995, US Patent 5384176). However, more recently Villa and coauthors (2010) proposed 
a new non-patented process, providing the required amount for a scale-up application and avoiding 
the costly and time consuming extraction from a natural source. 
 
 
 
Salicylic acid a suitable compound for new anti-biofilm strategies 
 
Salicylic acid (salicylate) is a plant-produced phenolic phytohormone, isolated from a wide range of 
plants and fruits and known to play an important role in several plant physiological processes, such as 
the induction of plant defense responses against pathogen attack (Hara et al., 2012). For over 4000 
years it has been used for the treatment of diseases becoming the most widely used drug in the world 
with a long list of medical purposes included both systemic and topical uses (Damman, 2013).  
Recently, salicylic acid has been observed to be another promising compound suitable for alternative 
and innovative anti-biofilm strategies to replace the traditional less-effective biocides. Several studies 
demonstrated that salicylic acid at a concentration that does not affect microbial viability is able to 
counteract biofilm formation against a wide range of bacteria and fungi. Faber and colleagues (1993) 
reported that salicylic acid inhibited P. aeruginosa, Enterobacter aerogenes, K. pneumoniae, E. faecalis, 
and C. albicans cells adhesion on catheter surfaces with a reduction of biofilm formation over 90 % in 
the case of Enterobacter and Pseudomonas. In addition, Faber and co-workers (1995) demonstrated a 
satisfactory dose-related inhibition of S. epidermidis and P. aeruginosa biofilm formation on plastic 
contact lens, lens cases and commonly used medical polymers such as polyethylene and polystyrene 
surfaces treated with sodium salicylate. Muller and collaborators (1998) reported that S. epidermidis 
bioﬁlm decreased up to 55 % in the presence of 5 mM (691 mg/mL) salicylic acid while Teichberg and 
collaborators (1993) using electron microscopy analysis demonstrated a dramatic impact of salicylic 
acid on S. epidermidis biofilm. Prithiviraj and co-workers (2005) also showed that when salicylic acid 
was added into the culture medium at physiologically relevant concentrations (0.1 to 1 mM) the ability 
of P. aeruginosa to form bioﬁlm was diminished in a concentration-dependent manner. More recently, 
Abd El Aziz and co-workers (2012) found that salicylic acid inhibited P. aeruginosa bioﬁlm production 
up to 68 % at the range of concentration 10-100 µg/mL and eradicated a pre-formed bioﬁlm up to 64% 
in concentrations below 100 µg/mL acting in a dose dependent manner and with no or little effect on 
the bacterial viability. In addition these researchers reported that salicylate salt increase the 
therapeutic efficacy of traditional antibiotic against cells adhesion and subsequent biofilm formation. 
When salicylate was added to the antibiotic ciproﬂoxacin/N-acetylcysteine combination, the bioﬁlm 
was reduced up to 99 %. Similarly, El-Banna and colleagues (2012) reported that salicylate at both 
concentration 10 µg/mL and 100 µg/mL inhibited biofilm production on catheter segments of E. coli, 
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K. pneumonia, Proteus mirabilis and P. aeruginosa up to 68 %, and disrupted pre-formed biofilms by 
up to 62 % depending on microorganism and salicylate concentration. In addition salicylate (100 
µg/mL) in combination with gentamicin and amikacin showed a better dose-dependent inhibitory 
effect on biofilm production (up to 79 %) and an improved disruptive effect on the pre-formed biofilms 
(up to 78 %). The effect of salicylate combination with antimicrobials was also reported by Polonio and 
co-workers (2001). These researchers proved that the combination of salicylate (5 mM) with 
vancomycin 1 µg /mL inhibited biofilm formation of S. epidermidis by ≥99.9 % and when biofilm-coated 
polystyrene beads were exposed to 5 mM sodium salicylate and 4 µg/mL vancomycin there was a >99.9 
% reduction in viable count. Sub-inhibitory concentrations of salicylic acid were also demonstrated to 
successfully attenuate biofilm formation by different plant pathogens such as P. syringae pv syringae, 
Pectobacterium carotovorum and A. tumefaciens (Logonenko et al., 2013; Plyuta et al., 2013). The 
performance of salicylic acid on a multi-species biofilm was also evaluated. Dowd and co-authors 
(2009) set up an vitro multi-species chronic wound biofilm model using P. aeruginosa, E. faecalis and 
S. aureus as model microorganisms and they found that salicylic acid at 10 mM and 20 mM differently 
targeted the three microorganisms with a major impact on S. aureus strain.  
Beside these promising studies, the mechanism by which salicylic acid performs its anti-biofilm activity 
remains to be elucidated. It was hypothesized that salicylic acid interferes with bacterial quorum 
sensing signals involved in biofilm formation. Yang and colleagues (2009) experimentally showed the 
ability of salicylic acid to suppress the expression of genes associated with the las/rhl quorum sensing 
N-acyl homoserine lactone-based signaling system in P. aeruginosa. Similarly, Bandara and co-authors 
(2006) reported that salicylic acid reduced the production of N-acyl homoserine lactone signals and 
the expression of some virulence factors. Langonenko and co-authors (2013) also showed that salicylic 
acid affect P. aeruginosa biofilm production inhibiting the activity of LuxR-like regulator involved in 
cells-to-cells communication system and decreasing swimming motility. On the contrary Da and 
colleagues (2010) asserted that the quorum-sensing disruption is not the predominant mechanism of 
action since they proved that P. aeruginosa mutant lacking for the lasR gene, involved in the quorum-
sensing system and an hypothetical salicylic acid target, exhibited an unexpected decreasing biofilm 
formation profile similar to the wild type strain after salicylic acid treatment, suggesting that the 
inhibitory effect of salicylic acid depends on more than just quorum-sensing disruption, which appears 
to play only a relatively small role in the cellular response. In addition, under the hypothesis that 
quorum-sensing disruption is the predominant mode of action and on the basis that some gene 
products of the quorum-sensing regulons are necessary for swarming motility, a salicylic acid 
dependent reduction in the swarming motility of P. aeruginosa would expected, with complete 
abolishment of swarming in the quorum-sensing mutant. However both the wild type and the quorum-
sensing mutant were showed capable of swarming under the given experimental conditions, providing 
additional evidence that quorum-sensing interference is not the predominant mechanism of salicylic 
acid, as previously thought. To elucidate the salicylic acid mechanism of action, Chow and colleagues 
(2011) compared the ability of P. aeruginosa fliC mutants (flagellum knockout) and pilB mutants (type 
IV pilus knockout) strains to their respective wild-type for their swarming, swimming, and twitching 
ability under the presence of salicylic acid. Motility assays showed that sub-inhibitory concentrations 
of 25 and 50 mM salicylic acid significantly decreased bacterial swarming motility in a mutant strain 
while twitching and swimming motility showed less inhibitory results, supporting the idea that the 
motility structures are the targets of salicylic acid. However, since biofilm-forming capacity was still 
observed in both the motility mutants, the authors concluded that probably salicylic acid not 
preferentially targets on mechanisms or motility systems and hypothesized a possible salicylic acid 
pleiotropic effect on other factors implicated in biofilm formation. A potential explanation for the 
inhibitory effect on motility and biofilm formation is that salicylic acid may downregulate the 
expression of flagella genes by affecting their transcriptional activity which results in the reduction of 
flagellin protein forming the filament on the single polar flagellum of the bacterium (Dongo et al., 
2012). 
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The various and sometimes contradictory effect of salicylic acid on these processes lets suggest the 
presence of complex and overlapping regulatory networks controlling QS, motility and biofilm 
formation which have still to be clarified (Lagonenko et al., 2013). 
 
 
 
Functionalization of polymeric material with anti-biofilm natural compounds 
 
The main bottleneck to spread and use the new powerful and eco-friendly anti-biofilm compounds is 
their incorporation into a system able to resist over a working time scale. In the recent years different 
passive and active anti-biofilm coating strategies have been investigated with the idea to create novel 
eco-friendly coating surfaces by the use of less toxic natural product instead of the traditional 
antimicrobial agents (Coenye et al., 2011). In the passive coating approaches the surface is spread with 
one or more molecules able to reduce bacterial adhesion by altering the properties of the substrate so 
that conditioning films do not form and/or bacteria-substrate interactions are not favorable (Garcia-
Fernandez et al., 2009). In an early research, glass slides coated with zosteric acid were proved to 
reduce the attachment of Acinetobacter sp. on the slide compared to the control surface (Todd et al., 
1993). In other ﬁeld study, ceramic tiles were coated with crude zosteric acid and then placed into a 
marine environment; treated slides were proved to accumulate significantly fewer bacteria than 
controls for 48 h (Zimmerman et al., 1995). Unfortunately, the effectiveness of passive coatings for 
reducing bacterial adhesion is limited in the time and varies greatly depending on bacterial species. 
Moreover the anti-biofilm properties of the coating surface can be masked by an adsorbed 
conditioning film, thereby diminishing the effectiveness (Hetrick et al., 2006). In the active approaches 
the anti-biofilm molecule is superficially bound to the surface of a polymeric material or incorporated 
into the interior of the polymer the polymeric material, directly or by means of a carrier, and actively 
eluted from the surface by the contact  with  an  aqueous  environment (Garcia-Fernandez et al., 2009). 
The anti-biofilm activity is the result of the free-ﬂoating molecules that interact with bacteria in the 
surface surrounding area (Barrios et al., 2005; Hetrick et al., 2006). A lot of efforts to incorporate 
natural compounds with anti-biofilm activity in different polymers are reported in the literature. 
Geiger and coauthors (2004) produced a new anti-biofilm biocompatible polyester material coated 
with zosteric acid encapsulated in polystyrene microcapsules. Barrios and coauthors (2005) and Newby 
and colleagues (2006) incorporated zosteric acid into silicone coatings developing different strategies 
to achieve its slow release in the surrounding area. Release of salicylic acid from materials to inhibit 
bioﬁlm formation has also been reported. Bryers and collaborators (2006) and Rosenberg and 
colleagues (2008) proposed a salicylic acid-releasing poly(anhydride-ester) polymers able to inhibit 
respectively P. aeruginosa and Salmonella enterica bioﬁlms while Nowatsky and coauthors (2012) 
developed a new material by coating an urethane acrylate resin with salicylic acid. A recently studied 
salicylic-acid eluting coating involves ultraviolet-cured polyurethane acrylate polymer containing 
salicyl acrylate. Under aqueous environments, the polymer hydrolyzes and releases salicylic acid, 
leaving the backbone intact. The rate of salicylic acid release is dependent upon the composition of 
the polymer, and the release of such acid was shown to inhibit biofilm formation of S. epidermidis, 
Bacillus subtilis, E. coli, P. aeruginosa, as well as S. aureus (Lo et al., 2014). Similarly glass coverslips 
coated with poly(anhydride) ester with salicylic acid bound to the polymer backbone were used to 
study the release of salicylic acid during polymer degradation and its effect against Salmonella 
typhimurium. Continuous release of salicylic acid from coverslips resulted in a prevention of biofilm 
formation (Guinta et al., 2011). However also this strategy suffers from recurrent problems and 
limitations. The prerequisite for a good performance is the continuous and constant elution of the anti-
biofilm molecules from the surface, with a sufficient release rates to deter bacterial attachment and 
slow enough to ensure the long service life of the coating (Barrios et al., 2005). Unluckily, the amount 
of the substance released is influenced by several factor, i.e. the processing parameters, the loading 
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dose, the applied technique, the molecular size of the molecule and the physic-chemical properties of 
the polymeric material that makes arduous a strict monitoring of the anti-biofilm rate from the surface. 
In most of cases these materials exhibit discontinuous release rate according to first-order kinetics 
with an initially high release and afterwards exponential decrease of the released. In addition, a too 
much high molecule concentration is reached close the surface, mostly reaching a concentration lethal 
for microorganisms (von Eiff et al., 2005). Indeed these questions limit the coatings effectiveness to 
only a short period of time, making this system often unfeasible for a wide range of practical 
applications such as medical materials and devices. 
The problem about the release rates in aqueous medium is likely attributable to the fact that most 
polymeric matrices and anti-biofilm compounds have incompatible physical characteristics. Most of 
the coating matrices are hydrophobic polymers, while some anti-biofilm compounds are hydrophilic, 
making their miscibility with the coating matrices difﬁcult. The result is a non-uniform distribution of 
the molecules inside the material that increases the tendency of the surfaces to absorb and diffuse 
water through the polymer matrix allowing the anti-biofilm molecules to diffuse out (Barrios et al., 
2005; Newby et al., 2006; Nowatzki et al., 2012). Barrios and coauthors (2005) investigated various 
techniques of incorporating zosteric acid into a model silicone coating to determine how the leaching 
can be controlled when zosteric acid is entrapped inside a coating. The authors proved that as the 
distribution of zosteric acid became more uniform, the leach rates reduced extending the working time 
of the coating. To slow the leaching of zosteric acid, more homogenous distribution of smaller zosteric 
acid aggregates or even individual zosteric acid molecules within the silicone coating would be desired. 
On the contrary large aggregates created large pathways in the thickness of the coating allowing the 
water to enter and dissolve them. As a results the solubilized anti-biofilm molecules quickly leaves the 
coating through these pathways making it inefficient. The only use of mixtures of pyridine/water and 
acetone/water as entrapment solvents produced homogeneous coatings with good anti-biofilm 
properties compared to pure silicone. Beside these efforts, no constant rate was reached since 
substantial high rate occurred during a ﬁrst stage, and then the rate gradually leveled off, and 
approached an almost constant value only in the second stage. A further problem is that the release 
of the anti-biofilm compounds could affects the polymers integrity. In the research of Bryers and 
collaborators (2006) salicylic acid was released from the surface by hydrolysis of the main chain bonds 
of the polymer. As a consequence, materials made from these polymers lost mechanical strength and 
structural integrity as they degraded, a property suitable for some applications but not for others 
(Novatzky et al., 2012). 
With this perspective it is become imperative to develop new technologies with both long anti-biofilm 
working life and without the problem of constant release. The covalent bind of these natural molecules 
to the surfaces could easily side-step the problem of constant release, guaranteeing the long life of the 
material since molecules are permanently attached and integrated in the scaffold structure of the 
polymers. However this kind of approach requires a deep knowledge of the exact structural elements 
required by the molecules for exerting their anti-biofilm activity since this approach supposes to 
identify a binding site in the molecule structure necessary for its immobilization on the surface without 
destroying the biological activity. However in most of the cases, this information is not available and 
only few studies about structure-anti-biofilm activity-relationships are reported in literature. 
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Aim of the research 
 
 
 
 
It is proved that microorganisms in form of biofilm communities are able to colonize every surface that 
offer minimal condition for life. All human artefact surfaces like industrial installations, work benches, 
harbor systems and also medical devices are susceptible to biofilm colonization with devastating 
consequences in term of social and economic impact. Unfortunately, the traditional approaches 
including biocides and antibiotics are not consistently and universally effective against deleterious 
bioﬁlms since adopting the sessile mode of life, microorganisms improve their resistance to 
antimicrobial agents up to several orders of magnitude. In addition, increasingly restrictive regulations 
limiting the use of substances hazardous to human health and the environment have resulted in 
several biocides being banned. In this contest the development of new improved effective solutions 
able to replace the presently dominating drug/device products is becoming imperative.  
The new technology would be able to interfere with the key-steps that orchestrate surface-pathogen 
interactions in order to hamper infection cascade. Depriving microorganisms of their ability to develop 
biofilm without affecting their existence may decrease selection pressure for drug-resistant mutations, 
restoring the efficacy of traditional antimicrobial agents. The ideal approach would create permanently 
non-leaching, long-lasting bio-hybrid materials by covalent functionalization of polymeric materials 
with bio-inspired non-toxic and biocide-free anti-biofilm compounds with novel targets, unique modes 
of action and properties that are different from those of the currently used antimicrobials. The natural 
compounds zosteric acid (p-(sulfoxy) cinnamic acid) and salicylic acid were previously proved to be 
powerful anti-biofilm agents able to successfully reduce bacterial and fungal biofilm at concentrations 
that not affect microorganism viability.  
 
The aim of the PhD project is to develop new effective biocide-free materials able to resist to biofilm 
over a working timescale. In this project zosteric acid and salicylic acid are selected as suitable anti-
biofilm compounds for new preventive or integrative approaches against bacterial and fungal biofilm 
formation. Specifically the aim of the project is to develop new anti-biofilm materials by covalently 
anchoring zosteric acid and salicylic acid to commercial polymeric materials in a procedure that allow 
the anti-biofilm compounds to preserve the biological function upon the conjugation process and 
over a working timescale. This research is addressed in providing a new improved solution able to 
reduce the incidence of biofilm formation with a mode of action distinct to the traditional antimicrobial 
strategies. In this approach, no molecules are leached from the surface, sidestepping the problem of 
the compound release kinetics and providing long term protection against bacterial colonization since 
the molecule is permanently attached to the surface. In addition the risk of developing resistant 
microbial strains is reduced, as the concentration of the anti-biofilm agent is constantly below the 
lethal concentration. The proved low toxicity of both zosteric acid and salicylic acid has the potential 
to spread this technology to different sectors resulting in new safe and eco-friendly types of products 
available for a wide range of applications included medical devices and food packaging. The 
understanding of the precise mode of action of these anti-biofilm compounds will also bring toward 
the design of more efficient and manufacturable technologies. 
 
In detail the research will be structured as follows. 
PART A: Determination of zosteric acid and salicylic acid chemical structure determinants of their 
anti-biofilm activity and identification of their molecular target. 
- The chemical structural elements of zosteric acid and salicylic acid required for their anti-
biofilm activity will be investigated. A small library of molecules related to the scaffold of 
zosteric acid and salicylic acid will be synthesized and their anti-biofilm activity against the 
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bacterium model Escherichia coli will be verified through a quantitative biofilm assay. The 
ability of each compound to be a carbon and energy source and to affect planktonic growth 
will be also evaluated. Obtained data will be used to identify possible modifications in zosteric 
acid and salicylic acid structure necessary for their binding with the reactive positions on the 
polymers without attempting their anti-biofilm activity.  
- Molecular targets and pathways involved in zosteric acid and salicylic acid anti-biofilm activity 
will be investigated by proteomic approaches. A small-scale affinity purification of proteins 
from E. coli extracts on immobilized zosteric acid and salicylic acid moieties will be performed. 
E. coli proteins bound to a functionalized matrix will be eluted by competition, analyzed by 
SDS-PAGE and identified by mass spectrometry techniques.  
PART B: Functionalization of surfaces with zosteric acid and salicylic acid and investigation of 
their anti-biofilm performance. 
- In collaboration with chemists, methods to efficiently functionalize a polyethylene surface with 
zosteric acid and salicylic acid will be developed. Physical and chemical treatments will be 
performed to activate the polymeric surface making it suitable for the covalent attachment of 
zosteric acid and salicylic acid. Surface functionalization and the anti-biofilm compounds 
stability and retention will be verified on both new and used material. 
- The anti-biofilm efficacy of the innovative materials will be investigated against E. coli biofilm 
using CDC reactor to simulate flow conditions normally encountered in vivo. The number of 
adhered cells on both traditional and functionalized polyethylene surface will be established 
by plate count assays. Biofilm grown on both treated and control material will be also 
submitted to microscopic analysis. The ability of biofunctionalized materials to enhance the 
susceptibility of established biofilms to traditional antimicrobial agents will be also evaluated. 
To test this, a mature biofilm grown in the cell flow chamber with and without the bio-hybrid 
material, will be stained with a fluorogenic probe and exposed to commercially available 
antimicrobial agents. The effect of biocide exposure will be visualized in vivo measuring 
fluorescence lost by direct time-lapse confocal laser scanning microscopy and quantifying the 
antimicrobial attack through image analysis. In addition simple plate count method will be 
performed after the antimicrobial treatment. 
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A scaffold-based library survey shows the structural features 
responsible of the anti-biofilm activity of zosteric acid against 
Escherichia coli 
 
 
 
 
Abstract 
 
The natural compound zosteric acid or p-(sulfooxy)cinnamic acid (ZA) has been proposed as a 
preventive or integrative approach against biofilm formation. Advantages would be conferred by 
covalently coupling the molecule to the surface of a material in a way to deliver the active moiety to 
the cellular target. The development of this preventive strategy is limited by the lack of information 
about the structural chemical determinants required for ZA anti-biofilm activity. In this study 43-
member library of small molecules based on ZA scaffold diversity was designed and screened against 
Escherichia coli to understand the structural reason for biofilm inhibition at sub-lethal concentration 
and identify functional groups that could be exploited for the covalent linkage to an abiotic surface. 
Structure-activity relationship considerations revealed that the carboxylic acid moiety conjugated to 
the double bond in trans configuration was an essential requirement in ZA chemical structure to 
guarantee a good anti-biofilm performance, while the deletion of the sulphate ester group seems not 
to compromise the ZA anti-biofilm activity. Moreover the biological results revealed that the para 
position on the phenyl ring is a good point for the coupling to a polymer.  
 
 
 
Introduction 
 
Direct observations of a wide variety of natural habitats have established that 99% of microorganisms 
grow in form of biofilms, complex structured communities of microorganisms associated with surfaces 
and embedded in a self-produced extracellular polymeric substances. It is reported that biofilms are 
able to colonize every surface that offers minimal condition for the life included all human artefact 
surfaces like industrial installations, work benches, water distribution systems and also medical sector 
with devastating consequences in term of social and economic impact (Costerton et al., 1987). 
Especially in the clinical area, the role of biofilms in the contamination of medical implants has been 
well established. Unluckily, these implants are major contributors to morbidity and mortality among 
hospitalized patients as they are associated with high risk of biofilm infections (von Eiff et al., 2005; 
Hall-Stoodley et al., 2004).  
The most detrimental property of bioﬁlms is that conventional antimicrobial practices have been 
proved inadequate since, by adopting the sessile mode of life, microorganisms improve their resistance 
to antimicrobial agents up to several orders of magnitude (Smith, 2005; Darouiche, 2007; Donlan, 
2011). In addition, the long term and intensive use of antibiotics and biocides has dramatically 
supported the development of resistant microbial strains reducing the possibility of treating biofilm 
effectively (Andersson et al., 2010). Increasingly restrictive regulations limiting the use of substances 
hazardous to human health and the environment, have also resulted in several biocides being banned.  
With this perspective the development of new improved therapeutic solutions able to reduce the 
incidence of biofilm-associated contaminations has become imperative. An innovative approach could 
be the use of biocide-free anti-biofilm agents with novel targets, unique modes of action and 
properties that are different from those of the currently used antimicrobials (Kaplan, 2009). The use 
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of sub-lethal doses of bio-inspired molecules able to interfere with specific key steps that are involved 
in biofilm formation could be an interesting strategy (Villa et al., 2012a; Cappitelli et al., 2014). In this 
context, nature represents an immense source of new bioactive substances with unrivalled structural 
diversity and complexity (Wong et al., 2008; Villa et al., 2009). Plants have adaptively developed 
fascinating strategies over millions of years to prevent harmful bacterial colonization on their living 
tissues in response to an ever-present pathogen pressure. These natural strategies have inspired anti-
biofilm strategies and could be a promising starting point for novel therapeutic approaches (Villa et al., 
2013). Zosteric acid or p-(sulfoxy) cinnamic acid (ZA), a secondary metabolite produced by the seagrass 
Zostera marina, might be suitable for implementation as a preventive or integrative approach against 
biofilm formation. At sub-lethal concentrations, ZA is able to reduce both bacterial and fungal 
adhesion, and plays a pivotal role in shaping biofilm architecture, in reducing biofilm biomass and 
thickness, in thwarting budded-to-hyphal-form transition, in extending the performance of 
antimicrobial agents, showing cytocompatibility towards soft and hard tissue (Villa et al., 2010; Villa et 
al., 2011; Polo et al., 2014). The comparative proteomic study on E. coli cells exposed to ZA showed 
that the compound acts as an environmental cue leading to global stress on bacterial cells, which 
promotes the expression of various protective proteins, the signal molecule autoinducer-2 production, 
and the synthesis of flagella, to escape from adverse conditions (Villa et al., 2012b).  
Despite the promising results, ZA-based technology is far from real applications as the immobilization 
of the bioactive compound on a polymeric material is still in its infancy.  Barrios et al. (2005) and Newby 
et al. (2006) incorporated ZA into silicone coatings to achieve its slow release in the surrounding area. 
Geiger and coauthors (2004) produced a new anti-biofilm biocompatible polyester material with 
encapsulated ZA. However, this approach posed several problems such as the non-uniform distribution 
of ZA inside the material and the formation of aggregates due to the incomplete miscibility of ZA in the 
polymers (Newby et al., 2006). In addition, a constant release rate of the active compound has neither 
been achieved nor monitored, facts that might make the system less attractive for a medical 
application (Geiger et al., 2004). 
Advantages would be conferred if we could covalently couple the bioactive molecule to the surface of 
a material in a way to deliver the active moiety to the cellular target. In this approach, no molecule 
would be leached from the surface, sidestepping the problem of the compound kinetics release, 
providing long-term protection against bacterial colonization, and reducing the risk of developing 
resistant microbial strains, as the concentration of the anti-biofilm agent would be constantly below 
the lethal concentration while maintaining the molecule bioactive. At present the main bottlenecks 
that limits the development of the aforementioned ZA-based materials is the lack of information about 
the exact chemical structural elements required for its anti-biofilm activity. 
In this follow-up study, a 43-member library of small molecules based on ZA scaffold diversity (Table 
1) was designed and screened against E. coli to understand the structural reason for biofilm inhibition 
at sub-lethal concentration and identify functional groups that could be exploited for the covalent 
linkage to an abiotic surface. The compounds were characterized by the introduction of substituents 
at different positions on phenyl ring and several side-chain modifications, such as the removal of the 
insaturation and the substitution of the carboxylic acid with an alcohol, an aldehyde and ester 
functionalities in order to maximize diversification of the structure along with their physicochemical 
and biological properties. Moreover, both E/Z isomers were prepared in order to explore the role of 
the double bond (Figure 1).  
Thus, the first aim of this study was to identify important structural determinants for ZA anti-biofilm 
activity as a basis to mapping potential binding sites for both the polymeric surface and the cellular 
target, and eventually develops ZA analogues with improved anti-biofilm activity.  
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Code  Cmpd R  R1  R2  R3  E/Z  
ZA  Zosteric acid 4-OSO3H  H  H  COOH  E  
1  Coumaric acid * 4-OH  H  H  COOH  E  
2  4-Methylcinnamic acid  4-CH3  H  H  COOH  E  
3  4-Formylcinnamic acid * 4-COH  H  H  COOH  E  
4  Cinnamic acid * - H  H  COOH  E  
5  4-Methoxycinnamic acid * 4-OCH3  H  H  COOH  E  
6  4-Fluorocinnamic acid * 4-F  H  H  COOH  E  
7  4-Cyanocinnamic acid  4-CN  H  H  COOH  E  
8  4-Carboxycinnamic acid 4-COOH  H  H  COOH  E  
9  4-Chlorocinnamic acid * 4-Cl  H  H  COOH  E  
10  4-Aminocinnamic acid * 4-NH2  H  H  COOH  E  
11  4-(Trifluoromethyl)cinnamic acid  4-CF3  H  H  COOH  E  
12  4-Nitrocinnamic acid * 4-NO2  H  H  COOH  E  
13  3-Chlorocinnamic acid * 3-Cl  H  H  COOH  E  
14  3-Hydroxycinnamic acid * 3-OH  H  H  COOH  E  
15  3,4-Dichlorocinnamic acid * 3-Cl; 4-Cl  H  H  COOH  E  
16  2,4-Dichlorocinnamic acid * 2-Cl; 4-Cl  H  H  COOH  E  
17  2-Chlorocinnamic acid  2-Cl  H  H  COOH  E  
18  2-Methoxycinnamic acid * 2-OCH3  H  H  COOH  E  
19  2-Chloro-4-fluorocinnamic acid * 4-F; 2-Cl  H  H  COOH  E  
20  Caffeic acid * 3-OH; 4-OH  H  H  COOH  E  
21  2-Hydroxycinnamic acid * 2-OH  H  H  COOH  E  
22  3-Hydroxy-4-aminocinnamic acid * 4-NH2; 3-OH  H  H  COOH  E  
23  Methyl coumarate 4-OH  H  H  COOCH3  E  
24  Methyl 4-methoxycinnamate 4-OCH3  H  H  COOCH3  E  
25  Ethyl 2-hydroxycinnamate * 2-OH  H  H  COOCH2CH3  E  
26  Methyl cinnamate *  -  H  H  COOCH3  E  
27  Ethyl β-methylcinnamate * -  CH3  H  COOCH2CH3  E  
28  Ethyl cinnamate * -  H  H  COOCH2CH3  E  
29  Cinnamaldehyde * -  H  H  COH  E  
30  α-Methyl cinnamaldehyde * -  H  CH3  COH  E  
31  Cinnamyl alcohol * -  H  H  CH2OH  E  
32  Cis coumaric acid * 4-OH  H  H  COOH  Z  
33  Cis methyl coumarate 4-OH  H  H  COOCH3  Z  
34  Cis 4-methoxycinnamic acid 4-OCH3  H  H  COOH  Z  
35  Cis methyl 4-methoxycinnamic acid 4-OCH3  H  H  COOCH3  Z  
36  Cis ethyl cinnamate -  H  H  COOCH2CH3  Z  
37  Cis cinnamic acid -  H  H  COOH  Z  
38  Cis zosteric acid 4-OSO3H  H  H  COOH  Z  
39  3-(4-Methoxy)phenylpropionic acid * 4-OCH3  H  H  COOH  -  
40  3-Phenylpropionic acid * -  H  H  COOH  -  
41  3-(3,4-Dihydroxy)phenylpropionic acid * 3-OH; 4-OH  H  H  COOH  -  
42  3-(4-Hydroxy)phenylpropionic acid * 4-OH  H  H  COOH  -  
43 Coumarin * - H H - - 
 
 
 
Table 1. Cinnamic acid analogues used in the present study. * Commercially available compounds. 
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Materials and Methods 
 
Synthesis of a small library of zosteric acid related compounds  
All the reagents including solvents were purchased from Sigma-Aldrich and were used without any 
further purification. All reactions involving air-sensitive reagents were performed under nitrogen 
atmosphere and anhydrous solvents were used when necessary. The Biotage-Initiator microwave 
synthesizer was used. Reactions were monitored by thin layer chromatography (TLC) analysis on 
aluminium-backed Silica Gel 60 plates (0.2 mm, Merck) and were visualized under a UV lamp operating 
at wavelengths of 254 and 365 nm. Visualization was aided by opportune staining reagents. 
Intermediates and final compounds were purified by flash chromatography using Merck Silica Gel 60 
(70-230 mesh). The purity of final compounds were determined by HPLC analysis and were > 95 %. 1H 
and 13C NMR spectra were recorded at room temperature on a Varian 300 MHz Oxford instrument. 
CDCl3, CD3OD, acetone-d6 and DMSO-d6 were used as deuterated solvents for all spectra run. Chemical 
shifts are expressed in ppm from tetramethylsilane resonance in the indicated solvent (TMS: 0.0 ppm) 
and coupling constants (J-values) are given in Hertz (Hz). 1H NMR data are reported in the following 
order: ppm, multiplicity (s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; br, broad), and 
number of protons. Melting points and NMR data are consistent with literature data.  
 
Synthesis of cinnamic acid derivatives  
Zosteric acid was synthesized as already described in a previous work (Villa et al., 2010). The cis isomer 
38 was obtained starting from cis 4-hydroxycinnamic acid 32 under microwave irradiation in the 
presence of sulphur trioxide pyridine complex in acetonitrile (Figure 2). The final product was isolated 
as sodium salt. The majority of the substituted cinnamic acid derivatives were prepared in high yield 
(>90%) by the Knoevenagel-Doebner procedure. In detail, compounds 2, 7, 8, 11 and 17 were obtained 
through a one-pot reaction between the suitable substituted benzaldehyde and malonic acid in 
refluxing pyridine to induce decarboxylation (Szymanski et al., 2009) (Figure 3). The trans geometries 
of the ethenyl π-bonds were confirmed by proton-proton coupling constants. Cis cinnamic acid 37 was 
synthesized from the commercially available ethyl phenylpropiolate. The subsequent hydrogenation 
of alkyne in the presence of Lindlar catalyst and pyridine in methanol led to the corresponding cis-
alkene 36. Then ester group was hydrolyzed under alkaline condition to provide the final compound 
37 (Figure 4). Esters of cinnamic acid in cis (33) or in trans configuration (23, 24) were prepared by 
Fischer esterification of the carboxylic group (De et al., 2011). The protection of the hydroxyl group as 
methyl ether in the presence of iodomethane in dry N,N-dimethylformamide provided the compounds 
35. Hydrolysis of ester was performed in alkaline conditions to obtain the compound 34 (Figure 2). 
Figure 1. Structural formula of chemical compounds used in this study: a) zosteric acid, b) cinnamic acid (4), c) cinnamic acid 
derivatives. 
 
 
          a                                                  b                                                     c          
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Escherichia coli strain and growth condition  
The well characterized Escherichia coli ATCC 25404 was used as a model system for bacterial biofilms. 
The strain was stored at –80 °C in suspensions containing 20 % glycerol and 2 % peptone, and was 
routinely grown in Luria-Bertani broth (LB, Sigma-Aldrich) at 30 °C for 16 h. 
 
Planktonic growth in presence of ZA related compounds 
Planktonic growth of E. coli in LB medium supplemented with 0 (negative control), 0.183, 1.83, 18.3, 
183 and 1830 µM of the synthesized molecules and 3 % of dimethyl sulphoxyde (DMSO) were carried 
out in 384-well microtiter plates. Growth curves at 30°C were generated using the PowerWave XS2 
microplate reader (Biotek). Growth was followed by measuring the optical density at 600 nm (OD600) 
every 10 min for over 24 h in wells inoculated with 3 µl (3 % vol/vol) of an overnight culture (final 
concentration 107 cells/mL). OD-based growth kinetics were constructed by plotting the OD of 
suspensions minus the OD of the non-inoculated medium against incubation time. The polynomial 
Gompertz model (Zwietering et al, 1990) was used to ﬁt the growth curves to calculate the maximum 
speciﬁc growth rate (OD600/min), using GraphPad Prism software (version 5.0, San Diego, CA, USA). 
Six biological replicates of each treatment were performed. Obtained data were normalized to the 
negative control and reported as the mean of these. Percentage reduction in comparison with the 
control was also calculated. 
 
Cellular growth with the ZA related compounds as the sole carbon and energy source 
The ability of bacteria to grow with each compound as the sole carbon and energy source was tested 
using a mineral medium (KH2PO4 30 g/L, Na2HPO4 70 g/L, NH4Cl 10 g/L, pH 7) supplemented with 1830 
µM of each synthesized molecule and 3% of DMSO. Bacteria were added to a final concentration of 
107 cells/mL and grown at 30 °C for 72 h. The positive control was the mineral medium supplemented 
with glucose at both 1830 µM and 10,000 µM concentration. Microbial growth was followed by 
measuring OD600. All the experiments were repeated three times. 
 
Microplate-based biofilm assay in presence of ZA related compounds 
Biofilm was assessed quantitatively using fluorochrome labeled cells in hydrophobic 96-well black 
sided plates as previously reported by Villa et al. (2010). Briefly, 200 μL of phosphate buffered saline 
(PBS, 0.01 M phosphate buffer, 0.0027 M potassium chloride pH 7.4, Sigma-Aldrich) containing 107 
cells supplemented with 0 (negative control), 0.183, 1.83, 18.3, 183 and 1830 µM of each synthesized 
molecule and 3 % of DMSO were placed in microtiter plate wells. Cells were incubated 18 h at 30°C. 
The microtiter plate wells were washed two times with 200 μL PBS and adhered cells were stained 
using 10 µg/mL 4,6-diamidino-2-phenylindole (Sigma-Aldrich) in PBS for 20 min in the dark at room 
temperature. Fluorescence intensity was measured using the fluorometer VICTOR™ X Multilabel Plate 
Readers (Perkin Elmer) at excitation wavelength of 335 nm and emission wavelength of 433 nm. A 
standard curve of fluorescence intensity versus cell number was determined and used to quantify the 
anti-biofilm performance of the ZA related compounds. Four measurements were performed for each 
condition. Obtained data were normalized to the negative control and reported as the mean of these 
data. Percentage reduction in comparison to the control was also calculated. 
 
Statistical analysis 
Analysis of variance (ANOVA) via a software run in MATLAB (Version 7.0, The MathWorksInc, Natick, 
USA) was applied to statistically evaluate any significant differences among the samples. Tukey’s 
honestly significant different test (HSD) was used for pairwise comparison to determine the 
significance of the data. Differences were considered significant for p ˂ 0.05. 
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Results 
 
DMSO did not affect E. coli planktonic growth and cells adhesion  
DMSO was necessary to dissolve the molecules in the aqueous medium but, firstly, its possible impact 
on E. coli as carbon and energy source and on the growth and cell adhesion was assessed. Three % 
DMSO was not a carbon and energy source for the microorganisms. In addition, no significant 
differences among the number of planktonic and adhered cells with or without 3% DMSO were 
observed (Table 2). 
 
 
DMSO 
concentration 
Planktonic growth 
(OD600/min) (x103) 
Cells adhesion 
(No. adhered cells) (x107) 
0 % 1.33±0.01a 2.02±0.39a 
3 % 1.28±0.03a 1.92±0.18a 
 
 
 
 
 
ZA related compounds were not a carbon and energy source for E. coli 
The ability of E. coli to grow with 43 ZA-related compounds at 1830 µM as the sole carbon and energy 
source was tested and compared with a positive control with glucose at the same concentration.  
Figure 3. Reaction to obtain substituted cinnamic acid derivatives. Reagents and conditions: i) malonic acid, Py, piperidine, 
reflux, 80-180 min. 
 
 
Figure 4. Reactions to obtain cis cinnamic acid. Reagents and conditions: i) Lindlar catalyst, H2, pyridine, MeOH, rt, 16h; ii) 
1N NaOH, EtOH/THF (1:1), rt, 12 h. 
 
 
Table 2. Planktonic growth and cells adhesion with and without 3 % DMSO. According 
to post hoc analysis (Tukey’s HSD, p < 0.05), data sharing the same letter indicates no 
signiﬁcant diﬀerence. 
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E. coli in the positive control did not grow and showed an OD600 lower than 0.05 after 48 h incubation. 
The minimum glucose concentration in a mineral medium that supported E. coli growth was 10 mM 
(OD600: 0.201±0.007). Consequently, E. coli with glucose 10 mM was used as a positive control.  
E. coli did not grow in the presence of each ZA related compound as the sole carbon and energy source 
and showed an OD600 lower than 0.05 after 48 h incubation with each molecule. All derivatives were 
submitted to further biological assays in order to evaluate their ability to affect both planktonic growth 
and surface cell adhesion. 
 
ZA related compounds affect E. coli planktonic growth depending on their concentration 
E. coli maximum speciﬁc growth rates in the presence of each ZA related compound at 0.183, 1.83, 
18.3, 183 and 1830 µM were calculated and compared to a negative control grown without the 
molecule using the ANOVA statistic test (Table 3). Molecules able to reduce the maximum specific 
growth rate of E. coli planktonic cells respect to the negative control less than 10 % were coded as 0, 
between 10 % and 20 % were coded - 1, between 20 % and 30 % were coded - 2, and more than 30 % 
were coded  - 3. 
 
ZA related compounds affected E. coli cells adhesion depending on their concentration 
The number of adhered cells in the presence of each ZA related compound at 0.183, 1.83, 18.3, 183 
and 1830 µM was assessed quantitatively using fluorochrome labelled cells and compared to a 
negative control in the absence of the molecule using the ANOVA statistic test (Table 3). Molecules 
able to reduce the number of E.coli adhered cells respect to the negative control less than 20 % were 
coded 0, between 20 % and 30 % were coded - 1, between 30 % and 40 % were coded - 2 and more 
than 40 % were coded  - 3. Molecules able to increase the number of adhered cells respect to the 
negative control more than 20 % were coded + 1. 
 
ZA related compounds presented different biological trends  
With the aim to identify trends, planktonic growth and cells adhesion data were grouped to obtain a 
global picture of the biological activity of each ZA related compound at the different concentrations 
(Figure 5). Compounds showed: i) no biological activity (no reduction of the number of adhered cells 
and no planktonic growth effect), ii) anti-biofilm activity (reduction of the number of adhered cells and 
no  planktonic growth effect), iii) increased biofilm formation (increase of the number of adhered cells 
and no planktonic growth effect), iv) planktonic to biofilm mode of life transition (no reduction or 
increase of the number of adhered cells and planktonic growth effect) and v) biocidal effect (reduction 
of the number of adhered cells and planktonic growth effect). 
Five molecules (7, 12, 18, 19, 39) induced no biological activity at low and middle concentrations and 
planktonic to biofilm mode of life transition or biocidal effect at the maximum concentration (Trend 
1). Eight molecules (24, 27, 29-31, 40, 42, 43) showed the same trend but they promoted biofilm 
formation at the lowest concentration (Trend 2). Nineteen molecules (1-6, 8-11, 13-15, 20, 21, 23, 26, 
28, 41) had no biological activity at low concentration, showed an anti-biofilm activity at middle 
concentrations and induced biocidal effect or planktonic to biofilm mode of life transition at the 
maximum concentration (Trend 3). Nine molecules (ZA, 16, 17, 22, 25, 33-36) showed the same trend 
but they promoted biofilm formation at the lowest concentration (Trend 4). Finally, molecules 32, 37 
and 38 showed a peculiar trend (Trend 5). 
 
ZA related compounds presented different global anti-biofilm performance 
For each ZA related compound a global anti-biofilm performance value was calculated as (sum of cell 
adhesion codes of all concentrations)-(sum of planktonic growth code of all concentrations) (Figure 6). 
This value took into account i) the occurrence that ZA related compound induced a different bacterial 
response depending on the concentration, ii) the positive contribution of concentrations that reduce 
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the number of adhered cells; iii) the negative contributions of concentrations that enhance the number 
of adhered cells; iv) the negative contribution of concentrations that reduce planktonic growth.  
Molecules with an anti-biofilm performance value i) equal 0 were considered globally without anti-
biofilm performance; ii) below 0 were considered globally able to exert an anti-biofilm activity (-1: low 
anti-biofilm performance; -2: moderate anti-biofilm performance; ≤ -3: optimal anti-biofilm 
performance), iii) above 0 were considered globally able to improve biofilm performance (+1: low 
improvement of biofilm performance; +2: moderate improvement of biofilm performance; ≥ +3: 
optimal improvement of biofilm performance).  
Four molecules (7, 12, 14, 32) presented anti-biofilm performance equal 0. Twenty molecules 
presented anti-biofilm performance below 0 (-1: 16; -2: 5, 6, 13, 21, 23, 28; ≤ -3: ZA, 1-4, 8-11, 17, 20, 
22, 41). Twenty molecules presented anti-biofilm performance above 0 (+1: 19, 26, 31, 33, 36; +2: 15, 
25, 27, 39, 42, 43; +2: 15, 25, 27, 39, 42, 43; ≥ +3: 18, 24, 29, 30, 34, 35, 37, 38, 40).  
 
Carboxylic acid moiety conjugated to the double bond in trans configuration was important for ZA 
anti-biofilm activity 
The study involved the preparation and biological evaluation of analogues characterized by 
substitutions at different positions on the phenyl ring as well as a variety of side chains. This 
investigation highlighted features that could be useful for the design of new derivatives, with the aim 
to find compounds endowed with a better anti-biofilm activity compared to ZA. Interestingly, as 
reported in Table 3, cinnamic acid 4, a natural compound obtained by cinnamon lacking the sulfate 
monoester group, has shown an interesting anti-biofilm activity at a 1000-fold lower inhibitory 
concentration than ZA (0.183 vs 183 μM).  
The substitution pattern of the phenyl ring and the nature of the substituents were found to have a 
significant effect on the biofilm inhibitory activity. In the first instance, a broad variety of substituents 
with different electronic and steric properties were introduced at position 4 on the phenyl ring. 
Compounds (1-3, 5, 6, 8-11) showed an interesting activity (Trend 3) compared to the unsubstituted 
cinnamic acid 4, meanwhile the presence of cyano (7) and nitro (12) groups caused a loss in activity 
(Trend 1).  
Comparing the derivatives bearing a hydroxyl group (1, 14), as well as the chlorine atom (9, 13), 
respectively in position 4 and 3 on the phenyl ring, highlighted that the substitution at the para position 
was preferred (1 and 9 more active than 14 and 13), although the same trend was still present. On the 
contrary the substitution at position 2 was not well tolerated. Indeed, as for compound 17 the activity 
was reduced 10-fold compared to 9, while in the other cases the activity was almost completely 
abolished. To determine whether the introduction of a second substituent on the phenyl ring would 
enhance activity, a series of disubstituted derivatives (15, 16, 19, 20, 22) were synthesized. In general, 
each disubstituted compound was found to have a different behavior and a lower anti-biofilm activity 
compared to the corresponding monosubstituted compound. This effect was most evident for the 3,4-
dichlorocinnamic acid 15, whose activity was 10-fold lower than the monosubstituted counterpart 9. 
Following on from this, the side chain modifications were also explored. In general, the unsubstituted 
compounds having the carboxylic function protected as esters (26, 28) showed lower activity in 
comparison with cinnamic acid 4, and in particular the ethyl ester 28 was less active than methyl ester 
26. Besides, among the para-substituted cinnamic acid esters (23-24), the presence of a hydroxyl group 
23 seemed to be important for the anti-biofilm activity, since the corresponding 4-methoxy derivative 
24 was inactive. Moreover, derivatives bearing an aldehyde (29, 30) or an alcohol (31) in replacement 
of the carboxylic acid functionality were inactive (Trend 2), confirmed that the carboxylic moiety was 
essential for good anti-biofilm activity. To investigate the importance of the configuration of the 
double bond, the majority of cis derivatives (32-38) were synthesized and found to have a different 
behavior (Trends 4, 5) compared to the trans counterparts. Interestingly, exceptions to this rule were 
the cis isomer of zosteric acid 38 and cinnamic acid 37, that had lost their anti-biofilm activity (Trend 
5). Additionally, specific concentrations of 37 and 38 seemed to enhance the biofilm formation. 
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Similarly, some saturated derivatives (39-42) were chosen to investigate the role of the double bond. 
All the compounds exhibited the same trend (Trend 2) except for compound 41, a catechol derivative, 
that did not follow this general behaviour (Trend 3) probably due to a different mechanism of 
interaction (as compound 20).   
Finally, coumarin 43, which could be considered the cyclic derivative of 4, was unable to inhibit the 
biofilm growth, confirming the essential role of the side chain.  
As for the anti-biofilm performance, some additional observations could be drawn. Generally, zosteric 
acid derivatives followed the same behaviors described for the anti-biofilm activity, with some 
exceptions: i) derivatives 5 and 6, which have a methoxy group and a fluorine atom in the para position 
on the phenyl ring respectively, showed an anti-biofilm performance slightly lower than that of the 
cinnamic acid 4, which was still a positive result; ii) compound 17 anti-biofilm performance turned out 
to be better than that of the corresponding analogue 9, in which the chlorine atom was at position 4 
on the phenyl ring;  however, the general trend, according to which the substitution at position 2 was 
not well tolerated, was confirmed; iii) the anti-biofilm performance of the disubstituted halogen 
derivatives (15, 16, 19) was in general lower than that of the monosubstituted counterparts as well as 
the anti-biofilm activity. The same was not observed for compounds (20, 22), which were characterized 
by electron donating substituents, whose monosubstituted analogues showed a decreased anti-
biofilm performance; iv) the esters 26 and 28 showed the opposite behaviour, since the methyl ester 
26 exhibited an anti-biofilm performance lower than that of the ethyl ester 28; v) the majority of cis 
derivatives (32-38) were found to have a global anti-biofilm performance promoting biofilm formation.   
Among the tested molecules, six molecules (1, 4, 8, 11, 20) have the most interesting anti-biofilm 
performance by showing anti-biofilm activity in a wide range of concentrations with maximum at 
micromolar level and with no effect on planktonic growt 
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  Planktonic growth Cells adhesion 
Cmpd 
Conc. 
(µM) 
OD600/min 
(x10-3) 
% 
reduction 
Code 
(a) 
No. adhered 
cells (x107) 
% 
reduction 
Code 
(b) 
ZA 0 1.28±0.03a 0.00 0 1.92±0.18b 0.00 0 
0.183 1.32±0.06a 2.86 0 2.77±0.17d 44.59 1 
1.83 1.31±0.04a 1.76 0 1.54±0.29c -19.76 0 
18.3 1.29±0.04a 0.11 0 1.55±0.19c -19.34 0 
183 1.30±0.04a 1.07 0 1.39±0.13c -27.67 -1 
1830 1.30±0.04a 1.21 0 0.56±0.12a -70.56 -3 
1 0 1.28±0.03abc 0.00 0 1.92±0.18b 0.00 0 
0.183 1.31±0.03ab 2.06 0 2.29±0.16b 19.37 0 
1.83 1.26±0.04abc -1.72 0 1.03±0.14ce -46.05 -3 
18.3 1.23±0.02abc -3.99 0 1.42±0.24de -25.80 -1 
183 1.23±0.06abc -3.87 0 1.49±0.14de -22.36 -1 
1830 0.97±0.04e -24.17 -2 1.22±0.27cde -36.38 -2 
2 0 1.28±0.03a 0.00 0 1.92±0.18bc 0.00 0 
0.183 1.33±0.03a 3.41 0 1.86±0.23bcd -3.15 0 
1.83 1.32±0.03a 2.66 0 0.47±0.09a -75.40 -3 
18.3 1.26±0.07a -2.23 0 1.50±0.18cde -21.94 -1 
183 1.28±0.07a -0.48 0 1.39±0.32de -27.44 -1 
1830 0.87±0.03b -32.54 -3 1.40±0.28de -27.01 -1 
3 0 1.28±0.03abc 0.00 0 1.92±0.18b 0.00 0 
0.183 1.23±0.06abd -4.42 0 1.26±0.15ce -34.41 -1 
1.83 1.33±0.03ac 3.46 0 0.73±0.07ade -61.92 -3 
18.3 1.32±0.03ac 3.08 0 1.04±0.23cde -45.97 -3 
183 1.28±0.05abc -0.03 0 1.17±0.28ce -39.12 -2 
1830 1.02±0.01e -20.44 -2 1.33±0.08ce -30.69 -2 
4 0 1.28±0.03abc 0.00 0 1.92±0.18bef 0.00 0 
0.183 1.24±0.04abcd -3.32 0 1.25±0.43cdef -34.95 -2 
1.83 1.22±0.01abcdf -4.74 0 1.17±0.17cdf -38.77 -2 
18.3 1.19±0.04bcdef -7.58 0 1.78±0.10bcef -7.37 0 
183 1.14±0.05def -11.37 -1 1.44±0.15bcdef -25.03 -1 
1830 0.83±0.02h -35.10 -3 1.32±0.28cdef -31.11 -2 
5 0 1.28±0.03abc 0.00 0 1.92±0.18bceh 0.00 0 
0.183 1.24±0.02ac -3.14 0 1.92±0.26bcefgh 0.37 0 
1.83 1.23±0.03ac -4.12 0 1.17±0.11defl -39.15 -2 
18.3 1.14±0.01df -11.53 -1 1.58±0.13bcdefghl -17.47 0 
183 1.15±0.06de -10.43 -1 1.36±0.24bcdefghl -28.79 -1 
1830 0.94±0.04g -26.65 -2 1.14±0.25df -40.52 -3 
6 0 1.28±0.03a 0.00 0 1.92±0.18b 0.00 0 
0.183 1.30±0.07a 1.21 0 2.30±0.62b 19.90 0 
1.83 1.25±0.05a -2.36 0 2.05±0.20b 7.00 0 
18.3 1.31±0.01a 2.38 0 1.12±0.21c -41.44 -3 
183 1.16±0.03b -10.03 -1 1.25±0.25c -34.97 -2 
1830 0.85±0.03d -33.69 -3 1.39±0.23c -27.46 -1 
 
 
 
 
 
 
 
Table 3, part a. Planktonic growth and cells adhesion in the presence of each ZA related compound. 
Percentage reduction respect to the negative control is reported. a) Percentage reduction of the maximum 
specific growth rate: code (0) x > -10 %; code (-1)  -10 % ≤ x < -20 %; code (-2) -20 % ≤ x < -30 %; code (-3)        
x ≤ -30 %; b) Percentage reduction of the number of adhered cells: code (+1) x > +20 %; code (0)                           
+20 % ≤ x < -20 %; code (-1)  -20 % ≤ x <  -30 %; code (-2) -30 % ≤ x < -40 %; code (-3) x ≤ -40 %. According to 
post hoc analysis (Tukey’s HSD, p < 0.05), data sharing the same letter indicates no signiﬁcant diﬀerence. 
 
Chapter 3 
38 
 
   
  Planktonic growth Cells adhesion 
Cmpd 
Conc. 
(µM) 
OD600/min 
(x10-3) 
% 
reduction 
Code 
(a) 
No. adhered 
cells (x107) 
% 
reduction 
Code 
(b) 
7 0 1.28±0.03a 0.00 0 1.92±0.18bc 0.00 0 
0.183 1.29±0.03a 0.12 0 1.73±0.32bcd -9.57 0 
1.83 1.26±0.02a -1.99 0 1.75±0.37bc -8.60 0 
18.3 1.31±0.00a 1.90 0 1.88±0.41bc -1.95 0 
183 1.28±0.05a -0.41 0 1.56±0.20bcd -18.67 0 
1830 0.96±0.04c -24.88 -2 1.18±0.23cd -38.63 -2 
8 0 1.28±0.03a 0.00 0 1.92±0.18b 0.00 0 
0.183 1.30±0.04a 1.13 0 1.63±0.37b -14.90 0 
1.83 1.26±0.05a -1.68 0 1.14±0.19c -40.28 -3 
18.3 1.27±0.03a -1.14 0 1.06±0.18c -44.92 -3 
183 1.28±0.05a -0.51 0 1.14±0.11c -40.73 -3 
1830 1.11±0.01b -13.24 -1 2.19±0.28d 14.29 0 
9 0 1.28±0.03a 0.00 0 1.92±0.18bc 0.00 0 
0.183 1.25±0.04a -2.79 0 1.75±0.21bcd -8.89 0 
1.83 1.27±0.03a -0.79 0 1.43±0.25cde -25.63 -1 
18.3 1.30±0.05a 1.06 0 1.18±0.31de -38.64 -2 
183 1.12±0.00b -12.86 -1 1.40±0.31cde -27.19 -1 
1830 0.83±0.02c -35.27 -3 1.14±0.22de -40.36 -3 
10 0 1.28±0.03a 0.00 0 1.92±0.18bc 0.00 0 
0.183 1.26±0.04a -1.86 0 1.81±0.18bcdf -5.41 0 
1.83 1.24±0.02a -3.08 0 1.47±0.17cdef -23.51 -1 
18.3 1.24±0.02a -3.14 0 1.19±0.22deg -37.94 -2 
183 1.25±0.06a -2.43 0 1.57±0.18cdf -18.09 0 
1830 0.87±0.02d -32.40 -3 1.10±0.28deg -42.38 -3 
11 0 1.28±0.03abc 0.00 0 1.92±0.18b 0.00 0 
0.183 1.25±0.04abc -2.93 0 2.26±0.16c 18.06 0 
1.83 1.24±0.02abc -3.19 0 1.53±0.17d -20.05 -1 
18.3 1.31±0.01ab 2.04 0 1.43±0.28d -25.44 -1 
183 1.24±0.04ac -3.38 0 0.40±0.06a -79.23 -3 
1830 0.87±0.01f -32.56 -3 0.48±0.03a -74.86 -3 
12 0 1.28±0.03ab 0.00 0 1.92±0.18bc 0.00 0 
0.183 1.34±0.07ab 4.38 0 1.82±0.44bcd -4.88 0 
1.83 1.29±0.05abc 0.19 0 1.82±0.11bcd -5.16 0 
18.3 1.22±0.05bc -4.95 0 1.63±0.29bcd -14.70 0 
183 1.21±0.03c -5.56 0 1.54±0.30cd -19.83 0 
1830 0.99±0.03d -23.12 -2 1.30±0.33d -32.21 -2 
13 0 1.28±0.03ac 0.00 0 1.92±0.18bc 0.00 0 
0.183 1.29±0.02ac 0.41 0 1.78±0.05bce -7.13 0 
1.83 1.22±0.08ab -4.66 0 1.75±0.19bce -8.79 0 
18.3 1.31±0.02ac 2.40 0 1.31±0.24cdef -31.41 -2 
183 1.25±0.03abc -2.47 0 1.59±0.18de -17.14 0 
1830 1.00±0.02d -22.39 -2 1.19±0.24df -37.93 -2 
 
 
 
 
 
 
 
Table 3, part b. Planktonic growth and cells adhesion in the presence of each ZA related compound. 
Percentage reduction respect to the negative control is reported. a) Percentage reduction of the maximum 
specific growth rate: code (0) x > -10 %; code (-1)  -10 % ≤ x < -20 %; code (-2) -20 % ≤ x < -30 %; code (-3)        
x ≤ -30 %; b) Percentage reduction of the number of adhered cells: code (+1) x > +20 %; code (0)                           
+20 % ≤ x < -20 %; code (-1)  -20 % ≤ x <  -30 %; code (-2) -30 % ≤ x < -40 %; code (-3) x ≤ -40 %. According to 
post hoc analysis (Tukey’s HSD, p < 0.05), data sharing the same letter indicates no signiﬁcant diﬀerence. 
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  Planktonic growth Cells adhesion 
Cmpd 
Conc. 
(µM) 
OD600/min 
(x10-3) 
% 
reduction 
Code 
(a) 
No. adhered 
cells (x107) 
% 
reduction 
Code 
(b) 
14 0 1.28±0.03abc 0.00 0 1.92±0.18bcef 0.00 0 
0.183 1.21±0.02abcde -5.68 0 1.93±0.06bcefg 0.68 0 
1.83 1.27±0.01abc -1.20 0 1.70±0.14bcef -11.20 0 
18.3 1.23±0.04abcd -3.89 0 1.33±0.21abcef -30.56 -2 
183 1.30±0.02abc 1.57 0 2.29±0.50bcef 19.62 0 
1830 1.14±0.03bde -10.95 -1 4.25±1.35hi 121.57 + 
15 0 1.28±0.03a 0.00 0 1.92±0.18bc 0.00 0 
0.183 1.31±0.05a 1.90 0 1.76±0.08bce -7.98 0 
1.83 1.27±0.05a -1.23 0 1.72±0.18bce -10.36 0 
18.3 1.30±0.01a 1.46 0 1.41±0.14de -26.16 -1 
183 1.29±0.03a 0.63 0 1.53±0.23cde -19.96 0 
1830 0.86±0.02b -32.67 -3 1.58±0.26cde -17.47 0 
16 0 1.28±0.03a 0.00 0 1.92±0.18bf 0.00 0 
0.183 1.29±0.04a 0.21 0 3.59±0.37c 87.42 + 
1.83 1.31±0.05a 2.05 0 1.46±0.19def -23.68 -1 
18.3 1.28±0.04a -0.29 0 1.36±0.19de -28.82 -1 
183 1.29±0.05a 0.13 0 1.74±0.11bdf -8.95 0 
1830 1.03±0.05d -20.16 -2 1.33±0.17de -30.57 -2 
17 0 1.28±0.03abc 0.00 0 1.92±0.18bd 0.00 0 
0.183 1.28±0.03abcd -0.29 0 3.62±0.37c 88.79 + 
1.83 1.30±0.07abcd 0.87 0 1.76±0.08bdf -8.09 0 
18.3 1.33±0.04ab 3.62 0 1.37±0.14ef -28.33 -1 
183 1.29±0.02abc 0.68 0 1.49±0.19def -22.26 -1 
1830 1.05±0.04ef -17.95 -1 1.08±0.15h -43.68 -3 
18 0 1.28±0.03ab 0.00 0 1.92±0.18bcd 0.00 0 
0.183 1.28±0.02ab 0.07 0 2.16±0.15bc 12.75 0 
1.83 1.26±0.04abc -1.68 0 1.89±0.19bcd -1.22 0 
18.3 1.31±0.04ab 1.79 0 1.61±0.23bd -16.05 0 
183 1.20±0.03bc -6.82 0 1.95±0.25bcd 1.50 0 
1830 1.00±0.05c -22.04 -2 2.79±0.46e 45.65 + 
19 0 1.28±0.03a 0.00 0 1.92±0.18bc 0.00 0 
0.183 1.30±0.06a 0.88 0 1.93±0.44bcd 0.81 0 
1.83 1.29±0.05a 0.50 0 1.67±0.12bcd -12.94 0 
18.3 1.30±0.01a 1.58 0 1.65±0.19cd -13.94 0 
183 1.32±0.04a 2.69 0 1.80±0.28bcd -6.18 0 
1830 1.05±0.04b -18.13 -1 1.61±0.14cd -15.75 0 
20 0 1.28±0.03a 0.00 0 1.92±0.18bc 0.00 0 
0.183 1.30±0.03a 1.40 0 1.91±0.33bcd -0.13 0 
1.83 1.31±0.03a 2.18 0 1.58±0.10cde -17.44 0 
18.3 1.30±0.04a 1.14 0 1.52±0.23de -20.60 -1 
183 1.29±0.04a 0.12 0 0.60±0.04a -68.90 -3 
1830 1.13±0.02b -11.61 -1 0.72±0.13a -62.34 -3 
 
 
 
 
 
 
 
Table 3, part c. Planktonic growth and cells adhesion in the presence of each ZA related compound. 
Percentage reduction respect to the negative control is reported. a) Percentage reduction of the maximum 
specific growth rate: code (0) x > -10 %; code (-1)  -10 % ≤ x < -20 %; code (-2) -20 % ≤ x < -30 %; code (-3)       
x ≤ -30 %; b) Percentage reduction of the number of adhered cells: code (+1) x > +20 %; code (0)                          
+20 % ≤ x < -20 %; code (-1)  -20 % ≤ x <  -30 %; code (-2) -30 % ≤ x < -40 %; code (-3) x ≤ -40 %. According to 
post hoc analysis (Tukey’s HSD, p < 0.05), data sharing the same letter indicates no signiﬁcant diﬀerence. 
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  Planktonic growth Cells adhesion 
Cmpd 
Conc. 
(µM) 
OD600/min 
(x10-3) 
% 
reduction 
Code 
(a) 
No. adhered 
cells (x107) 
% 
reduction 
Code 
(b) 
21 0 1.28±0.03a 0.00 0 1.92±0.18bc 0.00 0 
0.183 1.32±0.04a 2.92 0 1.71±0.16bcd -10.57 0 
1.83 1.30±0.01a 0.95 0 1.60±0.18cde -16.42 0 
18.3 1.30±0.05a 1.62 0 1.72±0.23bcd -10.51 0 
183 1.32±0.00a 2.52 0 1.34±0.18def -30.22 -2 
1830 1.03±0.04b -20.07 -2 1.24±0.16def -35.24 -2 
22 0 1.28±0.03acd 0.00 0 1.92±0.18b 0.00 0 
0.183 1.21±0.01bcdf -5.58 0 3.07±0.17c 60.29 + 
1.83 1.29±0.03acd 0.75 0 2.66±0.23ce 38.91 + 
18.3 1.29±0.02acd 0.43 0 1.37±0.06deg -28.42 -1 
183 1.24±0.01abcdf -3.61 0 1.18±0.33df -38.53 -2 
1830 1.17±0.06bcf -9.14 0 0.99±0.04degh -48.14 -3 
23 0 1.28±0.03a 0.00 0 1.92±0.18b 0.00 0 
0.183 1.32±0.02a 2.93 0 2.26±0.22c 17.80 0 
1.83 1.29±0.07a 0.37 0 1.22±0.15d -36.25 -2 
18.3 1.31±0.06a 2.26 0 1.50±0.16d -21.75 -1 
183 1.12±0.03b -12.66 -1 1.24±0.15d -35.24 -2 
1830 0.56±0.02c -56.28 -3 1.47±0.23d -23.17 -1 
24 0 1.28±0.03a 0.00 0 1.92±0.18b 0.00 0 
0.183 1.26±0.03a -1.69 0 4.77±0.47c 148.78 + 
1.83 1.29±0.01a 0.37 0 1.83±0.22b -4.76 0 
18.3 1.31±0.01a 2.32 0 1.96±0.12b 2.38 0 
183 1.15±0.03b -10.36 -1 4.16±0.54c 117.10 + 
1830 1.09±0.01b -15.26 -1 9.52±1.19e 396.86 + 
25 0 1.28±0.03a 0.00 0 1.92±0.18b 0.00 0 
0.183 1.27±0.01a -0.72 0 2.60±0.15c 35.59 + 
1.83 1.29±0.02a 0.83 0 1.73±0.16b -9.71 0 
18.3 1.24±0.05a -3.48 0 1.67±0.08b -12.95 0 
183 1.12±0.04b -12.58 -1 1.64±0.24b -14.33 0 
1830 0.55±0.01c -56.89 -3 1.12±0.15d -41.78 -3 
26 0 1.28±0.03ab 0.00 0 1.92±0.18bc 0.00 0 
0.183 1.31±0.02ab 2.18 0 1.63±0.13bcd -15.20 0 
1.83 1.27±0.04abc -1.37 0 1.58±0.17cd -17.76 0 
18.3 1.26±0.06abc -1.92 0 1.52±0.25cd -20.80 -1 
183 1.25±0.03abc -2.92 0 1.47±0.11cd -23.44 -1 
1830 0.81±0.03e -37.06 -3 1.62±0.20cd -15.63 0 
27 0 1.28±0.03a 0.00 0 1.92±0.18bde 0.00 0 
0.183 1.28±0.04a -0.57 0 2.52±0.45c 31.74 + 
1.83 1.29±0.06a 0.23 0 1.99±0.23bd 4.07 0 
18.3 1.29±0.05a 0.20 0 1.95±0.11bd 1.79 0 
183 1.29±0.02a 0.60 0 1.67±0.18be -12.90 0 
1830 1.15±0.03b -10.65 -1 1.71±0.16be -10.97 0 
 
 
 
 
 
 
 
Table 3, part d. Planktonic growth and cells adhesion in the presence of each ZA related compound. 
Percentage reduction respect to the negative control is reported. a) Percentage reduction of the maximum 
specific growth rate: code (0) x > -10 %; code (-1)  -10 % ≤ x < -20 %; code (-2) -20 % ≤ x < -30 %; code (-3)      
x ≤ -30 %; b) Percentage reduction of the number of adhered cells: code (+1) x > +20 %; code (0)                            
+20 % ≤ x < -20 %; code (-1)  -20 % ≤ x <  -30 %; code (-2) -30 % ≤ x < -40 %; code (-3) x ≤ -40 %. According to 
post hoc analysis (Tukey’s HSD, p < 0.05), data sharing the same letter indicates no signiﬁcant diﬀerence. 
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  Planktonic growth Cells adhesion 
Cmpd 
Conc. 
(µM) 
OD600/min 
(x10-3) 
% 
reduction 
Code 
(a) 
No. adhered 
cells (x107) 
% 
reduction 
Code 
(b) 
28 0 1.28±0.03a 0.00 0 1.92±0.18b 0.00 0 
0.183 1.31±0.02a 1.67 0 1.94±0.01b 1.10 0 
1.83 1.28±0.02a -0.20 0 1.99±0.15b 3.77 0 
18.3 1.28±0.03a -0.61 0 1.76±0.10b -8.15 0 
183 1.28±0.05a 0.01 0 1.26±0.18c -34.39 -2 
1830 0.86±0.02c -33.01 -3 0.92±0.14d -52.00 -3 
29 0 1.28±0.03a 0.00 0 1.92±0.18bd 0.00 0 
0.183 1.29±0.05a 0.29 0 2.56±0.26c 33.75 1 
1.83 1.29±0.04a 0.23 0 1.79±0.11bd -6.83 0 
18.3 1.31±0.06a 1.72 0 1.93±0.24bd 0.73 0 
183 1.28±0.05a -0.43 0 2.14±0.15bcd 11.51 0 
1830 0.76±0.02b -40.52 -3 1.42±0.27d -25.78 -1 
30 0 1.28±0.03a 0.00 0 1.92±0.18be 0.00 0 
0.183 1.23±0.01a -3.95 0 2.38±0.21ce 24.26 1 
1.83 1.29±0.02a 0.31 0 1.82±0.18be -5.29 0 
18.3 1.32±0.03a 2.86 0 1.97±0.19be 2.99 0 
183 1.26±0.05a -2.10 0 2.06±0.22bce 7.33 0 
1830 0.83±0.03b -35.51 -3 1.40±0.16f -26.98 -1 
31 0 1.28±0.03a 0.00 0 1.92±0.18b 0.00 0 
0.183 1.23±0.03a -3.94 0 2.85±0.43c 48.69 1 
1.83 1.26±0.00a -2.14 0 1.58±0.29b -17.68 0 
18.3 1.29±0.01a 0.61 0 1.99±0.43b 4.02 0 
183 1.24±0.04a -3.25 0 1.85±0.22b -3.23 0 
1830 0.82±0.02d -36.19 -3 0.94±0.19e -50.79 -3 
32 0 1.28±0.03a 0.00 0 1.92±0.18bc 0.00 0 
0.183 1.29±0.07a 0.30 0 1.39±0.15abc -27.34 -1 
1.83 1.27±0.05a -0.88 0 1.64±0.11bc -14.39 0 
18.3 1.27±0.04a -1.26 0 1.83±0.14bc -4.30 0 
183 1.28±0.06a -0.16 0 1.62±0.19bc -15.26 0 
1830 1.25±0.02a -2.25 0 5.45±1.00e 184.36 1 
33 0 1.28±0.03a 0.00 0 1.92±0.18b 0.00 0 
0.183 1.25±0.06a -2.75 0 3.90±0.27c 103.54 1 
1.83 1.26±0.03a -1.49 0 1.88±0.09b -1.99 0 
18.3 1.32±0.02a 2.61 0 1.45±0.19d -24.08 -1 
183 1.13±0.03b -12.31 -1 1.31±0.24d -31.43 -2 
1830 0.74±0.02de -42.25 -3 1.51±0.16d -21.25 -1 
34 0 1.28±0.03a 0.00 0 1.92±0.18b 0.00 0 
0.183 1.26±0.03a -2.19 0 5.75±0.32e 199.95 1 
1.83 1.28±0.05a 0.08 0 1.93±0.16bc 0.83 0 
18.3 1.29±0.04a 0.64 0 1.14±0.09bc -40.43 -3 
183 1.10±0.02b -14.41 -1 3.02±0.12d 57.49 1 
1830 1.00±0.04c -22.27 -2 2.64±0.31d 37.76 1 
 
 
 
 
 
 
 
Table 3, part e. Planktonic growth and cells adhesion in the presence of each ZA related compound. 
Percentage reduction respect to the negative control is reported. a) Percentage reduction of the maximum 
specific growth rate: code (0) x > -10 %; code (-1)  -10 % ≤ x < -20 %; code (-2) -20 % ≤ x < -30 %; code (-3)       
x ≤ -30 %; b) Percentage reduction of the number of adhered cells: code (+1) x > +20 %; code (0)                             
+20 % ≤ x < -20 %; code (-1)  -20 % ≤ x <  -30 %; code (-2) -30 % ≤ x < -40 %; code (-3) x ≤ -40 %. According to 
post hoc analysis (Tukey’s HSD, p < 0.05), data sharing the same letter indicates no signiﬁcant diﬀerence. 
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  Planktonic growth Cells adhesion 
Cmpd 
Conc. 
(µM) 
OD600/min 
(x10-3) 
% 
reduction 
Code 
(a) 
No. adhered 
cells (x107) 
% 
reduction 
Code 
(b) 
35 0 1.28±0.03a 0.00 0 1.92±0.18bcd 0.00 0 
0.183 1.26±0.05a -2.19 0 2.87±0.56bc 49.69 1 
1.83 1.25±0.07a -2.61 0 1.72±0.19bd -10.13 0 
18.3 1.16±0.03b -9.96 0 1.12±0.14e -41.80 -3 
183 0.92±0.05c -28.33 -2 2.85±0.31f 48.83 1 
1830 0.55±0.02d -56.93 -3 5.72±0.25h 198.51 1 
36 0 1.28±0.03ab 0.00 0 1.92±0.18bdf 0.00 0 
0.183 1.23±0.02abc -4.03 0 2.87±0.56c 49.69 1 
1.83 1.24±0.02abc -3.79 0 1.78±0.24bd -7.38 0 
18.3 1.21±0.03bcd -5.71 0 1.13±0.17e -40.87 -3 
183 1.15±0.04cd -10.75 -1 2.27±0.17bf 18.70 0 
1830 1.08±0.02d -15.57 -1 5.60±0.65h 192.07 1 
37 0 1.28±0.03ab 0.00 0 1.92±0.18b 0.00 0 
0.183 1.32±0.04ab 2.71 0 2.46±0.17b 28.52 1 
1.83 1.28±0.07ab -0.56 0 2.36±0.26b 23.00 1 
18.3 1.30±0.03ab 1.27 0 1.35±0.28b -29.61 -1 
183 1.24±0.05a -3.17 0 5.08±0.53c 164.82 1 
1830 0.88±0.02c -31.64 -3 5.43±0.76c 183.29 1 
38 0 1.28±0.03a 0.00 0 1.92±0.18bd 0.00 0 
0.183 1.31±0.13a 2.28 0 3.79±0.61c 98.02 1 
1.83 1.31±0.01a 1.66 0 3.69±0.41c 92.49 1 
18.3 1.31±0.03a 2.24 0 3.54±0.20c 84.50 1 
183 1.24±0.03a -3.39 0 2.11±0.14bd 9.90 0 
1830 1.22±0.03a -4.98 0 4.30±1.01c 124.16 1 
39 0 1.28±0.03a 0.00 0 1.92±0.18b 0.00 0 
0.183 1.29±0.03a 0.31 0 1.86±0.35b -3.07 0 
1.83 1.27±0.04a -0.89 0 1.94±0.34b 1.04 0 
18.3 1.26±0.06a -2.16 0 1.98±0.24b 3.58 0 
183 1.27±0.02a -1.39 0 2.10±0.50b 9.41 0 
1830 0.95±0.05b -25.66 -2 1.83±0.19b -4.37 0 
40 0 1.28±0.03a 0.00 0 1.92±0.18bd 0.00 0 
0.183 1.26±0.04a -2.04 0 3.21±0.39cd 67.46 1 
1.83 1.24±0.03a -3.05 0 1.90±0.20bcd -0.85 0 
18.3 1.29±0.05a 0.56 0 1.92±0.16bcd 0.24 0 
183 1.31±0.03a 2.23 0 1.93±0.28bcd 0.60 0 
1830 0.82±0.03b -36.31 -3 1.39±0.24bd -27.57 -1 
41 0 1.28±0.03ac 0.00 0 1.92±0.18b 0.00 0 
0.183 1.27±0.04abc -0.89 0 2.09±0.40b 9.15 0 
1.83 1.24±0.04ab -3.19 0 1.63±0.21d -15.16 0 
18.3 1.24±0.03ab -3.45 0 1.87±0.20bd -2.50 0 
183 1.33±0.03ac 3.88 0 1.13±0.38ae -41.15 -3 
1830 1.16±0.03d -9.88 0 0.70±0.08ae -63.30 -3 
 
 
 
 
 
 
 
Table 3, part f. Planktonic growth and cells adhesion in the presence of each ZA related compound. 
Percentage reduction respect to the negative control is reported. a) Percentage reduction of the maximum 
specific growth rate: code (0) x > -10 %; code (-1)  -10 % ≤ x < -20 %; code (-2) -20 % ≤ x < -30 %; code (-3)      
x ≤ -30 %; b) Percentage reduction of the number of adhered cells: code (+1) x > +20 %; code (0)                          
+20 % ≤ x < -20 %; code (-1)  -20 % ≤ x <  -30 %; code (-2) -30 % ≤ x < -40 %; code (-3) x ≤ -40 %. According to 
post hoc analysis (Tukey’s HSD, p < 0.05), data sharing the same letter indicates no signiﬁcant diﬀerence. 
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  Planktonic growth Cells adhesion 
Cmpd 
Conc. 
(µM) 
OD600/min 
(x10-3) 
% 
reduction 
Code 
(a) 
No. adhered 
cells (x107) 
% 
reduction 
Code 
(b) 
42 
 
0 1.28±0.03ab 0.00 0 1.92±0.18b 0.00 0 
0.183 1.29±0.01abc 0.16 0 3.30±0.53c 72.26 1 
1.83 1.31±0.05abc 1.96 0 1.84±0.15b -3.76 0 
18.3 1.33±0.01bc 3.53 0 1.78±0.18b -7.28 0 
183 1.30±0.01abc 1.04 0 1.68±0.29b -12.13 0 
1830 1.03±0.02d -19.39 -1 2.23±0.38d 16.50 0 
43 0 1.28±0.03a 0.00 0 1.92±0.18bd 0.00 0 
0.183 1.28±0.04a -0.38 0 2.67±0.45cd 39.31 1 
1.83 1.29±0.05a 0.55 0 2.00±0.28bcd 4.48 0 
18.3 1.30±0.02a 1.61 0 1.99±0.33bd 4.03 0 
183 1.27±0.03a -1.19 0 1.95±0.34bcd 1.86 0 
1830 1.03±0.04b -19.67 -1 1.66±0.33bd -13.31 0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3, part g. Planktonic growth and cells adhesion in the presence of each ZA related compound. 
Percentage reduction respect to the negative control is reported. a) Percentage reduction of the maximum 
specific growth rate: code (0) x > -10 %; code (-1)  -10 % ≤ x < -20 %; code (-2) -20 % ≤ x < -30 %; code (-3)       
x ≤ -30 %; b) Percentage reduction of the number of adhered cells: code (+1) x > +20 %; code (0)                           
+20 % ≤ x < -20 %; code (-1)  -20 % ≤ x <  -30 %; code (-2) -30 % ≤ x < -40 %; code (-3) x ≤ -40 %. According to 
post hoc analysis (Tukey’s HSD, p < 0.05), data sharing the same letter indicates no signiﬁcant diﬀerence. 
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Figure 5. Biological activity of each ZA related compound at the different tested concentrations.            No biological 
activity;             Anti-biofilm activity;            Increased biofilm formation;            Planktonic to biofilm mode of life 
transition;             Biocidal effect.  
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Molecule 0 µM 0.183 µM 1.83 µM 18.3 µM 183µM 1830 µM 
Total 
value 
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Figure 6. Anti-biofilm performance of each ZA related compound. Total and related to each concentration value is 
reported. Anti-biofilm performance:             ≥ 3,           = 2;             = 1;            = 0;           = -1;           = -2;            ≤ -3. 
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Discussion 
 
 
 
Zosteric acid (ZA) has been proposed as a new anti-biofilm compound able to counteract both bacterial 
and fungal biofilm formation (Villa et al., 2010; Villa et al., 2011). Advantages would be conferred by 
covalently coupling this molecule to the surface of a material in a way to preserve the biological 
function. The development of this preventive strategy is limited by the lack of information about the 
structural chemical determinants responsible of its anti-biofilm activity. Previously Stanley and 
colleagues (2002) hypothesized that the antifouling effect of ZA lies in the high affinity for water shown 
by its sulfate groups that increase the cell surface hydrophility. In contrast, Villa and co-authors (2011) 
demonstrated that the activity of methyl zosterate, which carboxylate moiety was replaced by a 
methyl ester group, had no anti-biofilm ability, suggesting that the activity of ZA sodium salt is not due 
to the presence of the sulfo-oxy ester group. 
In this research a new series of chemically modified molecules related to ZA scaffold were planned and 
investigated with the aim to better understand the structural requirements responsible for ZA the anti-
biofilm activity. Compounds were characterized by the introduction of substituents at different 
positions on phenyl ring and several side-chain modifications, such as the removal of the insaturation 
and the substitution of the carboxylic acid with an alcohol, an aldehyde and ester functionalities. 
Moreover, both E/Z isomers were prepared in order to explore the role of the double bond.  
All these molecules were submitted to a biological screening considering ZA as reference compound 
and using E. coli as model bacterial system. The molecules were tested at different concentrations 
starting from 1830 µM that is the concentration at which ZA performs its best anti-biofilm activity (Villa 
et al., 2010). Three % DMSO successfully solubilized the molecules inside the media affecting neither 
planktonic growth nor cell adhesion. This is in line with the results obtained by Pottz and collaborators 
(1967) who reported that the bacteriostatic concentration of DMSO for E. coli is 10% while the 
bactericidal concentration is above 30%. Bodini and coauthors (2009) also showed that DMSO did not 
significantly affect biofilm formation even at close-to-lethal concentrations.  
With the aim to identify trends, planktonic growth and cells adhesion data were grouped to obtain a 
global picture of the biological activity of each ZA related compound at the different concentrations. 
Molecules showed different biological activity depending on their concentration. At the highest 
concentrations, most of molecules inhibited biofilm formation and drastically reduced planktonic 
growth. Therefore, it was assumed that the suppression of biofilm formation was a result from the 
inhibition of bacterial growth rather than from specific anti-biofilm effects of the substances. Other 
molecules at the highest concentrations enhanced biofilm formation and also reduced bacteria 
planktonic growth. In this case the transition to the sessile mode of life was assumed as a protective 
response to survival in hostile environments (Davey et al., 2000; Donlan et al., 2002; Villa et al., 2012c). 
At high concentrations the movement of cells toward surfaces could be considered the step 
immediately before the killing effect as a kind of protecting way against hard stress condition (Plyuta 
et al., 2013). At the lowest concentrations, an enhancement of biofilm formation was also 
demonstrated for many of the molecules investigated. Biofilm enhancement by low concentration of 
small molecules is not new in the biofilm world. Very low concentrations of low-molecular weight 
compounds released as exudates by plants can act as chemical signals inducing bacteria to colonize 
specific plant areas developing a complex biofilm that positively interacts with the plant itself (Bais et 
al., 2006). Plyuta and colleagues (2013) demonstrated that very high concentration of several phenolic 
acid compounds completely suppressed Pseudomonas aeruginosa biofilm as a killing effect. In 
contrast, P. aeruginosa biofilm formation was up to 2- to 3-fold increased and planktonic growth was 
20-50% reduced under the action of some phenolic acids compared with the biofilm formed in their 
absence (Plyuta et al., 2013). Recent evidences also suggested that high concentration of some 
antibiotics eradicates bacteria while sub-inhibitory concentrations of them induce biofilm formation 
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(Hoffman et al., 2005; Linares et al., 2006; Migliore et al., 2013; Salta et al., 2013). Zaitseva and 
coauthors (2009) also observed the same effect for P. aeruginosa and Burkholderia cenocepacia under 
the action of some antimicrobial agents as nitrofurans and nitric oxide generators. Plyuta and 
collaborators (2013) hypothesized that enhancement of biofilm formation at sub-inhibitory 
concentrations of antibacterial drugs is probably a useful strategy of pathogenic bacteria facilitating 
their survival after intense antibiotic therapy, when low quantities of drugs remain in the human 
organism. Biofilm formation by plant pathogenic bacteria might be also an important factor of their 
protection against antibacterial action of plant-produced phenolics (Walker et al., 2004). However, the 
mechanisms underlying stimulation of biofilm formation at sub-inhibitory or weakly bacterial growth-
suppressing compound concentrations are currently unclear. As biofilm formation is a multi-stage 
process, these substances can affect several targets (Plyuta et al., 2013). 
Each ZA related compound was also associated to a global anti-biofilm performance value, calculated 
so that to take into account the occurrence that ZA related compounds induced a different bacterial 
response depending on their concentration and the positive or negative contribution of each single 
concentration to the global anti-biofilm performance. A reduction of adhered cells were considered a 
positive contribution to the anti-biofilm performance value, while both the increase of the adhered 
cells and the decrease of planktonic growth were considered a negative contribution.  
The molecules grouped on the basis on both their biological activity and anti-biofilm performance 
value allowed to recognize some chemical structure require to exert anti-biofilm activity. Structure-
activity relationship considerations revealed that the carboxylic acid moiety conjugated to the double 
bond in trans configuration was an essential requirement in ZA chemical structure to guarantee a good 
anti-biofilm performance, while the deletion of the sulphate ester group seems not to compromise the 
ZA anti-biofilm activity. Moreover the study revealed that the para position on the phenyl ring could 
be considered a good point for the coupling to a polymer. Indeed p-aminocinnamic acid bearing the 
same ZA active scaffold and an amino group in the para position of the phenyl ring was selected as 
suitable compounds to form a covalent linkage with appropriate functional groups of the polymeric 
material. 
Among the tested molecules, p-coumaric acid and trans cinnamaldehyde were previously investigated 
for their anti-biofilm properties against E. coli. Bodini and coauthors (2009) showed that millimolar 
amounts of p-coumaric acid did not affect E. coli quorum sensing activity. In our work we found that 
p-coumaric acid is able to reduce bacterial adhesion more than 40%, suggesting that this molecule has 
an anti-biofilm activity which mechanism is not related to quorum sensing. Niu and collaborators 
(2004, 2006) reported that at sub-lethal concentration trans cinnamaldehyde was effective against E. 
coli biofilm reducing the quorum sensing activity, leading to a morphological damage of cells and 
decreasing swimming motility. Similarly Brackman and co-authors (2008, 2011) showed that 
cinnamaldehyde and some cinnamaldehyde derivatives, at concentration that not affect bacterial 
growth, interfere with autoinducer-2 based quorum sensing in various Vibrio spp. by decreasing the 
DNA-binding activity of the response regulator LuxR. Our data indicated that trans cinnamaldehyde 
did not affect cells adhesion. It is reasonable to suppose that trans cinnamaldehyde has an effect 
during maturation but not in the first step of biofilm formation. 
 
 
 
Conclusion 
 
A series of structurally-related compounds was developed and tested and the performed studies 
highlighted the key role of specific structural features in relation to their anti-biofilm activity. As 
cinnamic acid showed an inhibitory activity also at 1000-fold minor concentration compared with ZA, 
it was identified as a promising anti-biofilm agent. In details, the carboxylic acid moiety conjugated to 
a double bond in trans configuration was an essential requirement for the inhibition of the biofilm 
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growth. Moreover, the anti-biofilm activity was also affected by the nature and the position of 
substituents on the phenyl ring. In conclusion, the cinnamic acid scaffold could be considered the 
starting point for the development of a new generation of derivatives characterized by improved 
activity to study and modulate bacterial adhesion.  
A further advance of this work might be the grafting of selected molecules, showing a good anti-biofilm 
activity and presenting specific functional groups, to a polymeric surface, obtaining a new material 
able to inhibit the sessile growth.  
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Scansion of Escherichia coli proteome for zosteric acid and 
salicylic acid target identification 
 
 
 
 
Abstract 
 
Recently the natural compounds zosteric acid and salicylic acid have been proposed as alternative 
biocide-free agents suitable for a preventive or integrative approach against biofilm formation. Beside 
these important results, the lack of information concerning the mechanism of action and the cellular 
receptors involved in their anti-biofilm activity limits the efforts to generate more potent derivatives 
based on the same target and activity structure. In this study, an affinity chromatography proteomic 
approach was employed to scan the entire Escherichia coli proteome with the aim to identify the 
molecular targets that directly interact with the anti-biofilm compounds zosteric acid and salicylic acid. 
Mass spectrometry analysis of SDS-PAGE-resolved pull-down proteins reveal that both zosteric acid 
and salicylic acid in E. coli directly interact with the same protein WrbA, suggesting a possible role of 
this protein in the biofilm formation process. Protein FkpA and Tdh were also identified as possible 
target for salicylic acid. However, many interpretations about the interaction of zosteric acid and 
salicylic with these proteins are possible and further experiments are necessary to clarify this question. 
 
 
 
Introduction 
 
The worldwide safety is seriously affected by the emergence and spread of microorganisms in form of 
biofilm, complex differentiated surface-associated microbial community embedded in a self-produced 
polymeric matrix (Stoodley et al., 2002). All human artefact surfaces like industrial installations, work 
benches, harbor systems and also medical devices are susceptible to biofilm colonization with 
important consequences in term of social and economic impact (Hall-Stoodley, 2004). The most 
detrimental problem is that microorganisms in form of biofilm are up to several orders of magnitude 
more resistant to antimicrobial agents making their removal from surfaces difficult or even impossible. 
In addition, increasingly restrictive regulations have banned the use of several biocides hazardous to 
human health and the environment leading to the inevitable need to develope innovative strategies 
(Villa et al., 2012).  
An innovative approach could be the use of biocide-free anti-biofilm compounds with novel targets, 
unique modes of action and properties that are different from those of the currently used antimicrobial 
agents. Nature has been proposed as an important source of new bioactive substances able to exert 
anti-biofilm properties at sub-lethal concentrations. These behave anticipating bioﬁlm formation by 
interfering with specific key step of its formation (Villa et al., 2013). Since this approach deprives 
microorganisms of their virulence properties without affecting their existence, the selection pressure 
for antibiotics and biocides resistance mutations decrease, posing promising perspective to restore the 
efficacy of traditional antimicrobial agents (Rasko et al., 2010). Despite the successes, many 
pharmaceutical companies have scaled down their efforts on natural products in favor of newer and 
faster combinatorial synthesis technologies. Parallel synthesis allows the rapid construction of 
compound libraries suitable for high-throughput screening. However, the perceived burst in innovative 
solutions through combinatorial synthesis has not been materialized. Combinatorial compounds are 
not so effective as natural compounds often exerting their effects in the micromolar range, in contrast 
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to high potency exhibited by many natural products (Cong et al., 2012). For these reasons, the interest 
in natural products has been rekindled. Recently, the emphasis has been placed on approaches that 
combine the power of natural products and organic chemistry that lead to optimize processes or the 
synthesis of natural product mimics (Ortholand et al., 2004). The potential bottleneck of this approach 
is the general lack of information concerning the mechanism of action and cellular receptors of many 
bioactive natural products. Without an understanding of the nature of products-targets binding, 
efforts to generate more potent derivatives or mimics through structure-activity relationship studies 
may prove futile. In addition, identification of targets allows the prediction of potential toxicities in an 
early stage of drug development and the prioritization of drug candidates (Wong et al., 2008). 
Recently, the natural compounds zosteric acid (ZA) and salicylic acid (SA) have been proposed as 
alternative biocide-free agents suitable for a preventive or integrative approach against biofilm 
formation. Both ZA and SA were proved to reduce, at sub-lethal concentrations, both bacterial and 
fungal adhesion and play a role in shaping biofilm architecture, in reducing biofilm biomass and 
thickness and in extending the performance of antimicrobial agents (Barrios et al., 2005; Villa et al., 
2010; Villa et al., 2011; El-Banna et al., 2012; Polo et al., 2014). Proteomic study on E. coli suggested 
that ZA acts as environmental cue leading to global stress on bacterial cells, which favors the 
expression of various protective proteins, the signal molecule autoinducer-2 production, and the 
synthesis of flagella, to escape from adverse conditions (Villa et al., 2012). Other researchers 
hypothesized that SA interferes with bacterial quorum sensing signals involved in biofilm formation 
and inhibits bacteria motility suggesting the presence of a complex and overlapping effect against 
biofilm cells (Bandara et al., 2006; Yang et al., 2009; Chow et al., 2011; Lagonenko et al., 2013).  
The aim of this research is to elucidate the molecular targets and pathways involved in ZA and SA anti-
biofilm activity, as a starting point to develop new improved and more efficient anti-biofilm solutions. 
In this study, the proteomic approach of the affinity chromatography coupled with mass spectrometry 
analysis was used for ZA and SA E. coli cellular target identification. As this approach identifies the 
direct binding targets of a compound, the true targets of ZA and SA were isolated among a complex 
mixture of proteins and no indirect inferences of a target hypothesis were generated. Moreover, in 
this approach the entire proteome is scanned for targets identification instead of relying on a 
predeﬁned set of recombinant proteins, as in the case of other approaches offering high selectivity 
and resolution for the proteins of interest. 
 
 
 
Materials and Methods 
 
Escherichia coli strain and growth condition  
The best characterized Escherichia coli strain K-12 ATCC 25404 wild type was used throughout the 
study. The strain was stored at –80 °C in suspensions containing 20 % glycerol and 2 % peptone, and 
was routinely grown in Luria-Bertani broth (LB, Sigma-Aldrich) at 30 °C for 16 h. 
 
Compound synthesis 
Cinnamic acid (CA), p-aminocinnamic acid (p-ACA), salicylic acid (SA), p-aminosalicylic acid (p-ASA) 
were purchased by Sigma-Aldrich and were used without any further purification (Figure 1). Zosteric 
acid (ZA) was synthesized as already described in a previous work by Villa and collaborators (2010). 
  
Biological assay 
ZA, CA, p-ACA, SA, p-ASA were used in planktonic growth, carbon source and biofilm assays at 0 
(negative control), 0.183, 1.83, 18.3, 183 and 1830 µM with the addition of 3 % of dimethyl sulphoxyde 
to make the molecules soluble. All tests were performed as described in Chapter 3 and data were 
reported as percentage reduction respect to the negative control. Molecules were considered able to  
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affect planktonic growth when reduced cell growth more than 10 % respect to the negative control 
and to affect biofilm formation when reduced the number of adhered cells more than 30 % respect to 
the negative control. Analysis of variance (ANOVA) via a software run in MATLAB (Version 7.0, The 
MathWorksInc, Natick,USA) was applied to statistically evaluate any significant differences among 
each concentration of a compound. Tukey’s honestly significant different test (HSD) was used for 
pairwise comparison to determine the significance of the data. Differences were considered significant 
for p ˂ 0.05.  
 
Extraction of total soluble cell proteins 
An E. coli overnight culture was centrifuged at 5,000 g for 15 min at 4 °C three times, washed and 
resuspended in 200 mM Tris-HCl, 40 mM NaCl buffer (pH 7.5) (protein extraction buffer) to a final 
concentration of 250 mg of cells for mL. Soluble protein extract was obtained by sonication (seven 1-
min sonication cycles followed by 2 min cooling periods, all on ice, in a Sonoplus UW-2070 sonicator) 
and cell debris was removed by centrifugation at 10,000 g for 45 min at 4 °C. The sample protein 
concentration was determined using the Bradford method with bovine serum albumin as standard 
(Bradford, 1976). 
 
Matrix functionalization with p-aminocinnamic acid/p-aminosalicylic acid 
Five milliliters of drained NHS-Activated Sepharose 4 Fast Flow (Ge Healthcare Life Sciences, 
17090601) were washed 10 times with cold 1 mM HCl and then suspended in 0.2 M NaHCO3, 0.5 M 
NaCl, 3 % DMSO buffer (pH 8.3) (coupling buffer). p-ACA and p-ASA dissolved in the coupling buffer at 
the concentration of 0.4 M were added to the matrix (10 µmol ligand/µmol NHS), mixed in a rotary 
shaker overnight at 4 °C. After one washing with the coupling buffer, remaining unreacted groups were 
blocked with 0.5 M ethanolamine, 0.5 M NaCl (pH 8.3). Subsequent 10 washing steps were performed 
according to the manufacturer's instructions. To generate the control matrix (EA/matrix), matrix was 
incubated with only coupling buffer and equally treated as described above. 
 
Fluorescent spectra of p-aminocinnamic acid and p-aminosalicylic acid free in solution and matrix 
immobilized  
Fluorescence spectra of p-ACA and p-ASA free in solution and matrix-immobilized were independently 
acquired in a Perkin-Elmer LS 50B spectrofluorometer. Emission spectra were recorded over the 250-
600 nm range with emission and excitation slit widths set at 3.0 nm. Spectra of p-ACA and p-ASA free 
in solution were recorded by dissolving 2.6 mM p-ACA and 5.0 mM p-ASA in 0.4 M NaHCO3, 1 M NaCl, 
3% DMSO buffer (pH 8.3) (dilution buffer). Spectra of matrix-immobilized p-ACA and p-ASA were 
Figure 1. Chemical compounds used in this research: a) zosteric acid (ZA); b) cinnamic acid (CA);      
c) p-aminocinnamic acid (p-ACA); d) salicylic acid (SA); e) p-aminosalicylic acid (p-ASA). 
a 
b 
d 
e 
c 
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recorded by suspending respectively 25 µL and 12.5 µL of functionalized matrix in 2 mL of dilution 
buffer. Control spectra of dilution buffer and ethanolamine-saturated matrix were also acquired at the 
same experimental conditions. 
 
Matrix hydrolysis 
The functionalized matrix was submitted to hydrolysis reaction in order to break the chemical bond 
between p-ACA/p-ASA and the matrix. The matrix was hydrolyzed by treatment with a 4 N aqueous 
solution of NaOH (1 mL). The suspension was stirred at room temperature for 4 hours. Reactions were 
monitored by thin layer chromatography (TLC) analysis on aluminium-backed Silica Gel 60 plates (0.2 
mm, Merck) and were visualized under a UV lamp operating at wavelengths of 254 nm. Visualization 
was aided by opportune staining reagents. The matrix was filtered off and washed. The aqueous layer 
was acidified to pH=1 with 2N HCl and then extracted with ethyl acetate (3x1 mL). The combined 
organic layers were dried over anhydrous sodium sulfate and the solvent was evaporated under 
reduced pressure. The obtained molecule was submitted to mass spectrometry analysis to be 
identified. 
 
Mass spectrometry analysis and molecule identification 
Products from matrix hydrolysis reaction were analysed by liquid chromatography-electrospray 
ionization- mass spectrometry (LC-ESI-MS) on an Ultimate 3000 Micro HPLC apparatus (Dionex, 
Sunnyvale, CA, USA) equipped with a FLM-3000-Flow manager module directly coupled to a LTQ 
Orbitrap XL hybrid FT mass spectrometer (Thermo Fisher Scientific, Waltham, MA, USA). Reverse-
phase chromatography was performed on a Jupiter C18, 5 μm, 150 x 1.0 mm column (Phenomenex, 
Torrance, CA, USA) and a 31 min run (gradient 0 to 40 % acetonitrile in water with 0.1 % formic acid 
over 20 min) at a flow rate of 80 µL/min. Mass spectra were collected at 60,000 of resolution in the 
Orbitrap analyser (mass range 50-1,000 Da). High resolution MS data were elaborated manually using 
the HPLC-MS apparatus management software (Xcalibur 2.0.7 SP1, Thermo Fisher Scientific). 
 
Protein pull-down 
The obtained functionalized matrix was washed with 5 mL of protein extraction buffer, centrifuged at 
700 g for 2 min at room temperature and incubated with the soluble extracted proteins for 2.5 hours 
at room temperature in a rotary shaker. Matrix and soluble extracted proteins were packaged into a 
15 mL chromatography column (i.d. 10 mm). One hundred mL of washing buffer were loaded into the 
column and a flow rate of 1.5 mL/min was applied to recover matrix unbound proteins. Proteins 
specifically bound to the functionalized matrix were recovered by competitive elution by loading into 
the column 15 mL of 60 mM competitor compound in 200 mM Tris-HCl, 40 mM NaCl buffer (pH 7.5) 
followed by 50 mL of 200 mM Tris-HCl, 1M NaCl 1 M, buffer (pH 7.5). CA or ZA were used to elute 
proteins bound to p-ACA functionalized matrix (p-ACA/matrix) while SA was used to elute proteins 
bound to p-ASA functionalized matrix (p-ASA/matrix). A compact single beam UV-monitor with flow-
through cell (GE Healthcare Uvicord SII Code; 280 nm filter) was employed for continuously monitoring 
protein concentrations during the chromatography. Chromatographic fractions were collected and 
protein concentration was determined by Bradford assay with bovine serum albumin as standard 
(Bradford, 1976). To increase the protein concentration, fractions were precipitated using cold 13 % 
trichloroacetic acid, centrifuged at 13,000 g for 30 min at 4 °C and subsequently washed by cold 
acetone.  
 
Denaturing gel electrophoresis  
Precipitated proteins were dissolved in Laemmli sample buffer and were separated by SDS-PAGE 
according to Laemmli (1970). Coomassie-stained bands and spot were manually excised from gels and 
subjected to analysis by mass spectrometry. 
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Mass spectrometry analysis and protein identification 
Excised bands were submitted to trypsin digestion as described by Di Pasqua and colleagues (2010). 
Trypsin digested peptides were analyzed by liquid chromatography-electrospray ionization-tandem 
mass spectrometry (LC-ESI-MS/MS) on the same HPLC and LTQ Orbitrap mass spectrometer previously 
reported in ‘Mass spectrometry analysis and molecule identification’. Reverse-phase chromatography 
was performed on the same column and at the same flow rate but with different chromatographic 
conditions: linear gradient 1.6 to 44 % acetonitrile in water with 0.1 % formic acid over 60 min and 
total LC-run of 95 minutes. Mass spectra were collected in data dependent scan mode (MS scan at 
60,000 of resolution in the Orbitrap and MS/MS scan on the three most intense peaks in the linear ion 
trap, mass range 300-2,000 Da). Selected peptides charge states were isolated with a width of m/z 2 
and activated for 30 msec using 35% normalized collision energy and an activation q of 0.25.  Protein 
identifications were obtained with the embedded ion accounting algorithm (Sequest HT) of the 
software Proteome Discoverer (version 1.4, Thermo) after searching a UniProtKB Protein 
Knowledgebase [release 2013_12 of 11-Dec-13; taxonomical restriction: Escherichia coli (strain K12), 
4431 sequence entries]. The search parameters were 10 ppm tolerance for precursor ions and 0.6 Da 
for product ions, 1 missed cleavage, carbamydomethylation of cysteine as fixed modification, oxidation 
of methionine as variable modification and on a decoy database search calculated false discovery rate 
under 5 %. 
 
Sequence alignments  
Sequences of obtained proteins were aligned with all bacterial and fungal proteome using the National 
Center for Biotechnology Information (NBCI) protein BLAST tool with a BLOSUM62 matrix and default 
parameters.  
 
 
 
Results 
 
Zosteric acid and salicylic acid chemical structure were modified without affecting their anti-biofilm 
properties 
Since Sepharose 4 Fast Flow matrix prepared with 6-aminohexanoic acid spacer arm and activated by 
esterification with N-hydroxysuccinimide is prone to form very stable amide linkages with molecules 
containing a primary amino group in their scaffold, ZA and SA were modified by adding an amino group 
in the para position of their chemical scaffold so to make them suitable for the chemical linkage with 
affinity the matrix.  
To verify that the deletion of the sulfate ester group in the para position of ZA and the addition of an 
amino group in the para position of ZA and SA, phenyl ring and did not affect the anti-biofilm 
performance of the compound, ZA, CA, p-ACA, SA and p-ASA were submitted to biological assays. 
To verify that a possible reduction of the number on adhered cells was given by an inhibition growth 
effect instead of a real anti-biofilm activity, the ability of each molecule to affect bacterial planktonic 
growth was performed measuring the maximum specific growth rate of bacteria in the presence of 
each compound at the different concentrations. ZA did not affect planktonic growth at any 
concentration while CA, p-ACA, SA and p-ASA affected planktonic growth only at the maximum 
concentration tested, showing a significant growth reduction (> 10 %) respect to the negative control 
(Table 1). 
The ability of each compound to be a carbon and energy source for the microorganism was verified. 
The experiment revealed that E. coli did not grow in the presence of each compound as the sole carbon 
and energy source and showed an OD600 significantly comparable with the negative control.  
Finally, the anti-biofilm performance of each compound was proved. As expected, at lethal 
concentration, molecules showed a reduction of the number of adhered cells, attributable to a killing 
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effect rather than to their anti-biofilm performance. At sub-lethal concentration, all the molecules 
showed at least one concentration with excellent anti-biofilm activity with a significant percentage 
reduction of adhered cells respect to negative control, up to 70 % for ZA, 46 % for CA, 46 % for p-ACA, 
67 % for SA, 72 % for p-ASA (Table 1). Therefore the deletion of the sulfate ester group from ZA scaffold 
and the addition of the amino group in the para position of the phenyl ring in ZA and SA structure did 
not affect their anti-biofilm performance. p-ACA and p-ASA were indeed selected for their covalent 
coupling with the chromatography affinity matrix.   
 
Cmpd µM 
Planktonic      
growth 
Cell         
adhesion 
 
Cmpd µM 
Planktonic     
growth 
Cell         
adhesion 
ZA 0 0.0±2.0 a 0.0±9.5 a  SA 0 0.0±2.0  a 0.0±9.5 a 
0.183 0.8±3.0 a 32.4±12.5 b  0.183 -1.1±3.6 a -28.8±12.7 bd 
1.83 1.8±3.0 a -24.8±11.7 c  1.83 0.3±4.9  a -31.6±13.4 bd 
18.3 0.1±3.1 a -31.8±12.5 c  18.3 2.7±0.9  a -47.0±12.2 bd 
183 1.1±3.2 a -27.7±6.9 c  183 -0.2±3.2  a -67.4±4.8 cd 
1830 1.2±3.4 a -70.6±6.0 d  1830 -44.0±1.0  b -50.0±8.0 bcd 
CA 
 
 
 
 
 
0 0.0±2.0 a 0.0±9.5 ad  p-ASA 0 0.0±2.0  a 0.0±9.5 a 
0.183 -3.3±3.4 a -46.9±12.2 bcd  0.183 -3.4±2.6  a 10.7±18.0 a 
1.83 -4.7±0.8 a -38.8±8.7 bcd  1.83 -0.9±4.6  a -70.7±3.4 b 
18.3 -5.2±2.7 a -7.4±5.4 acd  18.3 1.3±2.9  a -72.5±6.4 b 
183 -8.6±2.7 a -30.8±1.3 abcd  183 2.3±5.8  a -55.6±2.4 c 
1830 -35.1±1.6 b -32.1±8.6 bcd  1830 -22.9±1.0 b -31.0±7.4 d 
p-ACA 0 0.0±2.0 a 0.0±9.5 abcd        
0.183 -1.9±3.5 a 0.1±0.8 abce        
1.83 -3.1±1.6 a -23.5±9.0 bcd        
18.3 -3.1±1.8 a -42.1±9.0 cdf        
183 -2.4±4.6 a -21.4±4.3 ce        
1830 -32.4±1.9 b -46.6±13.1 df        
 
 
 
Matrix functionalization reaction was successfully optimized 
Different μmolligand/μmolNHS ratio at different pH values were tested to optimize the coupling 
conditions between p-AC and p-AS and the matrix. A ratio μmolligand/μmolNHS of 10/1 was the maximum 
tested since above this value molecules was less soluble. Fluorescence measurements using condition 
followed reported were used to monitor the reaction efficacy. A ratio μmolligand/μmolNHS of 10/1 at pH 
8.3 was chosen as the best reaction condition (Figure 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Percentage reduction of planktonic growth and adhered cell respect to the negative control. According to post hoc 
analysis (Tukey’s HSD, p < 0.05), data sharing the same letter indicates no signiﬁcant diﬀerence. 
Figure 2. Fluorescence  emission spectra of matrix suspension after coupling reaction (pH 8.3) with p-ACA (λex 350 nm, λem 
426 nm; ●) or p-ASA (λex 325 nm, λem 396 nm; ○ ) at different μmolligand/μmolNHS ratios in the optimal pH condition. NHS 
micromoles
 
were calculated considering NHS density value of 20 μmolNHS
 
/ml drained matrix. 
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Fluorescence measurements successfully detected the presence of ZA and SA active scaffold on the 
functionalized matrix 
Fluorescence measurements were used to verify p-ACA acid and p-ASA immobilization process and to 
highlight any changes in the molecule regions during the coupling reaction by comparing the 
fluorescence emission spectra of the molecules free in solution and covalently bound to the matrix.  
p-ACA excited at 380 nm showed an emission peak at 443 nm while p-ASA excited at 325 nm showed 
an emission peak at 395 nm (Figure 3). Analysis performed on fluorescence data revealed that p-ASA 
was 9-fold lower than p-ASA fluorescence at the same concentration. Matrix functionalized with p-ACA 
excited at 350 nm showed an emission peak at 426 nm while matrix functionalized with p-ASA excited 
at 325 nm showed an emission peak at 396 nm (Figure 3). Analysis performed on fluorescence data 
revealed that p-ASA/matrix was 2.4-fold lower than p-ASA/matrix fluorescence at the same amount. 
Since the control matrix did not exhibit fluorescence properties at the same experimental condition, it 
is possible to ascribe the fluorescence to the immobilized ZA and SA confirming the positive results of 
the immobilization process. Moreover, the comparison between the free and immobilized molecule 
spectra revealed that both p-ACA and p-ASA conserved their fluorescent properties after the 
immobilization process suggesting that the fluorogenic moieties of p-ACA acid and p-ASA acid were 
not altered during the matrix-coupling reaction. Little differences in the spectra between free and 
immobilized molecules may be ascribed to the different condition during the fluorescence detection 
(molecule free in solution and molecule immobilized on a suspended matrix). 
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Figure 3. Fluorescent emission spectra of free in solution and matrix immobilized molecules. Panel A: p-ACA (λex 380 nm); 
Panel B:         p-ACA/matrix, ― EA/matrix (λex 350 nm); Panel C: p-ASA (λex 325 nm); Panel D:         p-ASA/matrix, ― EA/matrix 
(λex 325 nm). 
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Mass spectrometric analysis confirmed p-ACA and p-ASA matrix immobilization  
In order to further verify the p-ACA and p-ASA immobilization process excluding any changes in the 
chemical scaffold of the molecules as a result of the coupling reaction, functionalized matrix were 
submitted to hydrolysis in order to break the amide bound between the complex p-ACA/matrix and p-
ASA/matrix and to release p-ACA and p-ASA in solution. Obtained molecules were analyzed by mass 
spectrometric techniques and thanks to the high resolution of the MS apparatus, their molecular 
masses were detected with high precision, confirming their identity. Mass spectrometry analysis 
registered a monoisotopic single charged mass ([M+H)+]) of 164.069 m/z in the hydrolysates produced 
by p-AC/matrix and a [M+H]+ of 154.049 m/z in the hydrolysates produced by p-SA/matrix (Figure 4). 
The theoretical [M+H]+ for p-CA is reported to be 164.071 m/z while the theoretical [M+H]+ for p-ASA 
is reported to be 154.050 m/z. Indeed there is a significant evidence that the product from p-
ACA/matrix hydrolysis and p-ASA/matrix hydrolysis correspond to p-ACA and p-ASA respectively 
(experimental mass error of 0.002/0.001 Da) confirming that the matrixes were functionalized with 
both p-ACA and p-ASA.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SDS-PAGE analysis of pull-down revealed bands bound to the matrix 
Proteins bound and unbound to the matrix functionalized with p-ACA and p-ASA were quantified and 
resolved by SDS-PAGE. Washing fractions were also loaded in the gel to make easier, under 
comparative conditions, the identification of interesting proteins in the fractions collected during 
elution by competition. 
The SDS-PAGE analysis demonstrated that in three independent experiments one protein of about 20 
kDa was eluted from the p-ACA/matrix by competition with both CA (Figure 5) and ZA sodium salt 
(Figure 5). No proteins were observed to bind the control resin functionalized with ethanolamine and 
eluted with the same competitors, indicating that the protein isolated on the matrix support 
specifically bound p-ACA (Figure 5). 
Figure 4. Extracted Ion Current (XIC) profiles of hydrolyzed p-ACA/matrix (panel A) and p-ASA/matrix (panel B) recorded 
during the LC-MS run. Retention time and m/z are evidenced. 
 
A 
B 
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Three proteins of about 20, 30 and 40 kDa were eluted from the p-ASA/matrix by competition with SA 
(Figure 5) in three independent experiments. No protein was observed to bind the control resin 
functionalized with ethanolamine and eluted with the same competitor, indicating that the proteins 
isolated on the affinity support specifically bound p-ASA (Figure 5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Both ZA and SA interact with the same protein WrbA 
Protein specifically bound to functionalized matrix and resolved by SDS-PAGE were cut from the gel 
and submitted to mass spectrometric analysis in order to be identified. Identified proteins and their 
characteristics are reported in table 2. In all cases, mass spectrometric analysis gave a result with a 
high score and coverage percentage, suggesting an unequivocal identification of the proteins. 
Mass spectrometric analysis revealed that the same protein WrbA (P0A8G6) was eluted from p-
ACA/matrix by competition with both sodium cinnamate and ZA confirming that p-AC/matrix bound 
specifically WrbA. WrbA was also eluted from p-ASA/matrix by competition with SA. Indeed WrbA was 
proved to be the possible molecular target for both ZA and SA. Protein FkpA (P45523) and Tdh (P07913) 
were also eluted from p-ASA/matrix by competition with SA.  
 
The blast search assay inside Bacteria and Fungi databases revealed that WrbA sequences exists in 
a diversity of microorganisms  
A BLAST search of all non redundant databases in Bacteria and Fungi was performed with WrbA protein 
sequence as the query.  
The search inside Bacteria databases returned 5792 sequences that had between 40% and 100% 
identity to WrbA (expect value ≤ 10-5), most of which belonged to different E. coli strains, Shigella ssp, 
Enterobacter ssp, Salmonella ssp, Klebsiella ssp, Cronobacter ssp, Yersinia ssp, Serratia ssp, 
Burkholderia ssp and Pseudomonas ssp. 
The search inside Fungi database returned 490 sequences that had between 36% and 91% of identity 
to WrbA (expect value ≤ 10-5) including Candida spp, Clavispora spp, Aspergillus spp and Fusarium spp.  
 
 
Figure 5. SDS-page analysis of the affinity chromatography of E. coli protein extract. Each gel is 
representative of three independent replicates. M: molecular mass marker, S: total soluble 
proteins from E. coli extract, U: proteins unbound, W: washing fraction  E: proteins bound to p-
ACA/matrix and eluted with CA (E1) and ZA (E2), proteins bound to p-ASA and eluted with SA 
(E3), proteins bound to EA/matrix and eluted with CA (E4), proteins bound to EA/matrix and 
eluted with ZA (E5), proteins bound to EA/matrix and eluted with SA (E6).  
Kda          M        S        U         W         W       E1       W        W           E2           E3          E4           E5         E6     
97  -    
 
66  -  
 
45  -  
 
 
30  -  
 
 
 
20  - 
 
 
14  - 
* * * 
* 
* 
Chapter 5 
60 
 
Matrixa 
 
Compb Accession 
numberc 
Gene 
named 
Proteine Scoref Coverageg 
p-ACA/matrix CA P0A8G6 wrbA 
NAD(P)H quinone 
dehydrogenase 
189.78 70.2 
p-ACA/matrix ZA P0A8G6 wrbA 
NAD(P)H quinone 
dehydrogenase 
684.32 71.72 
p-ASA/matrix SA P0A8G6 wrbA 
NAD(P)H quinone 
dehydrogenase 
1079.55 71.72 
p-ASA/matrix SA P45523 fkpA 
FKBP-type peptidyl-prolyl cis-
trans isomerase 
156.99 43.33 
p-ASA/matrix SA P07913 tdh L-threonine 3-dehydrogenase 521.32 59.53 
 
 
 
 
 
 
 
Discussion 
 
The natural compounds zosteric acid and salicylic acid were previously proved to be suitable molecules 
for innovative anti-biofilm strategies with novel target and mode of action compare to the traditional 
less effective antimicrobial agents. Although several studies were performed about their anti-biofilm 
properties, no information are available concerning their molecular target. The lack of this information 
represents a potential bottleneck to generate more effective derivatives based on the same target and 
activity structure. In this study, a pull-down system combined with mass spectrometry-based approach 
was successfully employed to screen the whole E. coli proteome in order to identify the molecular 
targets implicated in ZA and SA anti-biofilm responses. Biological assays performed on E. coli strain 
confirmed the anti-biofilm performance of ZA and SA and demonstrated that the addition of an amino 
group in the para position of the phenyl ring in both ZA and SA chemical structure did not affect their 
anti-biofilm activity. p-ACA and p-ASA were chosen as suitable molecules to successfully immobilize ZA 
and SA active scaffold on the solid phase support via an amide bond. Mass spectrometry analysis of 
SDS-PAGE-resolved pull-down proteins revealed that both ZA and SA in E. coli directly interact with the 
same protein WrbA. Crystallographic studies reported that WrbA is characterized by a tetrameric 
quaternary structure with a hydrophobic active site pocket that provides an ideal stacking environment 
for aromatic moieties, indeed well adapted to accommodate phenolic compounds such as ZA and SA 
and suggesting that interaction of both ZA and SA with WrbA can lead to modulation of the active site 
function (Andrade et al., 2007). 
In the past E. coli WrbA was reported to promote complex formation between the tryptophan 
repressor TrpR and its DNA operator sequences (Grandori et al., 1994). Subsequent experiments 
demonstrated that WrbA did not specifically bind to DNA and its involvement in transcription 
regulation was revoked. Anyway, although a direct connection to tryptophan repressor was retracted, 
a role in the tryptophan metabolism was considered possible especially related to the indole 
production. Indole is known as a metabolite of tryptophan which has recently been proved to 
participate in various aspects of bacterial life including virulence induction, cell cycle regulation, 
stresses resistance, genetic stability, controlling metabolic feedback and it is also proposed to be a 
quorum sensing signal with an important role in bioﬁlm formation process (Hu et al., 2010; 
Worthington et al., 2013). Indole is generated by the cytoplasmic enzyme, tryptophanase, which 
hydrolyses tryptophan to produce indole, pyruvate and ammonia, a reaction that occurs exclusively in 
bacteria. In E. coli, this process is catalysed by the TnaA protein (Li et al., 2013). In normal condition 
the sigma factor RpoS transcriptional regulator induces the expression of the tryptophanase gene tnaA 
Table 2. Proteins identified by mass spectrometry analysis. a) the matrix from which the protein was eluted; b) the 
competitor used in the elution step; c) the alphanumeric unique protein sequence identifier; d) the gene name; e) the protein 
name provided by UniProtKB protein knowledgebase; f) the protein identification’s SEQUEST HT Score; g) percentage of 
protein sequence covered by identified peptides (Coverage). 
Chapter 4 
61 
 
promoting tryptophan degradation, producing indole and stimulating WrbA expression to strengthen 
negative regulation of the trp biosynthetic operon (Lacour et al., 2004; Collect et al., 2007). We 
hypothesize that ZA and SA interact with WrbA with subsequent consequences on TnaA activity that 
results in the alteration of the produced indole amount. ZA and SA may negative interact with WrbA 
reducing its activity and leading to tryptophan accumulation that results in the increased 
tryptophanase activity and indole synthesis. Alternatively ZA and SA may positive interact with WrbA 
enhancing its activity so that the availability of tryptophan decreases leading to reduced tryptophanase 
activity and indole synthesis. In both cases the result is the changing of the amount of indole in the 
environment that results in a cell to cell communication alteration. Since quorum sensing is essential 
for biofilm formation, it is clear that the interference with quorum sensing signal leads to the 
destabilization of biofilm process. It is reported that either too little or too much indole can abolish the 
ability to increase bioﬁlm formation, in a dose dependent manner and with a strain specific activity. 
However, although both the hypothesis could be potentially possible to explain ZA and SA mode of 
action, a WrbA negative modulation by ZA and SA appears more probable. In a previous study, Villa 
and coauthors (2012) showed that E. coli in the presence of ZA exhibited an enhanced tryptophanase 
activity and an increased synthesis of indole. In addition it is reported that high concentrations (>600 
μM) of extracellular indole are produced by E. coli when cultured in rich medium and indole has been 
shown to decrease biofilm formation in E. coli in a non-toxic manner (Lee et al., 2007a; Lee et al., 
2007b). Domka and colleagues (2007) showed diminished conversion of tryptophan to indole as the 
bioﬁlm matures, suggesting decreased indole concentrations in developing (15 h) and mature (24 h) 
bioﬁlms. Indeed these researches validate the idea that increased amount of indole inhibits bioﬁlm 
formation which is in line with the hypothesis that ZA and SA activity might exert their anti-biofilm 
performance by negative modulation of WrbA activity.  
Recently, WrbA has been reported to be a ﬂavoprotein with the enzymatic activity of a NADH:quinone 
oxidoreductase (NQO) involved in the maintaining quinones in a fully reduced state (Patridge et al., 
2006). Quinones are compounds generally tethered to the plasma membrane or freely traverse the 
lipid bilayer. Although these compounds are essential for normal electron transport by cycling between 
the oxidized (hydroquinone) state and the two-electron reduced (hydroquinol) state, it has been 
demonstrated that such quinonoids also participate in deleterious redox cycling through direct 
interactions with single electron acceptors such as O2, leading to the accumulation of reactive oxygen 
species (ROS) such as superoxide, hydrogen peroxide, and the hydroxyl radical responsible of 
devastating consequence in the cells (Adams et al., 2005). In order to guard against the production of 
ROS from one-electron redox cycling, cells have evolved NQO to maintain quinones in a reduced state 
as a measure of protection against oxidative stress. A previous study by Villa and collaborators (2012) 
demonstrated that ZA makes E. coli cells more prone to accumulate ROS leading a stress condition to 
which the bacterium responds by activating defensive mechanisms against oxidative damage. 
Rudrappa and coauthors (2007) suggested that catechol, metabolite of SA by salicylate hydroxylase, 
plays a direct role in inhibiting Bacillus subtilis FB17 biofilm formation on the Arabidopsis thaliana root 
surface, possibly through induction of ROS in the roots, which further mediates the down regulation 
of gene involved in bioﬁlm formation. Indeed, although further studies will be necessary, we further 
corroborate the hypothesis that ZA and SA may negatively modulate the oxidoreductase activity of 
WrbA, maintaining a large amount of quinones in an oxidized state and leading to a ROS accumulation 
inside the cells with a deleterious impact on biofilm formation. Accumulation of ROS can result in the 
peroxidation of lipids, the destruction of cofactors, and the hydroxylation of proteins and nucleic acids 
inside the cells. Recent data also showed the ROS ability to modulate quorum sensing at certain level 
and their important role in biofilm formation (Čáp et al., 2012). The upset of ROS level caused by ZA 
and SA interaction with WrbA might interfere with quorum sensing signal destabilizing biofilm 
formation. Interestingly, some results suggest that ROS play a role in modulating the indole signaling 
pathway by the induction of tnaA expression (Ren et al., 2004). Kuczyńska-Wisnik (2010a) and co-
workers demonstrated that E. coli mutant strain that experiences endogenous oxidative stress showed 
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an enhanced expression of tryptophanase and increased indole production that delayed the bioﬁlm 
formation. In addition they demonstrated that antibiotics which promote ROS formation inhibit 
development of E. coli bioﬁlm in an indole-dependent way. This means that bacteria also use indole 
signal to modulate pathways dealing with the oxidative stress and resulting in bioﬁlm repression 
(Kuczyńska-Wisnik et al., 2010b). 
The transcription factor CsgD (curlin subunit gene D) from E. coli is considered the master regulator of 
biofilm formation. The wrbA gene was shown to be one of the regulation targets of CsgD and the 
location distribution of the CgsD-binding regions in the gene suggesting that the expression of wrbA is 
upregulated by CgsD supporting a WrbA role in biofilm formation (Ogasawara et al., 2011). 
On the basis of the previous considerations, we propose a possible mechanism by which ZA and SA 
interact with WrbA negatively modulating its activity and leading to enhanced production of both 
indole and ROS that cooperate in a complex network of events leading to biofilm growth inhibition. 
However further studies will be necessary for confirming this hypothesis. 
The blast search assay inside Bacteria and Fungi databases revealed that WrbA sequences exist in a 
diversity of microorganisms with a high percentage of identity, suggesting a possible important role of 
this protein in the microorganism life, probably associated to the response against environmental 
stresses. The presence inside other microorganisms of a protein with a similar sequence and activity 
may suppose that ZA and SA could also interact with these proteins leading to a possible effect on the 
biofilm development. For example, a number of strains belonged to Pseudomonas spp revealed to 
have in their proteome a NADH quinone oxidoreductase with up to 100 % of similarity to WrbA and in 
effect it was demonstrated that both SA and ZA are able to significantly reduce Pseudomonas spp 
biofilm (Faber et al., 1993; Polo et al., 2014). Similarly some Candida spp presented in their proteome 
a protein sequence with similarity with WrbA between 60 % and 97 % depending on the species. SA 
and ZA were described to significantly impact C. albicans biofilm reducing biofilm formation up to 90 
% (Faber et al., 1993; Villa et al., 2011). Indeed, in this study, the potential of ZA and SA against biofilm 
formation appears clear, especially because most of microorganisms that had been showed to have 
homologues sequences to WrbA inside their proteome are involved in human infections or agricultural 
diseases. 
Only related to SA, other two proteins were identified as possible molecular target. FkpA is a peptidyl-
prolyl isomerase that in E. coli periplasm is found to work in co-operation with other three proteins, 
PpiA, PpiD, and SurA, known as periplasmic cis-trans prolyl isomerases (PPIase) that facilitate the 
proper protein folding by increasing the rate of transition of proline residues between the cis and trans 
states. FkpA also displays chaperone properties that are independent of its PPIase activity implicated 
in protein aggregation prevention (Saul et al., 2004). Justice and collaborators (2005) proved that 
genetic inactivation of all four periplasmic isomerases resulted in a viable strain that exhibited a 
decreased growth rate and increased susceptibility to certain antibiotics but no single or double 
mutants were shown to have growth defects. The author hypothesized that even if the four 
periplasmic isomerases are not essential for growth under laboratory conditions, they may have 
signiﬁcant roles in survival in environmental and pathogenic niches, demonstrating a possible role in 
the production of both P and type 1 pili. Pili are composed of multiple subunits that are assembled in 
a hierarchical manner from the tip to the base with a mechanism in which chaperones actively 
contribute to the stabilization of the subunit preventing their premature aggregation in the periplasm 
(Sauer et al., 2004). It is reported that type 1 pili are essential for E. coli biofilm formation since are 
required for both the initial attachment and the movement along the surface. Cells harbouring lesions 
in genes encoding for the regulation or biogenesis of type I pili are reported not to attach to PVC (Pratt 
et al., 1998). Indeed it is reasonable to suppose that SA may interact with FkpA altering the PPIase 
and/or chaperone activity and resulting in incorrect assembling of pili with consequences on biofilm 
formation. A direct inhibitory effect of SA on swarming, swimming, and twitching motility in different 
Pseudomonas aeruginosa strains were previously illustrated, although any motility system was 
preferentially indicated as SA target (Chow et al., 2011). It was also shown that FkpA in E. coli reduced 
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the extracellular stress response by alleviating the RpoE-dependant stress response improving cell 
physiology, and enhancing cell surface display (Narayanan et al., 2008). The SA interaction with FkpA 
may modulate this protection system in a negative way, leading cells to a stress condition that inhibit 
bacterial adhesion and subsequent biofilm formation. 
The third protein by which SA seems to exert its anti-biofilm activity is Tdh, an L-Threonine 3-
dehydrogenase that in both prokaryotes and eukaryotes catalyzes the first step in the L-threonine 
degradation pathways (Epperly et al., 1990). Threonine has been shown to have an observable effect 
on the E. coli motility, significantly promoting swimming and twitching motility at low concentrations 
and significantly inhibiting biofilm formation at higher concentration (Goh, 2013). Morehouse and 
collaborators (2005) has shown that threonine is abundant in the rotor protein FliG, which is important 
for rotation of flagella in term of directionality. A possible interaction of SA with Tdh could modify the 
activity of this protein, leading to changes in the threonine amount with effect on bacteria motility and 
consequently on biofilm formation. 
Since SA interacts with different proteins, it probability exerts its anti-biofilm activity by different ways. 
This is in line with the amount of researches present in the literature that report various effects of SA 
on bacterial biofilm, suggesting the presence of complex and overlapping regulatory networks 
controlling quorum sensing, motility and biofilm formation. 
 
 
 
Conclusion 
 
In this study, a pull-down proteomic approach has successfully used to identify specific targets involved 
in ZA and SA anti-biofilm activity, by the screening of all E. coli proteome. The same protein WrbA was 
found to be the molecular target for both ZA and SA, suggesting a possible role of this protein in the 
biofilm formation process. However, any considerations about the mechanism by which ZA and SA 
interact with this protein are possible and further experiments are necessary to clarify this question. 
The confirmation of the relation between the biofilm formation and WrbA will open the way for the 
development of new and more effective therapies against biofilm formation. In addition, a 
computational approach could be used to screen and monitor the activity of the molecules, limiting 
time and cost consumption.  
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New bio-hybrid anti-biofilm surfaces functionalized with 
zosteric acid and salicylic acid compounds 
 
 
 
 
Abstract 
 
Recently the natural molecules zosteric acid and salicylic acid have been proposed as alternative 
biocide-free agents suitable for a preventive or integrative approach against biofilm formation. Beside 
this promising results, the lack of a system to efficiently spread and use these compounds leave this 
technology far from a real application. In this research zosteric acid and salicylic acid were successfully 
covalently immobilized on low density polyethylene surface, providing new no-leaching bio-hybrid 
materials available for a wide range of applications. O2 plasma treatment was firstly employed to 
activate the low density polyethylene surface. Subsequently, the graft-polymerization with 2-
hydroxyethyl methacrylate and the immobilization of the selected bioactive molecules on the 
polymeric surface successfully provided the new materials. The functionalized materials were proved 
to significantly reduce E. coli biofilm biomass up to 60 % respect to the non-functionalized control 
surface, with a mechanism that not affected bacterial viability. CLSM analysis also revealed a dramatic 
impact of immobilized zosteric acid and salicylic acid on biofilm morphology, showing a biofilm with a 
significantly reduced thickness and polysaccharide matrix amount. Moreover, biofilm grown on 
functionalized surfaces showed enhanced susceptibility to ampicillin and ethanol, further reducing 
biofilm biomass on functionalized surfaces up to 95 %. 
 
 
 
Introduction  
 
The spread and development of microorganisms in form of biofilm is recognized to be one of the most 
social and economic problem in all medical and industrial setting, causing devastating consequences 
in term of economic and social impact, also because biofilms present some features that make them 
extremely more resistant to the effects of antimicrobial agents (Hall-Stoodley, 2004). This consistent 
problem has motivated a lot of researchers and industrial companies to develop new materials as new 
solutions against biofilm formation, especially in the medical area where the biofilm formation is 
become an important cause of systemic infections. Altering the surface properties of polymeric 
material is one of the main issues to prevent or decrease biofilm infections. A number of disinfectants, 
antiseptics and antibiotics has been incorporated into different polymeric surfaces developing 
leachable anti-infective systems with a broad-spectrum of antimicrobial activity available to counteract 
infections (Coenye et al., 2011). This approach, however, suffers from problems. The release of the 
active compound is temporary, typically no longer than 24 h, and indeed unuseful for applications that 
required a longer protection. In addition, the prerequisite for a good performance is the continuous 
and constant elution of the anti-biofilm molecules from the surface, with a sufficient release rates to 
deter bacterial attachment and slow enough to ensure the long service life of the coating (Barrios et 
al., 2005). Unluckily, in most of cases these materials exhibit discontinuous release rate according to 
first-order kinetics with an initially high release and afterwards an exponential decrease of the 
released, providing the perfect condition for development of the anti-microbial resistance (von Eiff et 
al., 2005). 
Chapter 5 
68 
 
Heavy metal silver was also used as an anti-biofilm agent in the medical area by depositing silver on 
the surfaces of bio-materials using coating technology (Jiang et al., 2004). However coating medical 
devices with silver ions or metallic silver has disappointing results. Moreover silver nanoparticles could 
have genotoxic and cytotoxic effects on human cells (Rai et al., 2009; Jena et al., 2012). 
An alternative approach is to inhibit the tendency of surface-adhered bacteria to form bioﬁlms, rather 
than to kill them. Recently, the natural compounds zosteric acid (ZA) and salicylic acid (SA) have been 
proposed as new solutions able to affect biofilm development interfering with key steps of its 
formation (i.e. microbial adhesion and cell-to-cell communication signal) without affecting microbial 
existence and with a low risk for development of resistant mutations. Related studies proved the ability 
of ZA and SA to significantly reduce bacterial and fungal adhesion and play a role in shaping biofilm 
architecture, in reducing biofilm biomass and thickness and in extending the performance of 
antimicrobial agents, at a concentration that does not affect microbial life (Barrios et al., 2005; Villa et 
al., 2010; Villa et al., 2011; El-Banna et al., 2012; Polo et al., 2014). The aim of this work is to develop 
new anti-biofilm materials by covalently anchoring zosteric acid and salicylic acid to a polyethylene 
polymeric surface with in mind to create new anti-biofilm materials available for a wide range of 
applications and with a mode of action distinct to the traditional antimicrobial-based anti-biofilm 
technologies. In this approach, molecules are permanently attached to the surface. Thanks to the 
knowledge of their active side (see Chapter 4), the molecules are all oriented to externally exhibit their 
active scaffold, allowing the material to exert its anti-biofilm performance directly interacting with 
bacterial cells even at the early stages of biofilm formation. In addition, since no molecules are leached 
from the surface, their concentration remains constantly below the lethal levels, reducing the risk of 
developing resistant strains. The proved low toxicity of both zosteric acid and salicylic acid poses the 
basis to spread this technology to different sectors resulting in new, safe and eco-friendly types of 
products available for a wide range of applications.  
 
 
 
Materials and Methods 
 
Materials and sample preparation 
Low density polyethylene (LDPE) was purchased from Alfa Aesar as sheets and was prepared in the 
form of 1.6 mm thick round shape coupons (d=1.27cm). LDPE coupons were washed with a 3% aqueous 
solution of a neutral detergent efficient in removing greasy residues (AUSILAB 101, Carlo Erba 
Reagents) and an aqueous 1 M HCl solution. Then they were treated by extraction with acetone 
overnight and dried prior each plasma treatment. 
 
LDPE low pressure oxygen plasma treatment 
LDPE coupons were exposed to a low pressure oxygen plasma treatment in order to introduce new 
carbon-oxygen functionalities to LDPE surface. The apparatus used in this study consists in a parallel-
electrodes, capacitive-coupled plasma enhanced chemical vapor deposition (PECVD) system, made up 
of a cylindrical stainless steel vacuum chamber of 25 cm inner diameter with an asymmetric electrode 
configuration. The powered electrode is connected to a 13.56 MHz power supply, associated to an 
automatic impedance matching unit, while the other electrode is grounded and works as sample 
holder. The treatment was performed for 60 s at a total plasma process pressure of about 15 Pa, kept 
constant by balancing the incoming oxygen flux with the system pumping speed. Commercially 
(99.998% purity) available oxygen was supplied into the discharge vessel through a mass flow 
controller. The total gas pressure was measured by a capacitive vacuum gauge. Plasma treatment was 
performed as a function of RF power of 100 W. At first low pressure is created in the process reactor 
by means of a turbo-molecular pump combined with a rotary pump. At a pressure of 0.026 mbar, 
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oxygen was fed into the chamber (O2 flow= 15sccm). When the working pressure was achieved, the 
generator was switched on and the process gas become ionized.  
 
Grafting procedure 
For the polymerization processes, monomers are introduced into the chamber and react chemically 
among each other to form polymers and then settle down as a layer onto the treated part. LDPE 
samples were immersed for 10 s in a solution of 2-hydroxyethyl methacrylate (HEMA, 97 %, contains 
≤ 250 ppm monomethyl ether hydroquinone as inhibitor, used as-received without further 
purification; Sigma Aldrich) in ethanol (>99.8 %, Sigma Aldrich). Concentration of HEMA solutions was 
varied from 0.05 M to 1 M. Immersed LDPE samples were dried in air and then oxygen plasma treated 
in order to promote the graft-polymerization of the monomer. Oxygen pressure and treatment time 
were varied in order to optimize the process. Input power was kept constant at 100W to prevent any 
damages to the substrates. Finally, the samples were ultrasonically washed in ethanol for 5 minutes in 
order to remove the ungrafted macromolecules and dried in air at room temperature. The result of 
the treatment is a LDPE-HEMA-OH surface (LDPE-OH). 
 
Preparation of carboxylic acid derivatized LDPE-HEMA-OH surface 
The LDPE-HEMA-OH surface was treated with succinic anhydride to obtain LDPE-HEMA-COOH surface 
(LDPE-COOH). The LDPE-HEMA-OH coupons were immersed in 10 mL dichloromethane (DCM, Sigma 
Aldrich) with the addition of dry pyridine (2.5 eq, Sigma Aldrich). Succinic anhydride (2.5 eq; Sigma 
Aldrich) dissolved in 10 mL of tetrahydrofuran (Sigma Aldrich) was added to the reaction mixture. The 
reaction was allowed to proceed at room temperature for 24 h. The surface was washed with copious 
amounts of dichloromethane (10 x 10 mL) prior to dry in air.  
 
Immobilization of ZA and SA active scaffold via an amide bond formation 
LDPE-COOH was bound to p-aminocinnamic acid and p-aminosalicylic acid amino group via a 
condensation reaction to allow their binding to the surfaces. LDPE-COOH coupons (1 eq of carboxylic 
acid groups) were suspended in DCM (10 mL) and were activated with N-hydroxysuccinimide (1.2 eq,  
Sigma Aldrich) and N,N-dicyclohexylcarbodiimide (1.2 eq; 685178, Sigma Aldrich) for 20 min at room 
temperature under a nitrogen atmosphere. p-aminocinnamic acid and p-aminosalicylic acid (1.2 eq) 
were independently poured in the suspension with the activated carboxylic acid on coupons and the 
resulting mixture was stirred at room temperature for 16 h. The coupons were filtered off and washed 
with dichloromethane for many times (10 x 5 mL). Additional washes with dimethylformamide (3 x 3 
mL, Sigma Aldrich) were necessary to remove the remaining dicyclohexylurea (Sigma Aldrich). The 
resulted ZA and SA functionalized coupons (LDPE-ZA, LDPE-SA) were dried in vacuum to allow analytical 
analysis. 
 
Surface characterization by Attenuated Total Reflectance Fourier Transform Infrared spectroscopy  
Attenuated Total Reflectance Fourier Transform Infrared spectroscopy analysis (ATR-FTIR) 
measurements were performed using a SpectrumOne spectrophotometer (Perkin-Elmer, USA), by 
placing non-functionalized (LDPE, LDPE-OH, LDPE-COOH) and functionalized (LDPE-ZA, LDPE-SA) 
coupons on a diamond crystal mounted in ATR cell (Perkin-Elmer, USA). The spectra were collected 
over the wavenumber region 4000−650 cm−1 at 4 cm−1 resolution and 128 scans. The ATR-FTIR 
measurements provide mostly semi-quantitative information on the chemical changes of the near-
surface region, because the measured thickness of the layer is limited to 4 μm. Experiments were 
carried out under ambient conditions. 
 
Surface characterization by Confocal Laser Scanner Microscope 
Functionalized (LDPE-ZA, LDPE-SA) and non-functionalized coupons (LDPE, LDPE-OH, LDPE-COOH) 
were visualized using a Leica SP5 Confocal Laser Scanning Microscope (CLSM) (405 nm laser excitation 
Chapter 5 
70 
 
line, blu channel) before and after 10-fold used. Images were captured with a 40x, 0.8 NA water 
immersion objective and analyzed with the software Imaris (Bitplane Scientific Software, Zurich, 
Switzerland). The experiments were repeated two times. 
 
Escherichia coli strain and growth condition  
The well characterized E. coli MG1655 was used as a model system for bacterial biofilms. The strain 
was stored at –80 °C in suspensions containing 20 % glycerol and 2 % peptone, and was routinely grown 
in Luria-Bertani broth (LB, Sigma-Aldrich) at 37 °C.   
  
Biofilm growth in the CDC Reactor  
E. coli biofilm was grown on functionalized and non-functionalized coupons in the Center for Disease 
Control Bioreactor (CDC reactor, Biosurface Technologies, Bozeman, MT, USA). Inoculum of the 
bioreactor was prepared by inoculating 400 mL of sterile LB medium with an overnight culture of E. 
coli MG1655 strain and growing this culture at 37°C with continous strirring for 24 hours. After the 24-
h adhesion phase, the peristaltic pump was started and sterile 10 % LB medium was continuously 
pumped into the reactor at a rate of 8.3 mL/min. After 48 hours of dynamic phase, functionalized and 
non-functionalized coupons were removed, gently washed with PBS and processed to be analyzed. 
  
Plate count viability assay  
Collected coupons were transferred to 5 mL PBS. Sessile cells were removed from the coupon surface 
by 30 s vortex mixing, 2 min sonication (Branson 3510, Branson Ultrasonic Corporation, Dunburry, CT) 
followed by other 30 s vortex mixing. Using this procedure, all the cells were dislodged from the 
coupons. Serial dilutions of the resulting cell suspensions were plated on Tryptic Soy Agar (TSA, Fisher 
Scientific) and incubated overnight at 37 °C. CFUs were determined by standard colony counting 
method. The log10 number of viable bacterial cells was calculated. Data were normalized to the log10 
number for the control sample and percentage reduction respect to the negative control was also 
calculated. The experiments were repeated three times. 
 
Biofilm Imaging by Epifluorescence microscopic analysis 
Biofilm grown on both functionalized and non-functionalized coupons was stained using the Live/Dead 
BacLight viability kit (Molecular Probes-Life Technologies) enabling differentiation between cells with 
intact versus permeable membranes. Biofilms were directly incubated on the coupon with using 2 µL 
of each component per mL of sterile filtered PBS at room temperature in the dark for 25 min and then 
rinsed with sterile PBS, according to the manufacture instruction. 
Direct staining of total bioﬁlm mass on both functionalized and non-functionalized coupons was also 
achieved using 1x commercial solution of CellMask plasma membrane orange stain (Molecular Probes-
Life Technologies) in sterile PBS. CellMask orange staining does not distinguish between live and dead 
cells, but rather allows for the visualization of total cell mass. Biofilms were allowed to incubate for 30 
min in the dark at room temperature and then rinsed with sterile PBS.  
Coupons without biofilm were also stained with the dyes in order to exclude any false positive signals. 
Biofilm samples were visualized using a Nikon Eclipse E800 epifluorescent microsope with excitation 
at 480 nm and emission at 516 nm for the green channel and excitation at 581 nm and emission at 644 
nm for the red channel. Images were captured with a 60x, 1.0 NA water immersion objective and 
analyzed via MetaMorph 7.5 software (Molecular Devices, Sunnyvale, CA, USA). Percent area threshold 
of stained cells was performed by calculating at least ten random images for each sample for at least 
three coupons per experiment. The efficacy of the anti-biofilm material was calculated as percentage 
reduction in stained cells threshold area respect to the control images. Live/dead ratio was also 
determined by dividing percent area threshold of the alive stained cells by the percent area threshold 
of the dead stained cells in each sample.  
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Biofilm Imaging by Confocal Laser Scanning Microscopy 
Biofilm grown on both functionalized and non-functionalized coupons was stained using the lectin 
Concanavalin A-Texas Red conjugate (Molecular Probes-Life Technologies) to visualize the 
polysaccharide component of the EPS and Sybr green I ﬂuorescent nucleic acid stain (Molecular 
Probes-Life Technologies) to display bioﬁlm cells. Bioﬁlm were incubated with 200 µg/mL of ConA and 
1:1000 of commercial Sybr green dye solution in PBS at room temperature in the dark for 30 min and 
then rinsed with PBS. Coupons without biofilm were also stained in order to exclude any false positive 
signals. Biofilm samples were visualized using a Leica SP5 CLSM with excitation at 488 nm, and emission 
<530 nm (green and red channel). Images were captured with a 63x, 0.9 NA water immersion objective 
and analyzed with the software Imaris (Bitplane Scientific Software, Zurich, Switzerland). Bio-volume 
of both cells and matrix was calculated by summing the stained cells/matrix threshold area of each 
single plane. Cells and matrix bio-volumes were calculated considering at least five random images for 
each sample for at least three coupons per experiment. The efficacy of the anti-biofilm material was 
calculated as percentage reduction in bio-volume respect to the control images. Cells/matrix bio-
volume ratio was also determined by dividing bio-volume of cells with the bio-volume of matrix in each 
sample.  
 
Antibiotic and biocide susceptibility test 
Biofilm on functionalized and non-functionalized coupons were independently soaked in 15 mL of 100 
µg/mL Ampicillin (Amp, Fisher Scientific) and 20 % ethanol for respectively 24 h and 20 min. 
Functionalized and non-functionalized coupons were also soaked in 15 mL of water for 24 h and 20 
min as a negative control. The incubation time was chosen to mimic antibiotic therapies and daily 
disinfection procedures in hospital and industrial settings. After the treatment, coupons were soaked 
in distilled water for 10 min in order to neutralize the antimicrobial agent. Cells in the biofilm were 
collected in PBS for colony counting, as previously reported in the plate count viability assay section. 
Dispersed cells in the bulk liquid were washed by centrifugation at 8,000 g for 30 min and suspended 
in PBS for colony counting. Obtained data were expressed as log10/cm2 survived bacteria. The 
antimicrobial eﬃcacy percentage was also calculated as (no. of viable cells from bulk liquid x 100)/(no. 
of viable cells from bulk liquid + no. of viable cells from the remaining bioﬁlm). All antimicrobial 
experiments were conducted in triplicate.  
The susceptibility of biofilm on functionalized and non-functionalized 20 % ethanol was also carried 
out using the FC 270 flow cell apparatus (BioSurface Technologies, Bozeman, MT), performing the 
setup according to the manufacturer’s recommendations. The method consisted in determining the 
decrease in fluorescence intensity of cells previously stained with the syto-9 green fluorescent nucleic 
acid stain solution within the biofilm during exposure to ethanol using direct time-lapse confocal 
microscopy inside intact biofilm. Biofilms on functionalized and non-functionalized coupons were 
stained with 5 mM of SYTO-9 (Molecular Probes-Life Technologies) in PBS at room temperature in the 
dark for 30 min and then rinsed with PBS. A solution of 20 % ethanol was pumped through the flow 
cells at a rate of 1 mL/min rate for 20 min. The decrease in fluorescence intensity of the cells in the 
biofilm was imaged using a Leica SP5 CLSM with excitation at 488 nm, and emission <530 nm (green 
channel). Images were captured with a 63x, 0.9 NA water immersion objective and analyzed with the 
software Imaris (Bitplane Scientific Software, Zurich, Switzerland). The cells bio-volume of each single 
frame was calculated as previously reported in biofilm imaging by confocal laser scanning microscopy 
section and plotted against time. The bio-volume of each single frame was also used to calculate a 
mathematical model for ethanol susceptibility. 
 
Statistical Analysis 
ANOVA, via a software run in MATLAB environment (Version 7.0, The MathWorks Inc, Natick, USA), 
was applied to statistically evaluate any significant differences among the samples. Tukey’s honestly 
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significant different test (HSD) was used for pairwise comparison to determine the significance of the 
data. Statistically significant results were depicted by p-values < 0.05. 
 
 
 
Results 
 
ATR-FTIR successfully detect the presence of ZA and SA active scaffold on the functionalized surfaces 
Attenuated Total Reflectance Fourier Transform infrared spectroscopy (ATR-FTIR) analyses were 
carried out, in order to detect the presence of the ZA and SA active scaffold grafted on the surfaces.  
The LDPE surface analysis showed a typical polyethylene spectrum with a small number of 
characteristic peaks (Figure 1). After plasma exposure, the surface spectra did not change and no 
evidences for -OH or -COOH peaks were shown. No changes were also observed in both LDPE-OH and 
LDPE-COOH surfaces. 
After the covalent linkage with p-aminocinnamic acid and p-aminosalicylic acid the shape of the 
spectra changed (Figure 1), with significant differences respect to LDPE surface especially in the 
infrared-region between 1.600-1.800 cm-1 (C-O stretching, N-H bending). The spectra showed typical 
peaks of the amide bond confirming the presence of a covalent bond between ZA and SA active scaffold 
and LDPE surfaces. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CLSM analysis successfully demonstrated the polyethylene surface functionalization 
The auto-fluorescence of ZA and SA immobilized scaffold (data shown in chapter 4) was used to verify 
the surface functionalization by Confocal Scanning Laser Microscopy (CLSM). Acquired pictures of 
LDPE, LDPE-OH and LDPE-COOH control samples revealed a completely black background with the 
absence of fluorescence. On the contrary acquired picture of LDPE-ZA and LDPE-SA samples revealed 
the presence of an intense fluorescence signal that, since no fluorescence was detected in the control 
samples, could be attributable to the ZA and SA fluorescence moieties immobilized on the surface, 
demonstrating the successful of the functionalization process (Figure 2). To prove the retention and 
stability of the functionalized material, the CSLM analysis was repeated on 10-fold used coupons. 
Figure 1. Representative ATR-FTIR spectra of functionalized and non-functionalized surfaces.   
a) LDPE, b) LDPE-ZA, c) LDPE-SA. Black lines show the typical peaks of an amide bond confirming 
the successful of ZA and SA immobilization process.  
 
a 
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Pictures of LDPE, LDPE-OH and LDPE-COOH 10-fold used control coupons revealed a completely black 
background with the absence of fluorescence. Picture of LDPE-ZA and LDPE-SA 10-fold used coupons 
revealed the presence of an intense fluorescence signal comparable to that unused corresponding 
coupons, demonstrating that the coupons are not altered by their usage and that ZA and SA are 
successfully retained by the surface (Figure 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Representative CLSM images of unused and 10-fold used functionalized and non-functionalized polyethylene 
surfaces (405 nm laser excitation line; 40×, 0.8 NA water immersion objective). Blue fluorescence corresponds to the 
molecule presence on the surface. No-used coupon: a) LDPE, b) LDPE-OH, c) LDPE-COOH, d) LDPE-ZA, e) LDPE-SA. Ten-fold 
used coupon: f) LDPE-ZA, g) LDPE-SA. Scale bar=40µm. 
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Plate count viability assay demonstrated the efficacy of the functionalized polyethylene surface to  
reduce E. coli adhered cells 
Biofilm formation on both functionalized and non-functionalized coupons was monitored, measuring 
biofilm biomass by colony counting. CDC reactor was used to grow the biofilm to create flow condition 
normally encountered in vivo. After 24 h of static conditions followed by 48 h of dynamic conditions, 
the biofilm growth revealed significant differences in viable cell adhesion between the control sample 
(LDPE) and the functionalized material (LDPE-ZA and LDPE-SA) (viable adhered cells: LDPE 7.01±0.06 
log10 CFU/cm2; LDPE-ZA 6.55±0.17 log10 CFU/cm2; LDPE-SA 6.62±0.10 log10 CFU/cm2). No significant 
differences were detected in viable cells adhesion between the control sample LDPE and the linker 
control sample LDPE-OH and LDPE-COOH (viable adhered cells: LDPE-OH 7.00±0.08 log10 CFU/cm2; 
LDPE-COOH 6.99±0.08 log10 CFU/cm2), suggesting that the used linker does not affect biofilm biomass 
and consequently that the anti-biofilm performance of the functionalized materials is totally 
attributable to ZA and SA immobilized on the surface. The experiment revealed that LDPE-ZA and LDPE-
SA exploited an optimal anti-biofilm performance reducing viable adhered cells by 61.6 % and 60.0 % 
respectively in comparison to the LDPE control surface (Figure 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Functionalized polyethylene surfaces reduce E. coli biofilm biomass without affecting cell viability  
Plate count analysis revealed a reduced viability of bacteria recovered from the functionalized 
polyethylene surfaces. Epifluorescence microscopic techniques were additionally used to provide 
image analysis and quantiﬁcation of bacterial cells in situ. 
Direct microscopic visualization of the total biofilm biomass on functionalized and non-functionalized 
coupon is shown in Figure 4, where in situ bioﬁlms have been stained with the CellMask plasma 
membrane orange stain. Pictures analysis showed significant differences in the percentage area 
threshold of stained cells between the control LDPE and the functionalized LDPE-ZA and LDPE-SA 
materials (percentage threshold area of total cells: LDPE 91.04±3.88 %; LDPE-ZA 29.96±6.06 %; LDPE-
SA 35.45±4.54 %) (Figure 5).  No significant differences were detected in the threshold area of stained 
cells between the LDPE control sample and the LDPE-OH and LDPE-COOH linker control samples 
(percentage threshold area of total cells: LDPE-OH 87.40±3.73 %; LDPE-COOH 92.76±1.00 %), 
confirming that the used linker does not affect biofilm biomass (Figure 5). The analysis of the picture 
Figure 3. E. coli biofilm growth on functionalized and non-functionalized polyethylene surfaces. 
Error bars display the honestly significant difference (HSD) intervals using Tukey multiple 
comparison with a 95 % confidence level (Tukey's HSD, p < 0.05). According to post-hoc analysis, 
means sharing the same letter are not significantly different from each other. Values are based on 
results from at least three separate experiments. 
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revealed that ZA and SA functionalized material reduced biofilm biomass by 73.7 % and 61.06 % respect 
to the control LDPE. Coupons without biofilm and stained with the same dye did not produce 
detectable fluorescence suggesting that false positive signals were not produced (data not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Representative epifluorescence microscope images of E. coli biofilm stained with CellMask plasma membrane 
orange and grown on functionalized and non-functionalized polyethylene surfaces (60x, 1.0 NA water immersion objective): 
a) LDPE, b) LDPE-ZA, c) LDPE-SA. Red fluorescence corresponds to E. coli cells. λex: 554 nm and λem: 567. Scale bar = 20 µm. 
 
 
Figure 5. Percentage area threshold of CellMask plasma membrane orange stained cells on functionalized and non-
functionalized polyethylene surfaces. Error bars display the honestly significant difference (HSD) intervals using Tukey 
multiple comparison with a 95 % confidence level (Tukey's HSD, p < 0.05). According to post-hoc analysis, means sharing the 
same letter are not significantly different from each other. Values are based on results from at least three separate 
experiments. 
a 
b c 
LD
P
E
LD
P
E
-O
H
LD
P
E
-C
O
O
H
LD
P
E
-Z
A
LD
P
E
-S
A
0
20
40
60
80
100
b b
a a a
A
re
a
 %
Chapter 5 
76 
 
Staining for live and dead cells was also used to visualize biofilm biomass on functionalized and non-
functionalized surface. Direct imaging of bioﬁlms indicated that both functionalized and non-
functionalized surface resulted in few dead cells (red) within the bioﬁlm structures with any significant 
difference in the threshold area between the different surface. On the contrary, pictures analysis 
showed significant differences in the percentage threshold area of live cells between the control LDPE 
and the functionalized LDPE-ZA and LDPE-SA material (percentage threshold area of live cells: LDPE 
59.89±4.86 %; LDPE-ZA 26.89±5.11 %; LDPE-SA 17.61±3.34 %) (Figure 6-7). The analysis of the pictures 
revealed that LDPE-ZA and LDPE-SA functionalized material reduced the number of live cells by 55.0 % 
and 70.6 % respect to the control LDPE. No significant differences were detected in the threshold area 
of live cells between the control sample LDPE and the linker control samples LDPE-OH and LDPE-COOH 
(percentage threshold area of live cells: LDPE-OH 55.79±4.24 %; LDPE-COOH 51.10±7.48 %) (Figure 6). 
The relative percentage of live versus dead cells was also calculated in order to directly compare the 
number of live bacterial cells versus dead bacterial cells in each surface samples. Statistical analysis of 
live/dead ratio revealed no significant difference between LDPE, LDPE-OH and LDPE-COOH ratio while 
live/dead ratio significantly decreased on LDPE-ZA and LDPE-SA functionalized surfaces respect to LDPE 
(live/dead ratio: LDPE 8.70±0.55; LDPE-OH 7.83±0.75; LDPE-COOH 7.69±1.28; LDPE-ZA 4.77±1.21; 
LDPE-SA 2.67±0.62) (Figure 6). Coupons without biofilm and stained with the same dye did not produce 
detectable fluorescence suggesting that false positive signals were not produced (data not shown). 
These data suggested that i) the LDPE-OH and LDPE-COOH linker neither affect biofilm biomass nor 
cells viability; ii) LDPE-ZA and LDPE-SA functionalized surface reduced biofilm biomass with a 
mechanism that does not affect bacterial viability. 
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Figure 6. Percentage area threshold of Live/Dead BacLight viability stained cells on functionalized and non-functionalized 
polyethylene surfaces. Panel A: percentage area threshold of live and dead cells within the biofilm; Panel B: live/dead cells 
ratio within the biofilm. Error bars display the honestly significant difference (HSD) intervals using Tukey multiple comparison 
with a 95 % confidence level (Tukey's HSD, p < 0.05). According to post-hoc analysis, means sharing the same letter are not 
significantly different from each other. Values are based on results from at least three separate experiments. 
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Functionalized polyethylene surfaces affect the morphology of E. coli biofilm  
Three-D morphology of biofilm growth on control (LDPE) and LDPE-ZA and LDPE-SA functionalized 
polyethylene surface was detected by CLSM, with cells within the biofilm stained with Sybr green I 
nucleic acid dye and EPS polysaccharide matrix stained with Concanavalin A-Texas Red conjugate dye.  
As presented in figure 9, projection analysis as well as 3D-reconstructed images revealed a complex 
biofilm on LDPE, LDPE-OH, LDPE-COOH control polyethylene surface, with an intense red and green 
signal corresponding to multi-layers of cells organized in macro-colonies inside a well-structured 
polysaccharide matrix. On the contrary biofilm growth on LDPE-ZA and LDPE-SA functionalized surfaces 
showed a significant decrease in thickness with a mono-layer of dispersed cells and very low presence 
of polysaccharide matrix. In particular, on LDPE-ZA the matrix is completely disappeared. 
Figure 7. Representative epifluorescence microscope images of E. coli biofilm stained with Live/Dead BacLight viability 
kit and grown on functionalized and non-functionalized polyethylene surfaces (60x, 1.0 NA water immersion objective): 
a) and b) LDPE, c) and d) LDPE-ZA, e) and f) LDPE-SA. Red fluorescence corresponds to E . coli dead cells (λexcitation: 581 
nm and λemission: 644 nm while green fluorescence corresponds to E. coli live cells (λexc: 480 nm and λem: 516 nm). Scale 
bar = 20 µm. 
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Bio-volume percentages of both cells and polysaccharide matrix component were calculated. The 
analysis of the pictures revealed that LDPE-ZA and LDPE-SA functionalized material significantly 
reduced cells bio-volume by 91.4 % and 89.2 % respectively in comparison to the LDPE control sample 
(cells bio-volume percentage: LDPE 30.67±10.64 %; LDPE-ZA 2.61±0.06 %; LDPE-SA 3.31±0.58 %) 
(Figure 8). Picture analysis also revealed that LDPE-ZA and LDPE-SA functionalized material significantly 
reduced polysaccharide matrix bio-volume by 99.9 % and 94.0 % respectively in comparison to the 
LDPE control surface (matrix bio-volume percentage: LDPE 45.22±4.59 %; LDPE-ZA 0.03±0.05 %; LDPE-
SA 2.70±0.71 %) (Figure 8). 
No significant differences were detected in both cells and polysaccharide matrix bio-volumes between 
the biofilm grown on the LDPE, LDPE-OH and LDPE-COOH control sample surfaces (cells bio-volume 
percentage: LDPE-OH 37.40±12.38 %; LDPE-COOH 30.63±9.18;  2.61±0.06 %; matrix bio-volume 
percentage LDPE-OH 34.31±9.10 %; LDPE-COOH 38.56±5.43) (Figure 8). The relative percentage of 
each biofilm component (matrix versus cells) was also calculated in order to directly compare the 
amount of matrix versus the amount of cells on each surface. Statistical analysis of matrix/cells ratio 
revealed no significant difference between LDPE, LDPE-OH and LDPE-COOH surfaces, with a ratio value 
over 1 meaning a predominance of matrix respect to the cellular component (matrix/cells ratio: LDPE: 
1.60±0.34; LDPE-OH 1.30±0.25; LDPE-COOH 1.28±0.39). A significant reduction of matrix/cells ratio 
were found in the biofilm grown on LDPE-ZA and LDPE-SA functionalized surfaces, with value under 1, 
confirming the relevant decrease in the matrix amount respect to the biofilm grown on the control 
surfaces (matrix/cells ratio: LDPE-ZA 0.00±0.00; LDPE-SA 0.56±0.15) (Figure 8).  
Coupons without biofilm and stained with the same dye did not produce detectable fluorescence 
suggesting that false positive signals were not produced (data not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Bio-volume of the cells and polysaccharide matrix biofilm component grown on control and functionalized 
polyethylene surfaces. Panel A: bio-volume of cells and matrix within the biofilm; Panel B: cells/matrix bio-volume ratio 
within the biofilm. Error bars display the honestly significant difference (HSD) intervals using Tukey multiple comparison 
with a 95% confidence level (Tukey's HSD, p < 0.05). According to post-hoc analysis, means sharing the same letter are not 
significantly different from each other.  
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Figure 9. Representative CLSM images of E. coli biofilm on functionalized and non-functionalized polyethylene surfaces (λex 
at 488 nm, and λem < 530 nm , 60x, 1.0 NA water immersion objective): a) and b) LDPE, c) and d) LDPE-ZA, e) and f) LDPE-SA.  
Live cells were stained green with Syber green I, whereas the polysaccharide component of the EPS matrix was stained red 
with Texas Red-labelled ConA. Scale bar = 20 or 30 µm. 
a b 
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Enhanced antimicrobial agent susceptibility of E. coli biofilm formed on functionalized polyethylene 
surfaces 
To evaluate the susceptibility of E. coli biofilm to 100 µg/mL ampicillin and 20 % ethanol on control 
LDPE and LDPE-ZA and LDPE-SA functionalized surfaces, viable cells in both the bioﬁlm and the bulk 
liquid were quantiﬁed by plate count analysis.  
The treatment with ampicillin did not significantly affect the number of viable cells in biofilm grown of 
LDPE surface, since the number of viable cells in biofilm treated with ampicillin did not show significant 
differences respect to the biofilm grown on the same surface but treated with PBS (viable adhered 
cells: LDPE/PBS 7.05±0.07 log10 CFU/cm2; LDPE/Amp 6.87±0.18 log10 CFU/cm2) (Figure 10). On the 
contrary, the treatment with ampicillin drastically decreased the number of viable cells within the 
biofilm grown on both LDPE-ZA and LDPE-SA functionalized surfaces, in comparison to the 
corresponding negative control treated with PBS (viable adhered cells: LDPE-ZA/PBS 6.75±0.11 log10 
CFU/cm2; LDPE-ZA/Amp 5.64±0.01 log10 CFU/cm2; LDPE-SA/PBS 6.70±0.05 log10 CFU/cm2; LDPE-
SA/Amp 5.71±0.08 log10 CFU/cm2) (Figure 10). The enhanced susceptibility of the biofilm grown on 
functionalized surfaces to ampicillin was also confirmed by the antimicrobial efficacy percentage that 
appeared significantly higher on LDPE-ZA and LDPE-SA surfaces respect to LDPE surface (ampicillin 
efficacy percentage: LDPE/Amp 47.56±7.13 %; LDPE-ZA/Amp 85.59±0.84 %; LDPE-SA/Amp 85.47±1.92 
%)(Figure 10). The combination of both LDPE-ZA and LDPE-SA with ampicillin resulted in 96.2 % and 
95.5 % biofilm biomass reduction respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The treatment with 20 % ethanol significantly affected biofilm biomass on both the control and 
functionalized surface. The experiment showed a significant reduction in viable cells within the biofilm 
grown on both LDPE and LDPE-ZA and LDPE-SA functionalized surfaces respect to the corresponding 
negative control treated with PBS (viable adhered cells: LDPE/PBS 7.63±0.05 log10 CFU/cm2; LDPE/EtOH 
Figure 10. Ampicillin susceptibility test against E. coli biofilm pre-grown on functionalized and non-functionalized 
polyethylene surfaces. Panel A: Biofilm growth after 24 h treatment with 100 µg/mL ampicillin and PBS (negative control). 
Panel B: 100 µg/mL ampicillin efficacy percentage. Error bars display the honestly significant difference (HSD) intervals using 
Tukey multiple comparison with a 95 % confidence level (Tukey's HSD, p < 0.05). According to post-hoc analysis, means 
sharing the same letter are not significantly different from each other. Values are based on results from at least three 
separate experiments. 
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6.56±0.02 log10 CFU/cm2; LDPE-ZA/PBS 6.72±0.04 log10 CFU/cm2; LDPE-ZA/EtOH 6.26±0.06 log10 
CFU/cm2; LDPE-SA/PBS 6.64±0.08 log10 CFU/cm2; LDPE-SA/EtOH 6.26±0.08 log10 CFU/cm2) (Figure 11). 
However, the biofilm grown on the functionalized polyethylene surfaces appeared significantly more 
vulnerable to the ethanol treatment respect to the biofilm grown on non-functionalized surface. 
Statistical analysis performed on antimicrobial efficacy data revealed that the ethanol efficiency 
against biofilm grown on LDPE-ZA and LDPE-SA functionalized surfaces was significantly higher than 
ethanol efficiency against biofilm on LDPE surface (ethanol efficacy percentage: LDPE/EtOH 17.45±2.10 
%; LDPE-ZA/EtOH 70.52±2.12 %; LDPE-SA/EtOH 57.37±3.68 %) (Figure 11). Anyway the combination of 
both LDPE-ZA and LDPE-SA with ethanol allowed a further decrease in the number of viable adhered 
cells, with a reduction of 82.8 % and 83.1% in biofilm biomass on respectively LDPE-ZA and LDPE-SA in 
comparison to LDPE surface. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To corroborate these results, a direct time-lapse confocal microscope analysis of the 20% ethanol 
effect on a pre-formed biofilm grown on both control LDPE and LDPE-ZA and LDPE-SA functionalized 
surfaces was performed by flowing for 20 min the antimicrobial agent directly on the surface. The 
ethanol effect was measured as decrease in the fluorescence intensity of cells previously stained with 
the syto-9 green fluorescent nucleic acid stain solution able to bind intact live cells. The time-lapse 
image analysis revealed that ethanol treatment did not affect the cells green fluorescent of biofilm 
grown on LDPE control surface within the 20 min of the experiment, except for an initial non-significant 
decrease probably achievable to the detachment of a portion of biofilm from the surface for the 
presence of the flow. On the contrary, the ethanol treatment on biofilm grown on both LDPE-ZA and 
LDPE-SA functionalized surface significantly affected the biofilm biomass integrity, leading to a rapid 
completely loss in cells fluorescent intensity. Biofilm grown on LDPE-ZA completely lost its green 
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Figure 11. Ethanol susceptibility test against E. coli biofilm pre-grown on functionalized and non-functionalized polyethylene 
surfaces. Panel A: Biofilm growth after 20 min treatment with 20 % ethanol and PBS (negative control). Panel B: 20 % ethanol 
efficacy percentage. Error bars display the honestly significant difference (HSD) intervals using Tukey multiple comparison 
with a 95 % confidence level (Tukey's HSD, p < 0.05). According to post-hoc analysis, means sharing the same letter are not 
significantly different from each other. Values are based on results from at least three separate experiments. 
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fluorescent within 15 min while biofilm grown on LDPE-SA completely lost its green fluorescent within 
4 min (Figure 12).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The cells bio-volume of each single frame was calculated and used to re-elaborate a mathematical 
model explaining the biofilm cells response against the ethanol treatment in term of bio-volume 
reduction in function of the time x (equation 1). The model considered a first step in which the bio-
volume fluorescence gradually decreased with an exponential trend (equation 2) and a second step 
following a logistic trend (equation 3) in which the bio-volume fluorescence rapidly decreased until 
reaching 0 value.  
 
(1)         y(x)g(x) 
 
(2)         y(x) =  
y0 ∙ (a ∙ s0 + y0) ∙ exp [r ∙ (x − p)]
a ∙ s0 + y0  ∙ exp[r ∙ (x − p)]
                 
 
(3)          g(x) = exp [k ∙ (x − p)] 
 
 
Figure 12. Time-lapse CLSM representative images of the 20 % ethanol action against E. coli biofilm pre-grown on 
functionalized and non-functionalized polyethylene surfaces within 20 min. Live cells were stained green with Syto 9 (λex 488 
nm, and λem <530 nm , 60x, 1.0 NA water immersion objective). Line A: Biofilm pre-growth on LDPE control surface; Line B: 
Biofilm pre-growth on LDPE-ZA functionalized surface; Line C: Biofilm pre-growth on LDPE-SA functionalized surface. Scale 
bar = 20 µm. 
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Discussion 
 
 
 
The natural compounds zosteric acid (ZA) and salicylic acid (SA) were previously proved to be powerful 
anti-biofilm compounds able to counteract biofilm formation at sub-lethal concentration. Despite 
these promising results, a real application of these compounds is not feasible due to the lack of a 
suitable technology able to efficiently retain the anti-biofilm molecules over a working timescale. In 
the past, some researches were performed with the aim to incorporate ZA and SA in different 
polymeric materials able to gradually release the anti-biofilm molecules in the surrounding area 
(Geiger et al., 2004; Barrios et al., 2005; Bryers et al., 2006; Rosenberg et al., 2008; Guinta et al., 2011; 
Nowatsky et al., 2012; Lo et al., 2014). However, in most of cases these systems showed several 
problems such as the non-uniform distribution of the anti-biofilm compounds inside the material and 
the formation of aggregates due to the incomplete miscibility of the molecules in the polymers. In 
addition, a constant release rate of the active compound has neither been achieved nor monitored, 
limiting the effectiveness of the technology to only a short period of time and making this system often 
unfeasible for a wide range of practical applications (Barrios et al., 2005; Nowatsky et al., 2012).  
In this research a new improved anti-biofilm solution based on ZA and SA surface immobilization 
process was presented, providing a new class of bio-hybrid active materials with a novel target and 
mode of action. Here ZA and SA were successfully covalently bound to a low density polyethylene 
(LDPE) surface, in a procedure that allowed the anti-biofilm compound to preserve the biological 
function upon the conjugation process. In the previous chapters, ZA and SA chemical determinants 
responsible of their anti-biofilm activity were investigated. Moreover, the addition of an amino group 
in the para position of the phenyl ring in both ZA and SA chemical structure was proved not affecting 
the anti-biofilm activity of both molecules. Indeed, in this study a specific protocol to expose AZ and 
SA active scaffold on the external surface of the polymeric material via an amide bond was set up, 
allowing the anti-biofilm compound active moieties to directly interact with bacterial cells and 
successfully exerting their function. 
Low pressure glow discharge O2 plasma has been firstly used to increase wettability in a LDPE ﬁlm in 
order to improve its adhesion properties by the formation of some polar species on the exposed 
surface. LDPE plasma treatment causes the breakdown of some C–H bonds and the generation of 
activated species. The subsequent exposure of the activated surface to air causes oxygen incorporation 
on the LDPE surfaces, leading to surface oxidation and the formation of peroxide and hydroperoxide 
species. The use of plasma treatments has grown in interest in the last decades since it is an 
environmentally eﬃcient process that provides activated surfaces characterized by high uniformity. 
Moreover, the use of low pressure conditions allows to perform plasma treatments at low or moderate 
temperatures, reducing the material degradation that could occur with a different type of treatment 
and maintaining the bulk properties of the materials unchanged (Sanchis et al., 2006). Subsequently, 
the graft-polymerization with 2-hydroxyethyl methacrylate (HEMA) and the conversion of the terminal 
hydroxyl groups of HEMA side chains into the carboxylic acid derivatives by treatment with succinic 
anhydride provided the chemical condition to allow the amide bond formation between the modified 
LDPE surface and ZA and SA molecules bearing an amino group in the para position on their phenyl 
ring. 
The characteristics of the functionalized material were evaluated in each step by means of both contact 
angle measurements and Fourier Transform Infrared Spectroscopy (AFT-FTIR) analysis. The 
experiments revealed that O2 plasma treatment and HEMA graft-polymerization considerably reduced 
surface contact angle confirming that the procedure successfully improved surface wettability with a 
marked hydrophilic nature (data not shown). Theoretically, after plasma exposure significant changes 
in the measured ATR-FTIR spectra respect to untreated surface should have also been observed for 
the presence of some -OH or -OOH groups incorporated into the surface, with the appearance of two 
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broad peaks between 3.600-3.050 cm−1 and 1.800-1.520 cm−1. In this study, recorded spectra did not 
show evidence for -OH or -OOH peaks after plasma treatment. Moreover, no changes were observed 
after the graft-polymerization procedure (LDPE-OH) and the subsequent oxidation to carboxylic acid 
derivatives (LDPE-COOH), probably for the low concentration of the polar species undetectable by the 
instrument. However, after the covalent linkage with ZA and SA the shape of the spectra changed, 
showing significant differences respect to LDPE surface and displaying typical peaks of the amide bond, 
indeed confirming the presence of a covalent bond between ZA and SA active scaffold and LDPE 
surface. The auto-fluorescence of ZA and SA immobilized scaffold was also used to verify the surface 
functionalization by Confocal Scanning Laser Microscopy (CLSM). LDPE pictures acquired in each step 
of the functionalization procedure revealed the presence of an intense fluorescent signal after the last 
functionalization process, only attributable to the presence of ZA and SA active scaffold on the LDPE 
surface. The analysis repeated on 10-fold used coupons showed a maintained intense fluorescent 
signal, suggesting that ZA and SA were successfully retained by the surface and that the surface 
coupons were not affected by their usage. Further accurate analysis, such as X-ray Photoelectron 
Spectroscopy (XPS) measurements to determine the elemental composition of the surface and 
Scanning Electron Microscopy (SEM) analysis to provide an image of the physical modifications of the 
material were also performed confirming the success of the functionalization procedure (data not 
shown). 
The anti-biofilm performance of the modified materials were tested by using a standardized in vitro 
system aimed at replicating hydrodynamic flow conditions normally encountered in vivo. The Center 
for Disease Control (CDC) biofilm reactor was used to produce E. coli biofilm under continuous liquid 
shear to simulate conditions to which surfaces of a wide range of applications are subjected during 
their use.  
Biofilm biomass grown on functionalized and non-functionalized materials were collected and 
quantified by viable plate count assay. Epifluorescence microscopic techniques were additionally used 
to provide image analysis and quantiﬁcation of bacterial cells in situ. Accordingly, all the experiments 
revealed a significant decrease in biofilm biomass and viable cells between the control sample (LDPE) 
and the functionalized material (LDPE-ZA and LDPE-SA). On the contrary, no significant differences 
were detected in biofilm biomass and cells viability between the LDPE control sample and the LDPE-
OH and LDPE-COOH control linker sample. This result suggested that no functionalization step 
introduce modification in LDPE structure that affect biofilm biomass and cell viability. Consequently, 
the anti-biofilm performance of the functionalized materials is totally attributable to the ZA and SA 
active moieties covalently immobilized on the surface. Direct images of biofilms stained for live and 
dead cells revealed that both functionalized and non-functionalized surface resulted in a few dead cells 
within the bioﬁlm with no significant differences between the different surfaces. This result confirmed 
that ZA and SA functionalized surface reduced biofilm biomass with a mechanism that not affect 
bacterial viability, creating the prerequisite to reduce the risk of developing resistant microbial strains. 
In the past, Villa and collaborators (2010) reported that 500 mg/mL ZA was able to reduce cells 
adhesion up to 70 % while El-Banna and colleagues (2012) reported that SA at a concentration between 
10 and 100 µg/mL inhibited E. coli biofilm production up to 68 %. In this research it was proved that 
ZA and SA functionalized surfaces reduced biofilm formation of 62 % and 60 % respectively, proving 
the ability of ZA and SA to exert the anti-biofilm activity even immobilized on the surface, with a 
performance comparable to that they exert free in solution.  
Confocal Laser Scanner Microscope Analysis revealed a dramatic impact of immobilized ZA and SA on 
biofilm morphology. ThreeD-reconstructed images analysis showed a complex biofilm on LDPE, LDPE-
OH, LDPE-COOH control surfaces, with an intense fluorescence signal corresponding to multi-layers of 
cells organized in macro-colonies inside a well-structured polysaccharide matrix. On the contrary, 
biofilm grown on ZA and SA functionalized surfaces showed a significant decrease in thickness with a 
mono-layer of dispersed cells and significant lower bio-volume of polysaccharide matrix. Indeed the 
new materials provided new anti-biofilm solutions, not only able to affect biofilm biomass and cells 
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adhesion, but also able to deeply affect biofilm structure with massive changes especially in the biofilm 
thickness and matrix amount.  
It is well known that the susceptibility of E. coli biofilm to many conventional antimicrobial agents is 
reduced, compared to the susceptibility of planktonic cells (Hall-Stoodley, 2004). Indeed, the sensitivity 
of a biofilm grown on functionalized surfaces to conventional antimicrobial agents was examined, to 
prove the ability of these new materials to improve the antimicrobial efficacy. In this study ampicillin, 
an antibiotic with a wide range spectrum of activity, and ethanol, widely used to disinfect surfaces, 
were selected to be tested for their performance against an E. coli biofilm pre-formed on both control 
and ZA and SA functionalized surfaces. In particular, ethanol was chosen since it might be a promising 
solution because of its antimicrobial activity against a broad range of planktonic bacteria and fungi, its 
low cost and its universal availability. In addition, there are no evidences of acquired resistance to 
concentrated ethanol despite its extensive and long standing use as an antiseptic (Balestrino et al., 
2009). Both ampicillin and ethanol significantly reduced the number of viable adhered cells on 
functionalized materials respect to the corresponding sample treated with PBS and the antimicrobial 
efficacy value of both ampicillin and ethanol resulted significantly improved on LDPE-ZA and LDPE-SA 
functionalized biofilm, confirming the enhanced susceptibility of biofilm grown on ZA and SA 
functionalized material to the antimicrobial agents. The combination of the functionalized surface with 
both ethanol and ampicillin reduced viable biomass up to 92% with the antibiotic treatment and up to 
the 83 % with the biocide treatment. The direct time-lapse confocal microscope analysis of the 20% 
ethanol effect on a pre-formed biofilm grown on both control LDPE and LDPE-ZA and LDPE-SA 
functionalized surfaces also corroborated this result. The decrease in the green syto 9 dye fluorescence 
related to live cells was more rapid in the biofilm grown on ZA and SA functionalized material respect 
to biofilm grown on the control surface suggesting a faster penetration of ethanol in the biofilm grown 
on the functionalized surfaces.  
Ethanol penetration was described with a mathematical model that predicted an initial exponential 
trend followed by a logistic trend. Ethanol is known to eliminate bacterial cells by denaturing proteins 
and causing membrane leakage in a procedure that starts with the loss of respiratory activity 
(Balestrino et al., 2009). We suggest that in the exponential first step of fluorescent decreased bacterial 
cell respiratory activity start to decrease and cells respond to the adverse condition by the activation 
of protecting systems. However, the further treatment with ethanol led the cell to an extreme stress 
condition that resulted in its death with the quickly loss of fluorescence (logistic trend).  
It is reported that the restricted susceptibility of biofilms to antimicrobials depends on some 
characteristic that allow them to counteract environmental stress. The presence of a diffusion barrier 
provided by the EPS is recognized to be an important factor with the potential to reduce the 
antimicrobial penetration within the biofilm, either by physically slowing their diffusion or chemically 
reacting with them (Pace et al., 2006). CLSM analysis revealed that biofilm grown of ZA and SA 
functionalized surfaces is deeply damaged with a very low or no amount of polysaccharide matrix. 
Indeed it is reasonable that biofilm grown on ZA and SA functionalized material appears to be more 
susceptible to both antibiotic and biocide treatment that more easily penetrate within the biofilm 
exerting their effect even at a concentration below those normally used in the traditional applications. 
The experiments did not give evidence if the treatment caused the killing or the removal of the biomass 
from the biofilm. The plate count assay of cells in the bulk liquid after both antibiotic and ethanol 
treatment performed in the previous experiments, suggested the presence of some still alive cells. 
However, more experiments are required to clarify this hypothesis. 
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Conclusion 
 
 
 
In this research ZA and SA were successfully immobilized on a LDPE surface in a procedure that allowed 
their active moiety to exert the anti-biofilm activity even immobilized on a surface providing a new, 
improved solution able to reduce the incidence of biofilm formation. In this approach, no molecules 
are leached from the surface, sidestepping the problem of the compound release kinetics, providing 
long term protection against bacterial colonization, and reducing the risk of developing resistant 
microbial strains, as the concentration of the anti-biofilm agent is constantly below the lethal 
concentration. The biological assays demonstrated a dramatic impact of immobilized ZA and SA on 
biofilm formation, proving the efficacy of these materials. Moreover, biofilm grown on ZA and SA 
functionalized surfaces showed enhanced susceptibility to the traditional antimicrobial agents, even 
at concentrations below those normally used in the currently application. This study also posed the 
basis for the exciting possibility to extend the functionalization procedure to other types of polymeric 
materials creating new anti-biofilm bio-hybrid materials available for a wide range of application.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 5 
 
87 
 
References 
 
Balestrino D., Souweine B., Charbonnel N., Lautrette A., Aumeran C., Traor´e O.,  Forestier C. (2009). Eradication 
of microorganisms embedded in biofilm by an ethanol-based catheter lock solution. Nephrology Dialysis  
Transplantation, 10:3204-3209.  
Barrios C.A., Xu Q., Cutright T., Newby B.Z. (2005). Incorporating zosteric acid into silicone coatings to achieve its 
slow release while reducing fresh water bacterial attachment. Colloids and Surface B: Biointerface, 41:83-
93. 
Bryers J.D., Jarvis R.A., Lebo J., Prudencio A., Kyriakides T.R., Uhrich K. (2006). Biodegradation of poly(anhydride-
esters) into non-steroidal anti-inﬂammatory drugs and their effect on Pseudomonas aeruginosa bioﬁlms in 
vitro and on the foreign-body response in vivo. Biomaterials, 27:5039-48. 
Coenye T., De Prijck K., Nailis K., Nelis H.J. (2011). Prevention of Candida albicans biofilm formation. The Open 
Mycology Journal, 5:9-20. 
El-Banna T., Sonbol F.I., Abd El-Aziz A.A., Abo-Kamar A., Seif-Eldin D.W. (2012). Effect of the combination of 
salicylate with aminoglycosides on bacterial adhesion to urinary catheters. International Research Journal 
of Pharmaceuticals, 2:39-45. 
Geiger T., Delavy P., Hany R., Schleuniger J., Zinn M. (2004). Encapsulated zosteric acid embedded in poly[3-
hydroxyalkanoate] coatings—Protection against biofouling. Polymer Bulletin, 52:65-72. 
Guinta R.A., Carbone L.A., Rosenberg E.L., Uhrich E.K., Tabak M., Chikindas L.M. (2011). Slow release of salicylic 
acid from degrading poly(anhydride ester) polymer disrupts bimodal pH and prevents biofilm formation in 
Salmonella typhimurium MAE52. In Bailey W.C. (ed), Biofilms: Formation, Development and Properties, 
Nova Science Publishers, New York, pp. 649-658 
Hall-Stoodley L., Costerton W.J., Stoodley P. (2004). Bacterial biofilms: from the natural environment to infectious 
diseases. Nature Review Microbiology, 2:95-108 
Jena P., Mohanty S., Mallick R., Jacob B., Sonawane A. (2012). Toxicity and antibacterial assessment  
of chitosan-coated silver nanoparticles on human pathogens and macrophage cells. International Journal 
of Nanomedicine, 7:1805-1818. 
Jiang H., Manolache S., Wong A.C.L., Denes F.S. (2004). Plasma-enhanced deposition of silver nanoparticles onto 
polymer and metal surfaces for the generation of antimicrobial characteristics. Journal of Applied Polymer 
Science, 93:1411-1422. 
Lo J., Lange D., Chew B.H. (2014). Ureteral stents and Foley catheters-associated urinary tract infections: the role 
of coatings and materials in infection prevention. Antibiotics, 3: 87-97. 
Nowatzki P.J., Koepsel R.R., Stoodley P., Min K., Harper A., Murata H., Donfack J., Hortelano E.R., Ehrlich G.D., 
Russell A.J. (2012). Salicylic acid-releasing polyurethane acrylate polymers as anti-bioﬁlm urological 
catheter coatings. Acta Biomaterialia, 8: 1869-1880. 
Pace J.L., Rupp M.E., Finch R.G. (2006). Biofilms, Infection, and Antimicrobial Therapy. Taylor & Francis Group, 
Boca Raton. 
Polo A., Foladori P., Ponti B., Bettinetti R., Gambino M., Villa F., Cappitelli F. (2014). Evaluation of zosteric acid 
for mitigating biofilm formation of Pseudomonas putida isolated from a membrane bioreactor system 
International Journal of Molecular Sciences, 15: 9497-9518. 
Rai M., Yadav  A., Gade A. (2009). Silver nanoparticles as a new generation of antimicrobials. Biotechnology 
Advances, 27:76-83. 
Rosenberg L.E., Carbone A.L., Römling U., Uhrich K.E., Chikindas M.L. (2008). Salicylic acid-based poly(anhydride 
esters) for control of bioﬁlm formation in Salmonella enterica serovar Typhimurium. Letters in Applied 
Microbiology, 46: 593-599. 
Sanchis M.R., Blanes V., Blanes M., Garcia D., Balart R. (2006). Surface modiﬁcation of low density polyethylene 
(LDPE) ﬁlm by low pressure O2 plasma treatment. European Polymer Journal, 42:1558-1568. 
Villa F., Albanese D., Giussani B., Stewartd P. S., Daffonchio D., Cappitelli F. (2010). Hindering biofilm formation 
with zosteric acid. Biofouling, 26: 739-752. 
Villa F., Pitts B., Stewart P.S., Giussani B., Roncoroni S., Albanese D., Giordano C., Tunesi M., Cappitelli F. (2011). 
Efficacy of zosteric acid sodium salt on the yeast biofilm model Candida albicans. Microbial Ecology, 62: 
584-598. 
Von Eiff C., Kohnen W., Becker K., Jansen B. (2005). Modern strategies in the prevention of implant-associated 
infections. The International Journal of Artificial Organs, 28:1146-1156. 
 88 
 
 
 
 
 
Chapter 6 
 
89 
 
Conclusion 
 
 
 
 
The increase impact of biofilms on human society and their recalcitrant resistance to the antimicrobial 
agent has put a tremendous pressure on the scientific community to find alternative approaches for 
the treatment of surface associate biofilms. In this study, the idea to combine commonly used 
materials with small natural molecules that do not act as antibiotics but elicit biofilm formation was 
developed. Zosteric acid (ZA) and salicylic acid (SA) were previously reported as alternative biocide-
free agents able to significantly reduce, at sub-lethal concentrations, both bacterial and fungal 
adhesion and to play a role in shaping biofilm architecture, in reducing biofilm biomass and thickness 
and in extending the antimicrobial agents performance.  
In this research a new improved anti-biofilm solution based on ZA and SA surface immobilization 
process was presented. This strategy provided a new class of bio-hybrid active materials with a novel 
target and mode of action.  
The functionalization process was carried with a procedure that did not compromise the molecule 
active site conformation and function. A detailed study to identify the ZA and SA chemical structure 
and molecular target involved in their anti-biofilm activity was performed. The study highlighted that 
the carboxylic acid moiety conjugated to the double bond in trans configuration is an essential 
requirement in ZA chemical structure to guarantee a good anti-biofilm performance, while the deletion 
of the sulphate ester group seems not to compromise the ZA anti-biofilm activity. Moreover, the para 
position on ZA and SA phenyl ring could be considered a good point for the coupling to a polymer. 
Proteomic study also revealed that ZA and SA directly interact with the same protein WrbA, suggesting 
its possible role in the biofilm formation process. However, any consideration about the mechanism 
triggered by the interaction of ZA and SA with this protein is possible and further experiments are 
necessary to clarify this question. 
Based on this information, ZA and SA were successfully covalently bound to a low density 
polyethylene (LDPE) surface, overcoming the challenge to preserve the ZA and SA biological function 
upon the conjugation process and over a working timescale. A specific protocol to expose ZA and SA 
active scaffold on the external surface of the polymeric material via an amide bond was set up. This 
allowed the anti-biofilm compound active moieties to directly interact with bacterial cells and 
successfully exerting their function. The developed protocol resulted in new materials in which the 
problem of the molecule release was sidestepped. In addition an effective local concentration of anti-
biofilm agent was maintained over an extended period of time. Moreover, this preventive biocide-free 
strategy offers a solution to mitigate bacterial selection pressure with the potential to restore the 
efficacy of antimicrobial agents that are ineffective against sessile microorganisms. Biological assays 
revealed a dramatic impact of these materials on biofilm formation. Biofilm grown on functionalized 
material appeared deeply altered in both the number of adhered cells and morphology. In addition, 
biofilm grown on functionalized material presented enhanced susceptibility to the traditional 
antimicrobial agents.  
As ZA and SA low toxicity was widely proved, the delivery methods set up in this research could become 
a robust technological platform which could be adaptable to many applications such as engineering 
system surfaces and work benches but also to other materials such as for medicine and food packaging. 
The major industries and/or public organizations might pick up these successful developments and 
integrate them with their existing strategies. Indeed it appeared clear that this new technology could 
be the breakthrough in the fight against biofilm development. 
The understanding of ZA and SA mode of action represents a relevant achievement toward future 
researches aims to develope improved and more efficacy anti-biofilm technology. In the last years, 
combinatorial chemistry has evolved important and sophisticated design strategies able to manipulate 
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molecules proving new compounds with enhanced activity. In this research a platform of biologically 
active chemical structures with anti-biofilm activity and their cellular targets were identified. In the 
future the combination of this knowledge with the potentiality of the combinatorial chemistry could 
provide new effective anti-biofilm strategies in terms of efﬁcacy and selectivity for the target. ZA and 
SA active structures could be used as structural scaffolds or simply as building block to provide 
analogues or designed hybrid molecules with an increased chance to exert a potent biological activity. 
On the other hand the ZA and SA cellular targets could be used to predict the anti-biofilm potentiality 
of new molecules avoiding the in vivo screening of the compounds that appears ineffective since the 
early stage of the research. 
In conclusion this research allowed to create a new antibiotic free, eco-friendly, cost effective, anti-
biofilm technology based on natural molecule immobilization process that is available for a wide range 
of application, also posing the basis for the development of further improved anti-biofilm solutions. 
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